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Summary 
Electrogenic NADH:quinone oxidoreductases are large, membrane-embedded enzyme 
complexes found in the respiratory chain of prokaryotes and the mitochondria of eukaryotes. 
They represent the first module of the oxidative phosphorylation system which converts the 
energy from nutrients into an electrochemical gradient by coupling redox reactions to the 
translocation of cations across membranes. A long chain of events, such as the synthesis of 
ATP, ion homeostasis, reactive oxygen species production and bacterial motility depend on 
the activity of these complexes. 
Complex I consists of up to 45 subunits and can be found in the inner mitochondrial 
membrane of eukaryotes and in prokaryotes, where it is called NDH I. We investigated the 
isolated, hydrophobic ND5 subunit, which shows homologies to cation/proton antiporters, 
from human or Yarrowia lipolytica complex I. In vivo and biochemical analyses provided data 
on the cation translocation function and the alteration of function by disease-associated 
mutations. Taken together with the recently published 3D structure of bacterial complex I, 
these data allowed us to demonstrate that the ND5 subunit could possibly act as an 
antiporter module of mitochondrial complex I. 
Sodium ion translocating NADH:quinone oxidoreductase (Na+-NQR) is an enzyme found in 
many pathogenic bacteria. It consists of six subunits (NqrA - NqrF) whose 3D structures and 
enzymatic mechanisms were not known in detail at the time this project was initiated. By 
using high-resolution X-ray structures and site-directed mutagenesis, combined with 
biochemical studies, we proposed a model for catalysis and substrate selectivity on the 
atomic level of the electron input module of the complex, the NADH oxidizing domain of 
subunit NqrF. Furthermore, we analyzed the binding of silver ions to a cysteine residue in 
the NADH binding pocket and found that it leads to the inhibition of the Na+-NQR and to the 
killing of Vibrio cholerae in the nanomolar range. Subunit NqrA forms part of the quinone 
reductase module. By the use of physicochemical and biochemical methods we identified 
the herbicide 2,5-dibromo-3-methyl-6-isopropyl-p-benzoquinone (DBMIB) as a quinone 
antagonist and inhibitor of the Na+-NQR complex and discovered two adjacent quinone 
binding sites on NqrA. 
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Zusammenfassung 
Elektrogene NADH:Chinon Oxidoreduktasen sind grosse, in die Membran eingebettete 
Enzym-Komplexe der Atmungskette von Prokaryoten und Eukaryoten. Sie repräsentieren das 
erste Modul der oxidativen Phosphorylierung, welche die Energie aus Nährstoffen in einen 
elektrochemischen Gradienten wandelt, indem Redox-Reaktionen an den Transport von 
Kationen über eine Membran gekoppelt werden. Eine lange Kette an Abläufen in der Zelle 
hängt von der Aktivität dieser Komplexe ab, so z.B. die Synthese von ATP, Ionen-Homöostase, 
Produktion von reaktiven Sauerstoffspezies und Motilität von Bakterien. 
Komplex I besteht aus bis zu 45 Untereinheiten und findet sich in der inneren 
Mitochondrienmembran von Eukaryoten und in Prokaryoten, wo er als NDH I bekannt ist. 
Wir haben die isolierte, hydrophobe ND5 Untereinheit des Komplex I vom Menschen und 
der Hefe Yarrowia lipolytica untersucht, welche Homologien aufweist zu Kationen/Protonen 
Antiportern. In vivo und biochemische Analysen ermöglichten die funktionelle Untersuchung 
der Kationen-Translokation und der Veränderung der Funktion durch Krankheits-assoziierte 
Mutationen. Zusammen mit der kürzlich publizierten 3D Struktur des bakteriellen Komplex I 
haben es uns diese Daten erlaubt zu zeigen, dass die ND5 Untereinheit als Antiporter im 
mitochondriellen Komplex I fungieren könnte. 
Die Na+-translozierende NADH:Chinon Oxidoreduktase (Na+-NQR) wird häufig in pathogenen 
Bakterien vorgefunden. Sie besteht aus sechs Untereinheiten (NqrA - NqrF), deren 3D 
Struktur und Funktion zu Beginn dieses Projekts nicht im Detail bekannt waren. Durch 
hochauflösende Röntgen-Kristallstrukturen und ortsgerichtete Mutagenese sowie mittels 
biochemischen Methoden ist es uns gelungen, auf der atomaren Ebene ein Modell für die 
Katalyse und die Substratselektivität des Elektroneninput-Moduls, der NADH oxidierenden 
Domäne der Untereinheit NqrF, zu generieren. Wir haben weiterhin die Bindung von 
Silberionen an ein Cystein der NADH-Bindetasche analysiert und festgestellt, dass 
nanomolare Konzentrationen von Ag+ durch diese Bindung zur Hemmung der Na+-NQR und 
zum Abtöten von Vibrio cholerae führen. Die Untereinheit NqrA bildet einen Teil des Chinon- 
reduzierenden Moduls. Durch physikochemische und biochemische Untersuchungen 
konnten wir das Pflanzenschutzmittel 2,5-dibromo-3-methyl-6-isopropyl-p-benzoquinon 
(DBMIB) als Antagonisten zu Chinon und Inhibitor der Na+-NQR identifizieren, sowie zwei 
nebeneinanderliegende Chinon-Bindestellen auf NqrA charakterisieren. 
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1.1. The electron transport chain: the electrochemical capacitor of nature 
The advent of complex life required the evolution of a system to efficiently harness and 
store the energy of nutrients in high-energy compounds such as ATP. ATP is generated 
during fermentation, for example in yeasts or under conditions of intense muscular exertion, 
where pyruvate is converted to lactic acid. However, these processes provide only a limited 
amount of ATP. For one, they use endogenous organic molecules as electron acceptors 
which have to be regenerated, and secondly, this electron transfer releases little free energy, 
e.g. glycolysis yielding 2 molecules of ATP per molecule of glucose (Voet and Voet 2004). The 
employment of an electron transport chain to deliver electrons to an exogenous acceptor 
with a highly positive redox potential - such as molecular oxygen, O2 - is called oxidative 
phosphorylation (OXPHOS) and drastically increases the energetic yield to up to 36 
molecules of ATP per molecule of glucose (Nicholls and Ferguson 1992). In the mitochondrial 
respiratory chain, OXPHOS is accomplished by a series of redox enzyme complexes located 
within the mitochondrial inner membrane. The electrons enter at either the 
NADH:ubiquinone oxidoreductase (complex I) or the succinate dehydrogenase (complex II) 
and are transferred by the help of quinones to ubiquinone:cytochrome c oxidoreductase 
(cytochrome-bc1 or complex III), then to cytochrome c, on to cytochrome c oxidase (complex 
IV), and finally to O2, generating H2O (Alberts, Johnson et al. 2008). The electrons hereby 
follow a slope from negative to positive redox potential, formed by the various electron-
accepting cofactors. Table 1 lists a selection of respiratory chain components and their 
midpoint redox potentials. The midpoint potential Em7.2 represents the voltage that needs to 
be applied at pH 7.2 to bring half of the molecules into the oxidized state. Chemical species 
with a tendency to donate electrons have a negative Em and species that readily take up 
electrons have a positive Em. The energy released by a redox reaction between two species 
with different Em is described by the Gibbs function: 
   
         
where n is the number of electrons transferred and F is the Faraday constant. 
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Table 1: Midpoint redox potentials of components of the mitochondrial respiratory chain. 
Respiratory chain fragment Component n Em7.2 [V] 
Complex I NAD+/NADH  2 - 0.315 a 
 FMN 1 - 0.300 a 
 (Fe-S) N-1a 1 - 0.380 ± 0.010 
 (Fe-S) N-1b 1 - 0.250 ± 0.010 
 (Fe-S) N-2 1 - 0.030 ± 0.015 
 (Fe-S) N-3,4 * 1 - 0.245 ± 0.010 
 (Fe-S) N-5,6 * 1 - 0.270 ± 0.010 
Succinate dehydrogenase (complex II) FAD/FADH2 2 - 0.040 ± 0.020 
 fumarate/succinate 2   0.030 a 
 (Fe-S) S-1 1   0.030 ± 0.010 
 (Fe-S) S-2 b 1 - 0.245 ± 0.015 
 (Fe-S) S-3  1   0.060 ± 0.015 c 
Cytochrome-bc1 (complex III) ubiquinone-10 2   0.045 
 Rieske Fe-S 1   0.280 ± 0.015 
 cytochrome c1 heme 1   0.215 ± 0.010 
Cytochrome c cytochrome c 1   0.235 ± 0.005 
Cytochrome c oxidase (complex IV) cytochrome a heme 1   0.210 ± 0.010 
 copper A 1   0.245 ± 0.015 
 cytochrome a3 heme 1   0.385 ± 0.010 
Molecular oxygen O2/2 H2O 4   0.820 
a 
Adapted from (Wilson, Erecinska et al. 1974), Em values of protein-bound components are 
derived from de-energized mitochondria. 
*: combined values 
a: Em7.0, from (Nicholls and Ferguson 1992). 
b: remains oxidized, function unknown (Ohnishi and Salerno 1976) 
c: Em7.4, from (Ohnishi, Lim et al. 1976) 
 
 
First observed by Peter Mitchell (Mitchell 1961; Mitchell and Moyle 1967), the energy that is 
released as the electrons travel along complexes I, III, and IV is coupled to the pumping of 
protons out of the mitochondrial matrix across the inner membrane, resulting in an 
electrochemical gradient ΔμH+. ΔμH+ amounts to approximately 180 - 220 mV and consists of 
two components: the membrane potential Δψ, accounting for 150 - 180 mV and of ΔpH, 
contributing the remaining 30 - 70 mV (Mitchell and Moyle 1969; Nicholls 1974). 
This gradient is the biological equivalent of a capacitor (Wallace 2008), an electric 
component used to store energy through the separation of charges.  
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The capacitance of a plate capacitor - the amount of energy it can store - is described as: 
           
 
 
 
where ε0 is the electric constant, εr the permittivity of the capacitors dielectric, A the 
electrode area and d the distance between electrodes. 
 
The capacitance density of the inner mitochondrial membrane was determined to be in the 
range of 1.1 - 1.3 µF cm-² (Pauly and Packer 1960), which is a value comparable to 
conventional electrolytic capacitors (Yoshida, Imoto et al. 1992). This is an amazing number 
considering that this membrane does not act solely as a dielectric - a non-conducting layer 
separating charges - but simultaneously accommodates charge conducting elements such as 
ion channels and transporters. Combined with the high surface-to-volume ratio of the inner 
mitochondrion's cristae, the mitochondrial respiratory chain constantly provides enough 
potential energy to drive a multitude of cellular processes. F1Fo type ATP synthase (complex 
V) for example directly converts the electrochemical gradient into the high-energy γ-
phosphate bond of ATP, which is a chemical currency used when- and wherever work has to 
be done in a cell. In addition, the energy is used for the regulation of intracellular ion 
homeostasis, reactive oxygen species production and initiation of controlled cell death - 
apoptosis - in eukaryotic cells (Kumar, Abbas et al. 2004). It can also be simply dissipated as 
heat by the action of uncoupling proteins (Nedergaard, Ricquier et al. 2005). 
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1.2. NADH:quinone oxidoreductases 
There are three known types of respiratory NADH:quinone oxidoreductases (Yagi 1991; 
Friedrich and Scheide 2000; Kerscher 2000; Yagi, Seo et al. 2001; Bogachev and Verkhovsky 
2005; Zickermann, Kerscher et al. 2009): the proton- or sodium ion-translocating complex I 
(NDH I in bacteria) (Friedrich 1998), the non-electrogenic NADH:quinone oxidoreductases 
(NDH II) (Kerscher, Okun et al. 1999) and the sodium ion-translocating NADH:quinone 
oxidoreductases (Na+-NQR) (Barquera, Hellwig et al. 2002). These enzymes couple the 
oxidation of NADH, a reducing agent found in all living cells which is kept in its reduced state 
with the electrons that large organic nutrient molecules release during catabolism, to the 
reduction of ubiquinone (Q). The net reaction thus yields ubiquinol (QH2), the reducing 
substrate of enzyme complexes further along the respiratory chain, and NAD+, which is used 
as oxidizing agent in numerous cellular processes. NADH:quinone oxidoreductases of the 
NDH II type limit themselves to this reaction and do not participate in the generation of a 
transmembrane voltage, i.e. are non-electrogenic. Complex I and Na+-NQR in contrast tap 
into the exergonic energy released by the redox reaction by using it to pump H+ or Na+ from 
the mitochondrial matrix or the cytosol to the perimitochondrial space or the periplasm 
respectively. The accumulation of positively charged ions on the outside of the membrane 
leads to an electrical and chemical imbalance, summarized as ΔμH+ (proton motive force, 
PMF) or ΔμNa+ (sodium motive force, SMF). 
Prokaryotes may contain all three types of NADH:quinone oxidoreductases but the 
expression of each is usually tightly regulated. The chromosome of Escherichia coli for 
example features genes for both NDH I and NDH II. Under aerobic conditions, the expression 
of NDH II is upregulated and more than 80 % of the electron flux is directed from NADH to Q 
by NDH II (Bongaerts, Zoske et al. 1995; Wackwitz, Bongaerts et al. 1999; Unden, Achenbach 
et al. 2002). During anaerobic fumarate respiration or at the onset of exponential growth, 
where high amounts of ATP are required, NDH I represents the dominant dehydrogenase, 
shuttling electrons from NADH to menaquinone, which serves as a substrate for the DMSO 
or fumarate reductases (Tran, Bongaerts et al. 1997) and translocating protons or sodium 
ions, driving H+- or Na+-ATP synthases. Many archaea and gram-positive bacteria only 
contain NDH II. Chlamydia pneumoniae only expresses the Na+-NQR. Bacteria of the genus 
Vibrio contain NDH II and Na+-NQR and a few bacteria such as Klebsiella pneumoniae and 
Chapter 1 - General introduction Powerful Proteins 
 
 
8 
 
Yersinia pestis harbor all three types of enzymes (Bertsova and Bogachev 2004; Melo, 
Bandeiras et al. 2004). 
In eukaryotic organisms, only enzymes of the NDH I and NDH II type have been found so far. 
The yeast Yarrowia lipolytica contains, in addition to mitochondrial complex I, a type two 
dehydrogenase, which is oriented towards the external lumen (perimitochondrial space). 
Mitochondria of plants and of the yeast S. cerevisiae exhibit expression of different subtypes 
of the NDH II. In the latter, NDH II is even the sole NADH:quinone oxidoreductase type 
(Kerscher 2000); its well-known preference of the fermentative lifestyle may explain why it 
lost the NDH I operon over the course of evolution. Mitochondria of mammals and higher 
eukaryotes almost exclusively contain an extended form of NDH I, the respiratory complex I. 
Table 2 summarizes and compares the characteristics of the three types of NADH:quinone 
oxidoreductases, taken from (Yagi 1987; Friedrich, Heek et al. 1994; Pfenninger-Li and 
Dimroth 1995; Yagi, Yano et al. 1998; Nakayama 1999; Ushakova, Grivennikova et al. 1999; 
Kerscher 2000; Steuber 2001; Steuber 2001; Yagi, Seo et al. 2001; Gemperli, Dimroth et al. 
2002; Nakamaru-Ogiso, Seo et al. 2003; Melo, Bandeiras et al. 2004; Eschemann, Galkin et al. 
2005; Brandt 2006; Casutt, Huber et al. 2010). 
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Table 2: The three different types of NADH:quinone oxidoreductases. 
 NDH I (complex I) NDH II Na+-NQR 
Subunits 13 - 15, 40*, (45) 1 6 
Molecular mass [kDa] 530, 947*, (980) 42 - 64 220 
Cofactors  
1 noncovalent FMN, 2 
[2Fe-2S], 
6 - 8 [4Fe-4S] clusters 
1 noncovalent FAD or 
FMN 
1 noncovalent FAD, 2 
covalent FMN, 1 
noncovalent 
riboflavin, 1 [2Fe-2S] 
cluster 
Substrates 
NADH, dNADH, 
ferricyanide, 
hexammine-
ruthenium, 
menaquinone, Q1, Q6, 
Q8, Q9*, (Q10) 
NADH, Q1, Q2, Q6, n-
decyl-ubiquinone and 
other quinones 
NADH, dNADH, 
ferricyanide, Q1, Q2, Q8 
Coupling ion H+ or Na+ Not a pump Na+ 
Inhibitors 
Rotenone, 
rolliniastatin-1, 
annonin VI, pyridaben, 
fenpyroximate, 
piericidin A, Triton x-
100, EIPA, DCCD, 
capsaicin 
1-hydroxy-2-dodecyl- 
4(1H)-quinolone, 
platanetin 
 
Ag+, korormicin, 
HQNO, DBMIB1 
 
* in eukaryotes only. Properties particular to mammalian complex I are in parentheses 
1 this study; see chapter 3.3.3. 
 
 
1.2.1. Complex I (NDH I) 
Electron microscopy revealed that complex I is L-shaped and consists of a hydrophilic 
peripheral domain which reaches into the mitochondrial matrix (or bacterial cytosol) and a 
membrane domain comprising numerous membrane-spanning segments (Leonard, Haiker et 
al. 1987; Hofhaus, Weiss et al. 1991; Guenebaut, Vincentelli et al. 1997; Grigorieff 1998; 
Guenebaut, Schlitt et al. 1998; Dudkina, Eubel et al. 2005; Radermacher, Ruiz et al. 2006; 
Clason, Ruiz et al.). Complex I from E. coli seems to exhibit an additional horseshoe 
conformation, where the peripheral arm folds onto the membrane domain. This 
conformation is proposed to be the active form of complex I (Böttcher, Scheide et al. 2002) 
but could so far not be reproduced in crystallographic studies (Efremov, Baradaran et al. 
2010; Hunte, Zickermann et al. 2010). In 2006, the X-ray crystallographic structure of the 
peripheral arm of Thermus thermophilus complex I was determined (Sazanov and Hinchliffe 
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2006). This elucidated the spatial arrangement of the redox cofactors and established a 
model of the electron transfer chain (figure 1). In 2010, the 3D structure of the complete 
complex from Thermus thermophilus was solved (Efremov, Baradaran et al. 2010). 
 
 
Figure 1: The structure of complex I from Thermus thermophilus. Adapted from (Sazanov 
and Hinchliffe 2006; Efremov, Baradaran et al. 2010) and edited. A: Side views from the 
membrane plane and top view from the cytoplasm into the membrane. The proposed NADH 
and quinone binding sites are indicated. Names of the analogous mitochondrial subunits are 
in parentheses. Fe-S clusters are shown as red and yellow spheres, and flavin 
mononucleotide (FMN) as magenta spheres. B: Arrangement of redox centers in the 
hydrophilic domain. The overall orientation is similar to that in A, right-hand side. Cluster 
N1a is in subunit Nqo2; N3 and FMN in Nqo1; N1b, N4, N5, and N7 in Nqo3; N6a/b in Nqo9; 
and N2 in Nqo6. The main pathway of electron transfer is indicated by blue arrows, and a 
diversion to cluster N1a by a green arrow. The distances between the centers given in 
angstroms were calculated both center-to-center and edge-to-edge (shown in parentheses). 
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The bacterial enzyme comprises 13 - 15 subunits encoded by the nuoA - N genes (or nqo1 - 
15, the nomenclature differs, depending on the organism) and has a mass of about 530 kDa. 
The enzymes of certain Enterobacteria such as Escherichia coli, Yersinia pestis, 
Aquifex aeolicus, Pseudomonas aeruginosa, Salmonella typhi, Buchnera species and 
Klebsiella pneumoniae only contain 13 subunits, due to fusion of the NuoC and NuoD genes 
(Friedrich 1998). Thermus thermophilus contains, in addition to the 14 core subunits 
encoded by the nqo operon, Nqo15, a frataxin-like subunit (Sazanov and Hinchliffe 2006). 
The eukaryotic enzyme comprises at least 40 subunits and has a mass in the range of 1 MDa. 
Bovine complex I is made of 45 (Carroll, Fearnley et al. 2006), complex I from the yeast 
Yarrowia lipolytica of 40 different polypeptides (Morgner, Zickermann et al. 2008). In 
addition to the 14 core subunits conserved from prokaryotes, which catalyze the central 
redox and electrogenic functions, eukaryotes exhibit accessory subunits which do not 
participate directly in energy conservation but play an important role in complex I assembly 
and activity (Yadava, Potluri et al. 2008). The core subunits can be divided into seven 
hydrophilic and seven hydrophobic proteins (Zickermann, Kerscher et al. 2009): The latter 
are mitochondrially encoded, and in fact their genes make up the bulk of the mitochondrial 
DNA, which only contains 13 protein-coding sequences. They are the ND1 - 6 and ND4L 
subunits, corresponding to the membrane-embedded NuoA (ND3), NuoH (ND1) and NuoJ - N 
(ND6, ND4L, ND5, ND4, ND2) of the bacterial enzyme. The hydrophilic core subunits can be 
attributed to a dehydrogenase fragment consisting of FP24K (NuoE), FP51K (NuoF) and IP75K 
(NuoG) and a connecting fragment containing IP21K (NuoB), IP30K (NuoC), IP49K (NuoD) and 
IP23K (NuoI). 
As is the case with many multisubunit enzymes, complex I likely emerged from the fusion of 
preexisting modules for electron transfer and ion transport. The connecting fragment, 
together with hydrophobic subunits ND1 and ND5, is believed to have evolved from an 
ancestral enzyme which used hydrogen as an electron donor (Friedrich and Weiss 1996). 
Furthermore, subunits IP21K, IP30K and IP49K form an electron conducting module similar 
to membrane-bound [NiFe] hydrogenases (Friedrich and Scheide 2000). The dehydrogenase 
fragment is related to the flavin-containing diaphorase domain of NAD+-reducing 
hydrogenases. Subunits ND2, 4 and 5 very likely share a common ancestor (Kikuno and 
Miyata 1985) and exhibit sequence similarity to Na+/H+ antiporters (Mathiesen and 
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Hägerhäll 2002; Mathiesen and Hägerhäll 2003). So far, no ancestors of the membrane-
bound subunits ND3, ND4L and ND6 have been found. 
 
1.2.2. NDH II 
The so-called alternative or rotenone-insensitive NADH:quinone oxidoreductases, NDH II, are 
typically found in the inner mitochondrial membrane of plants and ascomycetous fungi, but 
also in many bacteria and archaea (Bandeiras, Salgueiro et al. 2002; Fang and Beattie 2002; 
Bandeiras, Salgueiro et al. 2003; Melo, Bandeiras et al. 2004). The first evidence of this non-
electrogenic type of enzymes was found in 1961, when Bonner and Voss observed that plant 
mitochondria were capable of oxidizing externally added NAD(P)H, but mammalian 
mitochondria were not (Bonner and Voss 1961). The NDH II are monomeric enzymes with 
molecular masses between 42 (Acidianus ambivalens) and 64 kDa (Neurospora crassa) and a 
non-covalently attached flavin adenine dinucleotide (FAD) as only redox cofactor. As an 
exception for this rule, NDH II dimers, or NDH II enzymes containing non-covalently bound 
flavin mononucleotide (FMN) or, in thermophilic organisms, covalently bound FMN have 
been described (Kerscher 2000; Bandeiras, Salgueiro et al. 2002; Fang and Beattie 2002; 
Bandeiras, Salgueiro et al. 2003). The 3D structure of NDH II reveals two βαβ dinucleotide 
folds with conserved GxGxxG motifs which participate in the binding of the NAD(P)H and 
flavin cofactors. If the flavin is covalently attached, the respective dinucleotide fold does not 
contain the GxGxxG motif (Wierenga, Terpstra et al. 1986). Binding to the membrane is 
suggested to occur by amphipathic helices, and in some cases transmembrane helices are 
predicted (Bandeiras, Salgueiro et al. 2002). The binding mode of the hydrophobic substrate 
ubiquinone is unknown and no binding site has been identified yet, but evidence for a two-
step, ping-pong type mechanism has been found, in which a hydride is transferred from 
NAD(P)H to the flavin, followed by two-electron transfer from the flavin to ubiquinone 
(Eschemann, Galkin et al. 2005; Yano, Li et al. 2006).  
It is likely that the NDH II shares a common ancestor with bacterial lipoamide 
dehydrogenases which exhibits considerable sequence similarity. Moreover, the two 
enzymes catalyze similar redox reactions (Bjorklof, Zickermann et al. 2000). It has been 
proposed that the first alternative NADH:ubiquinone oxidoreductases were external 
enzymes, attached to the outside of the mitochondrial membrane and shuttling electrons 
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from NADH produced in the cytoplasm into the respiratory chain (Kerscher 2000). Support 
for this hypothesis comes from the yeast Yarrowia lipolytica, which contains only a single 
external but no internal NDH II. This prototypic enzyme may have evolved into the internal 
NDH II by gene duplication and acquisition of a mitochondrial targeting sequence (Kerscher, 
Okun et al. 1999). 
 
1.2.3. Na+-NQR 
The discovery of the Na+-NQR dates back to 1981 (Tokuda and Unemoto 1981), when cells of 
Vibrio alginolyticus were found to maintain a membrane potential (ΔΨ) at alkaline pH 
through the extrusion of positive charges, despite the presence of a protonophore. Evidence 
for a NADH dehydrogenase activated by Na+ was reported even before that (Unemoto, 
Hayashi et al. 1977). 
Meanwhile numerous bacteria, many of them halophilic or halotolerant, have been found to 
exhibit similar Na+-dependent NADH:quinone oxidoreductases (Tokuda and Unemoto 1983; 
Khanna, Devoe et al. 1984; Tsuchiya and Shinoda 1985; Ken-Dror, Lanyi et al. 1986; Takada, 
Fukunaga et al. 1988; Tokuda and Kogure 1989; Semeykina and Skulachev 1990; Oh, Kogure 
et al. 1991; Unemoto, Akagawa et al. 1992; Hayashi, Nakayama et al. 1996; Kogure 1998; 
Barquera, Hellwig et al. 2002; Bogachev, Bertsova et al. 2002; Fujiwara-Nagata, Kogure et al. 
2003). Interestingly, several of these organisms such as Vibrio cholerae and 
Vibrio parahaemolyticus, Neisseria gonorrhoeae, Haemophilus influenzae, Yersinia pestis, 
Pseudomonas aeruginosa and Chlamydia trachomatis are pathogenic (Häse 2000). 
The Na+-NQR is a 220 kDa complex consisting of 6 subunits, NqrA - F, encoded by the nqr 
operon. It harbors at least five redox active cofactors: non-covalently bound FAD and [2Fe-2S] 
cluster in the NqrF subunit, two covalently bound FMNs in subunits NqrB und NqrC and one 
non-covalently bound riboflavin in subunit NqrB (Barquera, Ramirez-Silva et al. 2006; Tao, 
Casutt et al. 2008; Bogachev, Kulik et al. 2009; Casutt, Huber et al. 2010). Due to their 
homology to Na+-channeling proteins, NqrD and NqrE are thought to form the sodium-ion 
pore of the complex (Beattie, Tan et al. 1994). NqrA was shown to harbor at least one 
binding site for the terminal electron acceptor of the Na+-NQR, ubiquinone-8 (Casutt, 
Nedielkov et al. 2011). In addition, mutagenesis experiments have revealed an interaction 
between NqrB and quinones or quinone-like inhibitors (Hayashi, Shibata et al. 2002; Juárez, 
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Neehaul et al. 2012). However, the exact mechanism of the coupling between the reduction 
of the substrate, quinone, and the sodium ion translocation is still largely unclear. The 
physicochemical properties of the subunits from V. cholerae Na+-NQR are listed in table 3. All 
subunits save NqrA have at least one predicted transmembrane helix (TMH), which later 
have been experimentally mapped (Duffy and Barquera 2006). NqrD and NqrE are very 
hydrophobic and comprise 6 TMH each, NqrB has 9 TMHs. Interestingly, the grand average 
of hydropathy (GRAVY) scores (Kyte and Doolittle 1982) are negative for NqrC and NqrF, 
despite containing 2 or 1 TMHs, respectively. In contrast, NqrA has only a slightly negative 
GRAVY score but contains no TMH. This allows the interpretation that NqrA may contain 
hydrophobic patches which allow the binding to a hydrophobic surface or cofactor. NqrC and 
NqrF on the other hand use TMHs as membrane anchor, but may otherwise consist of 
globular, very hydrophilic domains. 
 
Table 3: The physicochemical properties of the subunits from V. cholerae Na+-NQR. 
Subunit NqrA NqrB NqrC NqrD NqrE NqrF 
Amino acid 
residues 
446 415 256 209 198 408 
Mw [Da] 
1 48'623.9 45'357.1 27'488.1 22'706.1 21'497.8 45'094.6 
App. Mw [kDa] 
2 52 27 32 14 13 47 
pI 6.05 7.16 6.40 8.56 6.55 4.98 
GRAVY score -0.087 0.556 -0.257 0.800 1.072 -0.141 
TMHs 0 9 2 6 6 1 
Cofactors  
FMN, 
riboflavin 
FMN   
FAD,  
[2Fe-2S] 
Adapted from (Casutt 2010) and edited. 
GRAVY: grand average of hydropathy 
1 Covalently bound FMN of NqrB and NqrC increases their molecular weight (Mw) by an 
additional 493.1 Da. 
2 Apparent molecular weight of subunits determined by their migration behavior on SDS-
PAGE 
 
 
Even though the overall reaction catalyzed by the Na+-NQR resembles that of complex I, its 
primary sequence shares almost no common motif with the H+- or Na+-translocating NDH I 
complexes, thus making a common ancestry unlikely (Beattie, Tan et al. 1994). One 
exception is the C-terminus of NqrA, which exhibits 21 amino acids that are conserved in the 
9.8 kDa protein of Neurospora crassa complex I, corresponding to the MWFE subunit of 
mammalian complex I (Marques, Duarte et al. 2003). MWFE is an accessory subunit 
Powerful Proteins  Chapter 1 - General introduction 
 
 
15 
 
important for the assembly of the holo-complex (Yagi and Matsuno-Yagi 2003). NqrB - NqrE 
have no homologs with known structure, but their genes show sequence similarity to the 
Rhodobacter nitrogen fixation genes rnfD, rnfG, rnfE, and rnfA, respectively (Müller, Imkamp 
et al. 2008). The sequences of subunits NqrD and NqrE are very similar. Furthermore, several 
transmembrane stretches of NqrB, NqrD and NqrE have counterparts in Na+-channel forming 
proteins and bear a slight resemblance to parts of the ND1, ND2, ND4 and ND5 subunits of 
complex I from different species (Beattie, Tan et al. 1994). NqrF can be divided into a C-
terminal and an N-terminal domain (Türk, Puhar et al. 2004). The C-terminal domain 
contains the NADH and FAD binding site and is related to the family of ferredoxin:NADP+ 
oxidoreductases (FNR) (Steuber 2001). This class of enzymes has been well-characterized 
and over 30 crystal structures have been solved (Karplus and Faber 2004). The N-terminal 
domain contains two iron atoms bound by two cysteine residues and is homologous to 
ferredoxins of the vertebrate type bearing a [2Fe-2S] cluster (Bogachev, Bertsova et al. 2001; 
Türk, Puhar et al. 2004). 
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1.3. Electron carriers of the NADH:quinone oxidoreductases 
1.3.1. NADH 
Nicotinamide adenine dinucleotide consists of a nicotinamide-ribose and an adenosine 
diphosphate (ADP) moiety which are linked via a phosphate bond at the ribose-C5 of the 
nicotinamide-ribose. It exists in two redox states, the oxidized nicotinamide adenine 
dinucleotide (NAD+) and the reduced nicotinamide adenine dinucleotide hydride (NADH), as 
shown in figure 2. The nicotinamide can bind the C1 of the ribose in two different ways, 
forming two diastereomers, α and β. Organisms only use the β-nicotinamide form of the 
compound, which they either synthesize de novo from tryptophan or aspartic acid or from 
niacin, known as vitamin B3 (Tarr and Arditti 1982). 
 
 
Figure 2: The two redox states of nicotinamide adenine dinucleotide. 
 
 
Many vital redox reactions in a cell use or produce NADH: Glycolysis, β-oxidation and the 
citric acid cycle serve as pathways for the breakdown of nutrients. The energy released 
thereby is stored as NADH and further metabolized in the electron transport chain under 
generation of Δψ. NADH also acts as an reducing agent and is used in anabolic reactions such 
as gluconeogenesis (Sistare and Haynes 1985). The total physiological concentration of NAD+ 
is estimated to be approximately 0.3 mM in animal cells (Yamada, Hara et al. 2006) and 1.0 
to 2.0 mM in yeast (Belenky, Bogan et al. 2007). Mitochondrial and cytosolic NAD+ 
concentrations are balanced by the action of mitochondrial shuttles such as the malate-
aspartate shuttle (Bakker, Overkamp et al. 2001). The total cellular amounts of NAD+ and of 
NADH are also comparable (Lin and Guarente 2003), but the ratio between free NAD+ and 
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NADH differs greatly (about 700:1, (Williamson, Lund et al. 1967)), due to the amount of 
protein-bound NADH.  
In addition to its role as redox cofactor, NAD+ is used as substrate for ADP-ribosylation 
(Ziegler 2000), RNA modification (Chen, Kowtoniuk et al. 2009), second messenger synthesis 
(Guse 2004) and bacterial DNA ligases (Wilkinson, Day et al. 2001). Furthermore, it has been 
proposed that NAD+ acts as extracellular signaling molecule (Ziegler and Niere 2004) and as 
neurotransmitter in smooth muscle synapses (Mutafova-Yambolieva, Hwang et al. 2007). 
NAD+ which is phosphorylated at the ribose-C2 of the adenosine-ribose moiety is known as 
nicotinamide adenine dinucleotide phosphate NADP+. Like NAD+/H, NADP+/H is used as a 
redox pair in many cellular reactions, but is distinctly preferred in biosynthetic reactions such 
as lipid synthesis and is prominently featured in photosynthetic organisms. It is important to 
note that usually, NAD+ and NADP+ converting enzymes have a high specificity for their 
respective substrate: Ferredoxin-NADP+ reductase (FNR), the terminal enzyme of the light 
reaction of photosynthesis, is highly specific for NADP+ over NAD+ (a 32'000-fold preference 
(Piubelli, Aliverti et al. 2000)), whereas the specificity of NADH:quinone oxidoreductases is 
vice-versa. 
 
1.3.2. Flavins 
Another class of nucleotide-based redox cofactors are the flavins. The name flavin is derived 
from the Latin word flavus, meaning yellow. The yellow color of flavins arises from the 
absorption of visible light in the range of 360 - 500 nm by the oxidized lumichrome moiety, 
which is a tricyclic isoalloxazine ring methylated at the C7 and C8 positions (figure 3). 
Lumichrome which has a linearized D-ribose bound to the N10 position is known as 
riboflavin, or vitamin B2. It is the most abundant flavin in nature and also serves as substrate 
for the biosynthesis of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). 
Riboflavin was first extracted from milk and natural sources are milk products, vegetables, 
egg, fish, meat and whole-grain bread. In FMN, riboflavin is phosphorylated at the 5'-
hydroxyl of the ribose moiety. In FAD, a second nucleotide, ADP, is attached by a phosphate 
bond to the riboflavin (figure 3). 
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Figure 3: The structure of flavin and flavin cofactors. From: (Casutt 2010). 
 
 
Flavins have three distinct redox states: the fully-oxidized flavoquinone, the one-electron 
reduced flavosemiquinone radical and the two-electron reduced flavohydroquinone. As the 
pH of the surrounding environment changes, each of these states could exist in a neutral, an 
anionic or a cationic form (Müller 1987). Depending on the redox and protonation state, 
flavins exhibit different optical properties: Oxidized flavoquinone appears yellow with 
characteristic maxima at 377 and 450 nm in the UV-visible spectrum. The neutral 
flavosemiquinone absorbs in the 550 - 650 nm range with a blue color. When deprotonated, 
the absorbance spectrum shifts to 370 - 490 nm, which appears red. Fully reduced 
flavohydroquinone shows a small but broad absorption maximum in the range of 350 nm 
and appears colorless (Massey and Palmer 1966). 
Flavoproteins are extremely abundant: genome searches indicate that around 4 % of all 
microbial polypeptides are associated with FMN or FAD or both cofactors. This only 
represents confirmed flavoproteins and proteins with sequence similarity to known flavin-
binding motifs. The actual number is likely to be even higher (Reid 2002). 
Most flavoenzymes contain a FMN or FAD cofactor which is tightly, but non-covalently 
bound. Still, a large number of covalently bound flavin coenzymes exist (Kearney and Kenny 
1974). Only a small subset of enzymes use riboflavin as a prosthetic group, most of which are 
involved in flavin synthesis, transport and storage (White and Merrill 1988). Examples of 
FAD-containing redox enzymes are monoamine-oxidase, ferredoxin-NADP+ reductase, 
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nitrate reductase and glucose oxidase (Zhou, Lewis et al. 1995; Deng, Aliverti et al. 1999). 
FMN flavoenzymes include flavodoxin, flavoredoxin, NADH-rubredoxin oxidoreductase, 
adenosine 5'-phosphosulfate reductase and FMN-binding protein (Kitamura, Kojima et al. 
1994; Zhou and Swenson 1995). 
 
1.3.3. Iron-sulfur clusters 
Iron-sulfur (Fe-S) clusters are inorganic redox cofactors consisting of two or more iron atoms 
bridged by sulfide ions and tetrahedrally coordinated to cysteine or histidine residues of a 
protein (Beinert 2000). The most common forms are the [2Fe-2S], [4Fe-4S] and [3Fe-4S] 
clusters. Electrons are usually transferred by one or more irons switching between the Fe2+ 
and Fe3+ oxidation states. 
Besides NADH:quinone oxidoreductases, there are many metalloproteins exhibiting iron-
sulfur clusters, such as the ferredoxins, hydrogenases and nitrogenases (Lippard and Berg 
1994). Since iron atoms have unpaired electrons, electron paramagnetic resonance (EPR) is 
known as the method of choice for the specific detection of iron-sulfur clusters and for the 
analysis of their properties. 
 
1.3.4. Quinones 
Quinones are a class of organic molecules containing a fully conjugated cyclic dione structure. 
The most abundant quinones in nature are aptly named ubiquinones, consisting of a 1,4-
benzoquinone redox-active head group and a polyprenyl side chain of variable length. As 
depicted in figure 4, the quinone head groups may contain different substituents R1, R1' and 
R2, which determine their structural and optical properties, but do not affect the redox 
behavior. Ubiquinones (Q) have methoxy groups in the R1 and R1' positions and a methyl 
group at the R2 position. Menaquinones (known as vitamin K2) have their R1 and R1' 
positions joined by an aromatic ring, forming a naphtoquinone system. In E. coli, 
biosynthesis of menaquinone or ubiquinone involves methylation at the R2 position of the 
demethylmenaquinone or demethylubiquinone by a C-methyltransferase encoded by the 
ubiE gene. Mutation of this gene led to deficiencies in bacterial growth and respiration 
(Wissenbach, Ternes et al. 1992). Other common quinones are phylloquinone (vitamin K1) 
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and plastoquinone. The former is a menoquinone variant used in posttranslational 
modification reactions. It has a tail consisting of one isoprenoid and 3 isopentyl units. 
Plastoquinone comprises a 1,4-benzoquinone with methyl groups at the R1 and R1' positions 
and no substituent at the R2 position (Crane 1959; Collins and Jones 1981; Nishida, Nishijima 
et al. 2006). It is used by the photosystem II to shuttle electrons to the cytochrome b6f 
complex and simultaneously drive proton uptake into the thylakoid lumen. Ubiquinone 
exhibits an analogous function in the Q cycle between the mitochondrial complex I and 
cytochrome-bc1 complex, where at least 1 mol ubiquinone/mol complex I is thought to act as 
an integral redox cofactor of the membrane, participating in the generation of ΔμH+ (Yano, 
Magnitsky et al. 2000). 
 
 
Figure 4: The redox states and general structure of quinones. 
 
 
Quinone reductases either catalyze two one-electron transfer steps or a single two-electron 
transfer reaction. The one-step reaction has a midpoint redox potential at pH 7 (Em,7) of 
+60 mV (determined in aqueous solution), whereas the two-step reaction involves the 
formation of a semiquinone radical anion with a potential of -160 mV and the subsequent 
reduction to the quinol (QH2) with an Em,7 of +280 mV (determined in the bc1 complex) and 
thus is the energetically favorable pathway (Nicholls and Ferguson 1992). 
Quinones can be differentiated by optical spectroscopy: Ubiquinone exhibits a characteristic 
absorption maximum at 275 nm (Fato, Estornell et al. 1996), whereas plastoquinone absorbs 
at 254 nm (Crane 1959). Theoretically, it is also possible to distinguish the semiquinone 
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anion from quinone and quinol species optically, but this is often hindered by absorption of 
other molecules in this wavelength range, such as the NADH used in kinetic studies of 
NADH:quinone oxidoreductases or the absorption of aromatic amino acid residues. The 
semiquinone radical can be detected by EPR (Land and Swallow 1970). In the study 
presented here, the formation of QH2 species by the Na
+-NQR was followed using the 
difference in absorbance between 248 and 268 nm, as described by Tokuda and Unemoto 
(Tokuda and Unemoto 1984). 
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1.4. Inhibitors 
Many of the specific NADH:quinone oxidoreductase inhibitors listed in table 2 exhibit a 
structural similarity to Q and are thought to compete with the substrate quinone or at least 
associate with the quinone binding site. They consist of a cyclic 'head' moiety with one or 
more conjugated ketone/enol groups and a long hydrophobic 'tail', facilitating interaction 
with the membrane (figure 5). Korormicin and 2-n-heptyl-4-hydroxyquinoline N-oxide 
(HQNO) are specific inhibitors of the Na+-NQR in the nanomolar range, which show non-
competitive inhibition in the presence of Q1 (Nakayama 1999). It is proposed that their tail 
groups interact with a hydrophobic pocket of NqrB (Hayashi, Shibata et al. 2002; Casutt, 
Nedielkov et al. 2011).  
 
 
Figure 5: Selected structures of NADH:quinone oxidoreductase inhibitors. Inhibitors specific 
for complex I (NDH I), alternative NADH dehydrogenase (NDH II) or Na+-NQR, as listed in 
table 2.  
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There are several known inhibitors which do not act as quinone analogs: rotenone and 
platanetin are flavonoids and are believed to interact with the flavoprotein regions of 
oxidoreductases. It is noteworthy that rotenone is a specific complex I inhibitor, whereas 
platanetin is specific for NDH II, hence why the NDH II is also called rotenone-insensitive 
NADH dehydrogenase. In addition, platanetin acts as uncoupler of the electron transport 
chain (Ravanel, Tissut et al. 1986). 5'-(N-ethyl-N-isopropyl)amiloride (EIPA) is a known 
inhibitor of cation/proton antiporters and has been shown to inhibit the Na+ translocation of 
the isolated NuoL subunit of E. coli NDH I (Gemperli, Schaffitzel et al. 2007; Pedersen, King et 
al. 2007). Silver ions (Ag+) act as specific inhibitor on NADH dehydrogenase activity of the 
Na+-NQR (Nakayama 1999), and 2,5-Dibromo-3-methyl-6-isopropyl-p-benzoquinone (DBMIB) 
is a quinone analog and herbicide known to inhibit the mitochondrial cytochrome-bc1 
complex as well as b6f complex of photosynthetic organisms (Rich, Madgwick et al. 1991). 
The mechanisms of Na+-NQR inhibition by Ag+ and DBMIB are investigated in chapters 3.3.1. 
and 3.3.3. of this thesis. 
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1.5. Scope of the study 
The aim of this work is to expand the current understanding of NADH:quinone 
oxidoreductases by investigating structural and functional properties of key catalytic 
subunits. The recently published X-ray structures of the membrane-embedded arm of 
bacterial complex I (Efremov, Baradaran et al. 2010; Efremov and Sazanov 2011) allow us to 
take a closer look at the sub-microscopic machinery that drives the generation of the 
electrochemical gradient which respiratory organisms depend on. Our experiments with the 
isolated ND5 subunit from human or Yarrowia lipolytica complex I, described in chapter 2, 
provide biochemical data on the ion translocation function and the alteration of function by 
disease-associated mutations. 
The composition of Na+-NQR is completely different from that of complex I, although both 
enzymes catalyze the same redox reaction. We strive for the elucidation of this prime 
example of diversity in nature by focusing our investigations on the hinge points that both 
complexes have in common: the oxidation of NADH and the reduction of ubiquinone. Two 
electrons from NADH are transferred to a FAD cofactor by the NqrF subunit. Using site-
directed mutagenesis and high-resolution X-ray structures combined with biochemical 
studies, it was possible to create a model for catalysis and substrate selectivity on the atomic 
level of this electron input module. In addition, Ag+ was found to irreversibly bind to a 
cysteine residue in the NADH binding pocket, which leads to inhibition of the Na+-NQR and 
killing of V. cholerae in the nanomolar range. Looking at the electron acceptor part of the 
complex, we identified DBMIB as an inhibitor of the quinone reductase module supposedly 
formed by NqrA and NqrB. By the use of physicochemical and biochemical methods, we 
learn about the mode of substrate binding and inhibition and propose a redox mechanism of 
the Na+-NQR involving at least two quinones. The investigations relevant to the Na+-NQR are 
described in chapter 3 of this thesis. 
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Chapter 2   
 
Production and functional characterization of the 
antiporter-like ND5 subunit of complex I from 
Homo sapiens and Yarrowia lipolytica 
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2.1. Introduction 
2.1.1. The structure of respiratory complex I 
Complex I is one of four energy-converting enzyme complexes of the respiratory chain in 
mitochondria, chloroplasts or bacteria. It represents the main site of entry for electrons into 
the respiratory chain and couples the transfer of two electrons from NADH to ubiquinone 
with the transport of four protons across the membrane, although the exact stoichiometry is 
still debated (Walker 1992; Yagi and Matsuno-Yagi 2003; Brandt 2006; Zickermann, Kerscher 
et al. 2009). The mitochondrial complex I consists of 45 subunits (Carroll, Fearnley et al. 
2006). The comparison with the smaller, bacterial complex I (Friedrich, Abelmann et al. 
1998; Gabaldon, Rainey et al. 2005) indicates that the core enzyme can be divided into two 
subcomplexes: seven hydrophilic subunits of the peripheral arm form the essential 
oxidoreductase module (FP51K, FP24K, IP75K, IP49K, IP30K, IP21K and IP23K), catalyzing all 
redox reactions between NADH and ubiquinone (Hirst 2005), whereas the seven ND subunits 
(ND1 - 6, ND4L), which are encoded by the mitochondrial genome (Fearnley and Walker 
1992), represent the hydrophobic, membrane-spanning arm of the enzyme and catalyze its 
electrogenic activity. 
In 2006, the X-ray crystallographic structure of the peripheral arm of Thermus thermophilus 
complex I was determined (Sazanov and Hinchliffe 2006). This structure elucidated the 
spatial arrangement of the redox cofactors, leading to a model of the electron transfer chain 
shown in figure 1. The peripheral domain contains a noncovalently bound FMN and 8 - 10 
Fe-S clusters, of which 7 are thought to participate in the electron transfer reaction (figure 
1B). In 2010, the structure of the complete complex from Thermus thermophilus was solved 
(Efremov, Baradaran et al. 2010) at a resolution of 4.5 Å, followed in 2011 by the structure of 
the membrane arm of E. coli NDH I at 3 Å (Efremov and Sazanov 2011). The knowledge of 
the complete structure gave insight into the coupling of the redox reaction to the 
electrogenic reaction: an indirect mechanism was proposed in which ubiquinone reduction 
leads to a change in the conformation of helices at the interface between the membrane 
arm and the peripheral arm. This conformational signal is relayed to the ion transporting 
modules ND2, ND4 and ND5 (and probably a fourth module at the interface between ND2, 
ND3, ND4L and ND6) by a 60 - 110 Å-long, amphipathic alpha-helix of subunit ND5, 
supposedly driving ion pumping in a manner reminiscent of a steam engine (Efremov and 
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Sazanov 2011). A similar mechanism was proposed in view of the 3D structure at 6.3 Å 
resolution of the complex I from Y. lipolytica (Hunte, Zickermann et al. 2010). Efremov and 
Sazanov propose that each ion transport module consists of two 5-helix repeats forming two 
half-channels which are connected by polar residues und thus constitute a continuous 
proton-translocation pore (Efremov and Sazanov 2011). 
 
2.1.2. Homology to cation/proton antiporters 
It has been first observed by Walker and colleagues (Fearnley and Walker 1992) that subunit 
ND5 from complex I exhibits significant sequence similarity to a subunit of multicomponent 
cation/proton antiporters belonging to the MrpA-type family of transporters. Members of 
this family are subunit MnhA of the cation/H+ antiporter from Staphylococcus aureus and 
subunit EchA of the energy-converting hydrogenase from Methanosarcina barkeri 
(Hamamoto, Hashimoto et al. 1994; Mathiesen and Hägerhäll 2002; Mathiesen and 
Hägerhäll 2003). These antiporters couple the transport of cations like sodium, potassium or 
lithium with the antiport of H+ and therefore play a role in the bacterial cation homeostasis 
(Hiramatsu, Kodama et al. 1998; Kosono, Morotomi et al. 1999; Blanco-Rivero, Leganes et al. 
2005; Swartz, Ikewada et al. 2005). The central fragment of NuoL/ND5 constitutes the most 
conserved region, exhibiting the highest sequence similarity to cation/H+ antiporters 
(Zhadanov, Grechanina et al. 2007). Experiments revealed that the ND5 homolog NuoL is 
even able to complement a Na+/H+ antiporter deficient mutant from Bacillus subtilis 
(Moparthi, Kumar et al. 2011). The combined evidence of homology to cation/proton 
antiporters strongly suggests that ND5, as well as its relatives ND2 and ND4, are likely to 
provide cation transport channels through the hydrophobic part of complex I (Gemperli, 
Schaffitzel et al. 2007). 
 
2.1.3. Mitochondrially encoded complex I subunits are hotspots for mutations 
causing muscular and neurodegenerative diseases 
The absence of suitable genetic tools for manipulation of mitochondrial DNA has made it 
difficult to study mutations in genes encoding for respiratory chain components which are 
associated with neurodegenerative diseases. In particular, a functional analysis of the ND5 
subunit of complex I is needed since it represents a hot spot for mutations (Liolitsa, Rahman 
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et al. 2003; Zhadanov, Grechanina et al. 2007). These mutations are frequently observed in 
mitochondrial and neurodegenerative diseases like Leber's hereditary optic neuropathy 
(LHON), MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-
like episodes), Leigh disease, Myoclonic epilepsy with ragged red fiber (MERRF) or 
Parkinson's disease (PD). Five of the most prevalent mutations are listed in table 4. All those 
diseases have in common that cells with a high energy demand are affected, which suggests 
a major disorder in the respiratory chain of these cells. A study aimed to elucidate the 
correlation between a dysfunction of complex I and neurodegenerative diseases. It showed 
that 1-methyl-4-phenylpyridinium and rotenone, inhibitors of complex I, cause drug-induced 
Parkinsonism in rodents (Caboni, Sherer et al. 2004). 
 
Table 4: Frequently observed mutations of human ND5 in neurodegenerative diseases and 
the corresponding amino acid exchanges introduced into ND5 from Yarrowia lipolytica. 
Human Y. lipolytica Disease Reference 
F124L F123L 
MELAS, PD, 
Leigh 
(Taylor, Morris et al. 2002; Parker and Parks 2005; 
Zhadanov, Grechanina et al. 2007) 
E145G E144G MELAS, PD (Liolitsa, Rahman et al. 2003; Parker and Parks 2005) 
A171V A170V LHON (Mayorov, Biousse et al. 2005) 
A236T  A239T  MELAS, MERFF (Naini, Lu et al. 2005) 
M237L M240L MELAS (Liolitsa, Rahman et al. 2003) 
MELAS: Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes, LHON: 
Leber's hereditary optic neuropathy, MERFF: Myoclonic Epilepsy with Ragged Red Fibers, PD: 
Parkinson's disease. 
 
 
2.1.4. Cation transport of the ND5 subunit of mitochondrial complex I 
The knowledge about complex I and its subunits was increased substantially in the last years. 
The crystallographic analysis of Y. lipolytica complex I (Hunte, Zickermann et al. 2010) and 
especially the recently published X-ray structure of the membrane bound subunits of NDH I 
from E. coli at 3.0 Å resolution (Efremov and Sazanov 2011) answers many open questions. 
However, a large number of unsolved questions remains. One of these questions is whether 
membrane bound subunits of complex I transport cations instead of, or in addition to, 
protons. Indications that the transport mechanism also includes a Na+ translocation event 
become more frequent. Thus far it could be shown that NDH I from E. coli transports Na+ in 
preference to H+ in native inverted vesicles from the Na+/H+ antiporter deficient E. coli 
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mutant EP432 (Steuber, Schmid et al. 2000). Sodium ion uptake could also be demonstrated 
with vesicles, containing a truncated version of the NDH I subunit NuoL (Steuber 2003). With 
other vesicles from S. cerevisiae cells expressing a protein A/NuoL fusion protein, Na+ and 
also K+ uptake was measurable (Gemperli, Schaffitzel et al. 2007). The ability to translocate 
sodium ions could also be shown for NDH I from other bacteria like Klebsiella pneumoniae 
(Gemperli, Dimroth et al. 2002; Gemperli, Dimroth et al. 2003; Vgenopoulou, Gemperli et al. 
2006) and Rhodothermus marinus (Batista, Fernandes et al. 2010). 
Recently, Roberts and Hirst presented evidence that the deactive form of mitochondrial 
complex I of Bos taurus (Roberts and Hirst 2012) catalyzes Na+/H+ antiport. Prior to that Lin, 
Puhar and Steuber could already show that complex I from the yeast Yarrowia lipolytica has 
the capacity to catalyze NADH-driven Na+ extrusion (Lin, Puhar et al. 2008) and that this 
function is thus not restricted to bacterial enzymes. This prompted us to investigate if the 
individual ND5 subunit of the Y. lipolytica complex also catalyzes Na+ transport. In the 
present study, five of the most frequent mutations in human ND5 were transposed to 
Y. lipolytica ND5, with the aim to study their effect on the cation transport activity of ND5 
(table 4). In addition, we hypothesized that cation transport by ND5 would interfere with 
alkali metal cation homeostasis in S. cerevisiae (Sychrova 2004). S. cerevisiae is an excellent 
model organism for the study of mitochondrial proteins (Schmidt, Hennig et al. 1983; Yaffe 
and Schatz 1984; Glick and Von Heijne 1996; Meisinger, Pfanner et al. 2006). The organism 
lacks complex I and relies on alternative NADH dehydrogenases for respiration (Foury, 
Roganti et al. 1998) which enabled us to study the function of a heterologously expressed 
ND5 subunit from human complex I.  
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2.2. Materials & Methods 
2.2.1. Chemicals and enzymes 
All chemicals were obtained from Sigma-Aldrich/Fluka, unless otherwise stated. Restriction 
enzymes and T4 DNA ligase were purchased from New England Biolabs. DNA polymerase 
and PCR buffers were obtained from Finnzymes. 
 
2.2.2. Construction of plasmids 
Escherichia coli K-12 strains DH5α or BL21 (DE3) (Hanahan 1983) (MBI Fermentas) served as 
host for the amplification of plasmids which conferred ampicillin resistance. The synthetic 
Homo sapiens ND5 gene (Eurofins Medigenomix) was cloned into plasmid pNLt1 (Gemperli, 
Schaffitzel et al. 2007) at Sal I restriction sites. The sfgfp gene encoding for an engineered 
superfolding green fluorescent protein (GFP) (Pedelacq, Cabantous et al. 2006) was 
amplified using PCR primers 5'-AAAATAGCGGCCGCACTAGTATGAGCAAAGGAG-3' (forward) 
and 5'-TCAGCCGAATTCTTGTAGAGTTCATCCATGCCATG-3' (reverse) and inserted at NotI and 
EcoRI restriction sites of pNLt1 containing the ND5 insert to generate plasmid pG5N (table 5). 
Restriction sites are underlined, bases annealing to the sfgfp gene are shown in bold. 
Plasmid pG was generated by cloning the sfgfp gene into pNLt1 using NotI and XhoI 
restriction sites. Oligonucleotide primers were synthesized by Sigma Genosys. Sequences 
coding for the mitochondrial targeting sequence of ATPase delta subunit (UniProt accession 
No. Q12165, (Giraud and Velours 1994)) and the Flag peptide (Einhauer and Jungbauer 2001) 
were joined to the Homo sapiens ND5 gene using PCR primers 5'-
TAGAGCGGCCGCACTAGTATGTTACGTTCAATTATTGGAAAGAGTGCATCAAGATCATTGAATTTCGT
CGCTAAGCGTTCATATATGACAATGCACACCACG-3' (forward) and 5'-GCAAACTCGAGTTATTTA 
TCGTCATCATCTTTATAATCGGTTATCAGTAAAAGAG-3' (reverse). Religation into template 
plasmid at restriction sites NotI and Xho I yielded plasmid pM5NF (table 5). Restriction sites 
are underlined, bases annealing to the Homo sapiens ND5 sequence are shown in bold. 
Oligonucleotide primers were synthesized by Microsynth. The sequence of the synthetic 
Homo sapiens ND5 gene was codon-optimized for E. coli and S. cerevisiae expression under 
retention of the amino acid sequence of human ND5 (ND5Hs) as deposited on Swiss-Prot 
(UniProt accession No. P03915). Single nucleotide substitutions in plasmids pM5N1F, 
Powerful Proteins   Chapter 2 - The antiporter-like ND5 subunit of complex I 
 
 
31 
 
pM5N2F, pG5N1 and pG5N2 (table 5) were introduced by the Quickchange mutagenesis kit 
(Stratagene) using primers 5'-ATAGGGTGGGTGGGAGTAGGC-3' (forward) and 5'-
TAATCGAATTGGGGCTATCGGCTTTATAC-3' (forward) and their reverse complement 
counterparts. The calculated molecular masses of the fusion proteins are 94876.6 Da 
(GFPND5Hs) and 70488.2 Da (MTS-ND5Hs-Flag) respectively. Vector pETHP for production of 
protein A fused to six histidines at its N-terminus in E. coli was generated by cloning the 
protA gene from plasmid YEp (ProtA-TEV-002c) (Schenk, Rush et al. 2001) into pET2C 
(Stratagene). 
The sequence of the Yarrowia lipolytica ND5 gene was codon-optimized for E. coli and 
S. cerevisiae expression under the retention of the amino acid sequence of 
Yarrowia lipolytica ND5 (ND5Yl) as deposited on Swiss-Prot (UniProt accession no. Q9B6D3). 
The optimized gene was synthesized (DNA 2.0) and cloned into plasmid pG5N (Steffen, 
Gemperli et al. 2010) at EcoRI and XhoI restriction sites to generate plasmid pGYl5N which 
encodes for a GFP N-terminally fused to the ND5Yl polypeptide. Using pGYL5N as template 
for site-directed mutagenesis (table 5), plasmid pGYL5N1 was created using primers 5'-
ATGGAAACGGATCCGCACCAAGTTCGCTTCTTTAGCCTGTTATCAATGCTCACCTTTTGG-3' and 5'-
ATGTGGGGGGAGGGCGTGAATG-3'; pGYL5N2, pGYL5N3, pGYL5N4 and pGYL5N5 were 
created using primer pairs 5'-CGTCTTATTTGTGGGTTGGGGGTTCATT-3' and 5'-CGCCAATGAAC 
CCCCAACCCACAAATAAGACG-3', 5'-CCGCACTGTCCGTTGTTCTGATGAATCGC-3' and 5'-CATCAG 
AACAACGGACAGTGCGGATTTCATGGC-3', 5'-GGTTAACGTTAACAATGGAAGGCCCG-3' and 5'-
GGAGTCGGGCCTTCCATTGTTAACGTTAACC-3', 5'-GTTAACGTTAGCACTGGAAGGCCCGAC-3' and 
5'-GGAGTCGGGCCTTCCAGTGCTAACGTTAACC-3' as well as flanking primers 5'-ATGGAAACGG 
ATCCGCACCAAGTTCGC-3' and 5'-ATGTGGGGGGAGGGCGTGAATG-3'. Mutated bases are 
shown in bold. BamHI and XhoI restriction sites were used for ligation into pGYL5N. 
Oligonucleotides were synthesized by Eurofins MWG Operon. PCR was performed on 
pGYl5N using primers 5'-AGAGGCGGCCGCACTAGTATGCATCATCATCACCATCACCATCACG-3' 
(forward primer, Microsynth) and 5'-TCAGCCGAATTCTTGTAGAGTTCATCCATGCCATG-3' 
(reverse primer, Sigma Genosys) and inserted at NotI and EcoRI restriction sites of pGYl5N to 
generate plasmid pHGYl5N, which adds an N-terminal 8xHis tag to the fusion protein. 
Restriction sites are underlined; bases annealing to the sfgfp template are shown in bold. 
The calculated molecular mass of the fusion protein is 100'669.5 Da (GFPND5Yl), the mass of 
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the histidine-tagged construct (His-GFPND5Yl) is 102'402 Da. All constructs were confirmed 
by DNA Sequencing (Microsynth AG, Balgach, Switzerland). 
 
Table 5: Plasmids used in this study.  
Plasmid Description and relevant characteristics Origin or reference 
pRS316 
Yeast shuttle vector; pBluescript derivative;  
URA3; CEN6 ARS4; Apr 
(Sikorski and Hieter 
1989) 
pNLt1 
E. coli nuoLN inserted into pGREG5006, a derivative of the 
pRS vector 
(Gemperli, Schaffitzel 
et al. 2007) 
pG Codes for SFGFP; URA3; Apr; KanMX 
(Steffen, Gemperli et 
al. 2010) 
pG5N 
Codes for ND5Hs with N-terminal SFGFP tag;  
URA3; Apr; KanMX 
(Steffen, Gemperli et 
al. 2010) 
pG5N1 pG5N containing a mutation coding for E145V in ND5Hs 
(Steffen, Gemperli et 
al. 2010) 
pG5N2 pG5N containing a mutation coding for D179A in ND5Hs 
(Steffen, Gemperli et 
al. 2010) 
pM5NF 
Codes for ND5Hs with N-terminal MTS and C-terminal Flag 
tag; URA3; Apr; KanMX 
(Steffen, Gemperli et 
al. 2010) 
pM5N1F pM5NF containing a mutation coding for E145V in ND5Hs 
(Steffen, Gemperli et 
al. 2010) 
pM5N2F pM5NF containing a mutation coding for D179A in ND5Hs 
(Steffen, Gemperli et 
al. 2010) 
pETHP Codes for His-tagged protein A; Apr 
(Steffen, Gemperli et 
al. 2010) 
pGYL5N Derivative of pG5N, containing the Y. lipolytica ND5 gene This work 
pHGYL5N Codes for GFPND5Yl with N-terminal 8xHis-tag  This work 
pGYL5N1 pGYL5N containing a mutation coding for F123L in ND5Yl This work 
pGYL5N2 pGYL5N containing a mutation coding for E144G in ND5Yl This work 
pGYL5N3 pGYL5N containing a mutation coding for A170V in ND5Yl This work 
pGYL5N4 pGYL5N containing a mutation coding for A239T in ND5Yl This work 
pGYL5N5 pGYL5N containing a mutation coding for M240T in ND5Yl This work 
Apr: ampicillin resistance, KanMX: kanamycin resistance, URA3: uracil selection marker 
 
 
2.2.3. Bioinformatic tools 
The amino acid sequences of human ND5 (UniProt accession no. P03915) and the homolog 
from Y. lipolytica (Q9B6D3) were aligned to Escherichia coli NuoL (P33607), the H+/Na+ 
antiporter MnhA from Staphylococcus aureus (Q9ZNG6) and to antiporter EchA from 
Methanosarcina barkeri (Q46G55) or complex I subunit Nqo12 from Rhodothermus marinus 
(Q4QSB1) respectively using the Clustal W (Thompson, Higgins et al. 1994) or the CLUSTAL Ω 
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(1.0.3) (Sievers, Wilm et al. 2011) multiple sequence alignment software on the EBI server 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). The 3D structure of E. coli NuoL (PDB 3RKO) 
was analyzed for possible ion pathways and cavities using CAVER 2.1.2 (Petrek, Otyepka et al. 
2006) and visualized with PyMOL (Schrödinger 2010). 
A hydrophobicity-based model of the transmembrane arrangement of human ND5 was 
generated using ten different topology prediction methods: TMHMM 
(http://www.cbs.dtu.dk/services/TMHMM-2.0/) (Sonnhammer, von Heijne et al. 1998), 
TMpred (http://www.ch.embnet.org/software/TMPRED_form.html) (Hofmann and Stoffel 
1993), SOSUI (http://bp.nuap.nagoya-u.ac.jp/sosui/sosui_submit.html) (Hirokawa, Boon-
Chieng et al. 1998), DAS (http://www.sbc.su.se/~miklos/DAS/) (Cserzo, Wallin et al. 1997), 
HMMTOP (http://www.enzim.hu/hmmtop/) (Tusnady and Simon 2001), TopPred 
(http://mobyle.pasteur.fr/cgi-bin/portal.py?form=toppred) (Claros and von Heijne 1994), 
MEMSAT (http://bioinf.cs.ucl.ac.uk/psipred/) (Jones, Taylor et al. 1994), Split 4.0 
(http://split.pmfst.hr/split/4/) (Juretic, Zoranic et al. 2002), PHDhtm (http://npsa-
pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_htm.html) (Rost, Casadio et al. 
1995), PolyPhobius (http://phobius.sbc.su.se/poly.html) (Kall, Krogh et al. 2005). All methods 
were used with default settings and an eukaryotic dataset where available. In the consensus 
topology model, all residues predicted as certain transmembrane were assigned a value of 
1.0. Residues predicted as 'putative transmembrane' or 'helical cap' were assigned a value of 
0.5. The sum of the values from ten different prediction methods was calculated. Residues 
achieving a sum of 6.5 or higher were defined as 'transmembrane', residues achieving a sum 
of 5, 5.5 or 6 were defined as 'putative transmembrane'. In the consensus model, the N-
terminus of ND5Hs was predicted to be located in the intermembrane space ( ='out'). 
 
2.2.4. Cell growth, protein expression and purification 
Standard protocols were followed for yeast manipulation (Abelson, Guthrie et al. 2004) and 
transformation using lithium acetate (Gietz, St Jean et al. 1992). All ND5Hs and ND5Yl 
constructs were expressed in S. cerevisiae strain BJ3505 ((Jones 1991), genotype MATα his3-
Δ200 pep4::HIS3 prbl-Δl.6R (gal3) ura3-52 lys2-801 trp1-Δ101(gal2) canl) which is URA3 
deficient and allows selecting for plasmids harboring the URA3 gene required for uracil 
synthesis. This strain is furthermore deficient in endoproteinases A and B, which diminishes 
Chapter 2 - The antiporter-like ND5 subunit of complex I  Powerful Proteins 
 
 
34 
 
proteolytic degradation (Jones 1991). Cells were grown as described previously (Gemperli, 
Schaffitzel et al. 2007). To grow cells expressing ND5 variants of Y. lipolytica, baffled flasks 
were used. GAL1 controlled expression of the ND5 fusion proteins was induced by transfer 
to minimal YNB medium (0.67 % yeast nitrogen base with supplementary amino acids and 
adenine) containing 2 % galactose for 27 h (mid-log phase) prior to harvesting. Cells were 
counted using a hemocytometer (Fisher Scientific). Cells were harvested and disrupted by 
one passage through an Emulsiflex C3 (Avestin) cell disruptor at approx. 25 kPsi in 10 mM 
Tris-HCl, 10 mM KCl, pH 8.0 in the presence of protease inhibitor mix (complete EDTA-free, 
Roche). Cell debris and unbroken cells were removed by centrifugation for 5 min at 4'000 x g. 
Membranes from the endoplasmatic reticulum and the nuclear envelope were obtained as 
described in (Gemperli, Schaffitzel et al. 2007). Mitochondria were isolated as described in 
(Meisinger, Pfanner et al. 2006). Mitochondrial membranes were separated into outer 
membrane and inner membrane according to the protocol described in (Daum, Bohni et al. 
1982). To obtain purified GFP as standard for the quantification of GFPND5Hs fusion proteins, 
crude extracts from S. cerevisiae transformed with pG were centrifuged for 60 min at 
35'000 rpm in a Beckman Type 70 Ti rotor. The supernatant containing the cytosolic fraction 
and GFP was concentrated by ultrafiltration and passed through a 0.2 µm filter. Proteins in 
1.3 M NH4SO4, 10 mM Tris/HCl, 1 mM EDTA (pH 8.0) were applied to a HiTrap Phenyl HP 
column (GE Healthcare) and eluted with a linear gradient from 2 M to 0 M NH4SO4 (Peckham, 
Bugos et al. 2006). Peak fractions were combined and loaded on a size exclusion 
chromatography column (Superdex 200 10/300, GE Healthcare), equilibrated with 200 mM 
NaCl in 10 mM Tris/HCl, 1 mM EDTA, pH 7.9. To purify His-GFPND5Yl encoded by plasmid 
pHGYL5N, membranes were collected as described above and solubilized for 2 h at 4 °C in 
20 mM Tris/HCl, 0.5 M NaCl, pH 8.0 containing 1 % Zwittergent 3-14. After centrifugation for 
30 minutes at 126'000 x g, the supernatant was passed through a 0.2 µm filter and loaded 
onto a Ni Sepharose HP column (5 ml bed volume, GE Healthcare) equilibrated with 20 mM 
Tris/HCl, 0.5 M NaCl, pH 8.0 containing 0.02 % Zwittergent 3-14. A washing step was 
performed with 5 column volumes of buffer containing 30 mM imidazole. His-GFPND5Yl was 
eluted with 400 mM imidazole. All steps were performed at 4 °C. His-tagged protein A used 
as standard for quantification of the protein A-NuoL fusion protein was produced in E. coli 
BL21 (DE3) transformed with pETHP (table 5). Following enrichment by Ni-NTA Agarose 
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(Qiagen), His-protein A was applied to a MonoQ anionic exchange column (GE Healthcare) 
and eluted with a linear gradient from 25 mM to 1 M NaCl in 20 mM Tris/HCl, pH 8.0. 
 
2.2.5. Membrane solubilization and protease protection assay 
Solubilization screening was performed in a volume of 200 µl with a protein content of 1 mg 
and 0.8 % - 2 % detergent in TBS (Ausubel, Brent et al. 1995). Samples were gently shaken at 
4 °C for 2 h and then centrifuged at 100'000 x g for 30 min. Pellets were resuspended in 
200 µl TBS and 20 µl of each fraction analyzed by SDS-PAGE. For the protease protection 
assay, ER vesicles and 10 % Zwittergent 3-14 solution were mixed in TBS to a final 
concentration of 10 mg total protein/ml and 1 % or 0.8 % detergent. The membranes were 
gently agitated for 1 h at 4 °C. Centrifugation for 30 min at 100'000 x g yielded solubilized 
membranes in the supernatant. Solubilized and native membranes (400 µg total protein) 
were incubated for 5 minutes at 37 °C with 20 U of Trypsin (1 x crystallized, Carl Roth GmbH). 
Aliquots were withdrawn after the indicated times and analyzed by SDS-PAGE. 
 
2.2.6. Analytical methods 
Protein was determined by the bicinchoninic acid method (Smith, Krohn et al. 1985) using 
the reagent from Pierce. ER membranes were analyzed by SDS-PAGE (Schägger and von 
Jagow 1987). Ten standard proteins in the range from 250 to 10 kDa were used (Precision 
Plus Protein Standards, Bio Rad). In some experiments the 25, 50, 75 kDa markers were 
fluorescently labeled (Western C Protein Standard, Bio Rad). The concentration of purified 
GFP and His-GFPND5Yl was determined from the absorbance of GFP at 485 nm using an 
extinction coefficient of 8.33 x 104 M-1 x cm-1 (Pedelacq, Cabantous et al. 2006). 
Rates of NADH oxidation by mitochondrial membranes with O2 as electron acceptor were 
determined spectrophotometrically in quadruplicates as described in (Tao, Casutt et al. 
2008). Antimycin was added at a concentration of 10 nM. 
The localization of ND5Hs and ND5Yl variants was determined by immunostaining with 
antibodies against the Flag peptide (Sigma-Aldrich), subunit 2 of Saccharomyces cerevisiae 
cytochrome c oxidase (Cox2p, Invitrogen), porin (Invitrogen) and dolichol phosphate 
mannose synthase (Dpms, Invitrogen) followed by incubation with horseradish peroxidase 
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conjugated secondary antibody (Sigma-Aldrich). Aliquots of mitochondrial fractions in 10 µl 
10 mM Tris/HCl, pH 7.4, were spotted onto nitrocellulose membrane (Hybond-C Extra, 
Amersham Bioscience) and washed with 25 mM Tris, 192 mM glycine, 0.05 % SDS in 25 % 
(v/v) methanol. Detection was performed by chemiluminescence using the ECL kit 
(Amersham Bioscience) and a Bio-Rad ChemiDoc XRS+ CCD system with 5 min exposure time. 
The fluorescence of GFP-tagged ND5 variants (Homo sapiens and Yarrowia lipolytica) was 
detected on 10 % to 14 % acrylamide gels after size separation by SDS-PAGE according to 
protocols for GFP-tagged membrane protein expression (Drew, Lerch et al. 2006). 
Fluorescence imaging was performed using a Typhoon Trio system (GE Healthcare) with 
excitation at 488 nm and a 526 nm emission filter. GFP and protein A standards, and their 
respective fusion proteins, were separated by SDS-PAGE and quantified by in-gel 
fluorescence (GFP) or chemiluminescence after Western blotting (protein A) using the 
ImageQuant TL software (GE Healthcare). 
LC-ESI-MS of purified His-GFPND5YL was performed with fragments obtained by tryptic in-gel 
digestion of the fluorescent band. The mass spectrometric analysis was performed by the 
Life Science Center service unit at the University of Hohenheim: The gel slices were first 
washed in 200 µl ddH2O and subsequently in 150 µl acetonitrile (ACN). The samples were 
incubated for 30 min at 56 °C in 150 µl DTT solution (10 mM DTT in 100 mM ammonium 
bicarbonate). DTT was removed and the samples were washed with 150 µl ACN, the liquid 
was discarded. 85 µl iodacetamide solution (55 mM iodacetamide in 100 mM ammonium 
bicarbonate) was added and the reaction was incubated for 20 minutes. Afterwards the gel 
slices were washed with 150 µl 100 mM ammonium bicarbonate and subsequently with 
150 µl ACN. Tryptic digest was done by addition of a trypsin solution (10 ng/µl in 40 mM 
ammonium bicarbonate) and performed at 37 °C over night. Samples were cooled to room 
temperature and 2 µl 10 % trifluoroacetic acid were added. The supernatant was transferred 
to a fresh reaction vessel and extraction of proteins was achieved by addition of 100 µl 
extraction buffer (5 % formic acid/ACN in a 1:2 concentration) at 37 °C. The tryptic peptides 
were dissolved in a volume of 10 µl 0.1 % formic acid before they were applied on a nano-
UPLC system (ultra performance liquid chromatography, Waters) connected to an FT-ESI-
massspectrometer (Thermo Fischer Scientific). For detection both linear iontrap (LTQ) and an 
orbitrap analyzer were used in parallel. 
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2.2.7. Preparation and immunostaining of cells for microscopic analysis 
A modified immunofluorescence protocol for yeast was used (Pringle 1991). Frozen 
S. cerevisiae BJ3505 cells were thawed and resuspended in PBS (Ausubel, Brent et al. 1995) 
containing 4 % paraformaldehyde, incubated for 1 h at room temperature and washed in 
PBS. Aliquots of 2 x 108 cells were pelleted (4'000 x g, 5 min) and resuspended in 1 ml PBS to 
which 150 U of lyticase and 2 µl β-mercaptoethanol were added. Formation of spheroblasts 
was stopped after 2 min by centrifugation (1'000 x g, 5 min) and washing twice in PBS. 
Coverslips (0.17 mm thickness) were coated with 100 µl 0.01 % poly-L-lysine for 10 min at 
room temperature. The coverslips were rinsed in double distilled H2O and subsequently 
dried under air for 1 h. The coverslips were placed coating-side up into a 24 well microplate 
(Greiner) and covered with cell suspension which was allowed to dry for 1 h at room 
temperature. After rinsing with PBS, the coverslips were incubated in blocking buffer (1 % 
BSA in PBS) for 1 h. For the localization of cellular compartments, coverslips were applied 
cell side down onto 20 µl drops of 5 µg/ml of primary antibodies (mouse anti-Dpms, 
Invitrogen; rabbit anti-neurospora porin, gift from R. Lill, University of Marburg; mouse and 
rabbit anti-Flag, Sigma-Aldrich) and, if indicated, 10 µg/ml of 4', 6-diamidino-2-phenylindol 
(DAPI) in blocking buffer. The coverslips were incubated in a humidified chamber at room 
temperature for 1 h. Excess antibody solution was removed with a fiber-free paper and the 
coverslips were washed five times with PBS. Incubation with secondary antibodies anti-
rabbit IgG Alexa Fluor 488 (Invitrogen), anti-rabbit IgG Cy3 (Sigma-Aldrich) and anti-mouse 
IgG Alexa Fluor 555 (Invitrogen) was performed using the same procedure as described for 
the reaction with primary antibodies. To perform labeling of the entire cell (i.e. cytoplasm 
and nucleus) and provide a background for visualization of GFPND5Hs, fixed and 
permeabilized S. cerevisiae BJ3505 cells were incubated in HCS CellMask Deep Red staining 
solution (Invitrogen) for 30 minutes at room temperature. Cells were washed three times in 
PBS. Coverslips were dried and subsequently inverted onto a clean microscopy slide 
containing a drop of fluorescent mounting medium (Dako). 
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2.2.8. Microscopic imaging 
Confocal laser-scanning microscopy was performed on a CLSM SP5 system (Leica) in single 
image and z-stack sequential scan modes. Excitation wavelengths were 405 nm for DAPI, 
488 nm for Alexa Fluor 488 and GFP, and 543 nm for Alexa Fluor 555 and Cy3.  
Widefield microscopy was performed on a Zeiss AxioImager.M1 and AxioCam MRm, using a 
Plan-Apochromat 100x oil objective, HXP 120 lamp. For detection of GFPND5Hs/Yl variants, a 
HE eGFP filter was used. For detection of the cellular background stained with HCS CellMask 
Deep Red, a CY5 filter was used. For computational image restoration, z-stacks were 
deconvoluted with the Huygens (SVI) or Axiovision (Zeiss) software and visualized as 
maximum intensity projection with the imaging software Imaris (Bitplane). 
 
2.2.9. Influence of salt on growth of S. cerevisiae 
S. cerevisiae BJ3505 cells transformed with plasmids encoding for ND5Hs variants (table 5) 
were grown for 24 h to saturation in liquid YNB-glucose, washed with water, and 
resuspended in YNB-galactose to induce ND5Hs expression. Ten-fold serial dilutions of cell 
suspension from OD600 10 to 0.001 were prepared and spotted in 5 µl aliquots onto YNB-
galactose agar plates. YNB medium contains 28 mM Na+, 7 mM K+ and no Li+ (Wickerham, 
Flickinger et al. 1946; Wickerham and Burton 1948; Nolan and Nolan 1972). In some 
experiments 600 mM NaCl, 800 mM KCl or 100 mM LiCl were added as indicated. Growth 
was monitored for 10 days at 30 °C under air. For growth experiments in liquid media, cells 
grown in YNB-glucose were washed with 10 ml H2O and adjusted to an absorbance at 
600 nm of 5. Aliquots of 1 ml were mixed with 4 ml YNB-galactose, and cells were grown 
aerobically under vigorous shaking (220 rpm) at 30 °C in the absence or presence of 100 mM 
LiCl. 
 
2.2.10. Sodium ion transport into ER vesicles 
Experiments were based on the protocol described in (Gemperli, Schaffitzel et al. 2007), with 
following modifications: Disposable 1 ml plastic syringes were equipped with a HDPE support 
screen (pore size 35 µm) and subsequently filled with 0.3 ml of a potassium ion loaded 
cation exchanger resin (DOWEX 50WX4-200). The resin was rinsed with ddH2O before use. 
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Vesicles were prepared in 50 mM MES, 50 mM KCl pH 6.0 and shock frozen in liquid nitrogen. 
150 µl of vesicle solution were thawed on ice, centrifuged for 30 minutes at 30'000 x g and 
resuspended in 312 µl of 50 mM Tris/MES, 50 mM KCl, pH 8.0. Eight µl of a NaCl solution 
(400 mM) were added to establish a sodium ion gradient across the membrane of the 
vesicles. The final, external Na+ concentration in the assay was 5 mM. To remove external 
Na+ after 10, 30, 60 and 90 seconds, 70 µl aliquots of the reaction mixture were withdrawn, 
immediately loaded on the Dowex column and eluted with 800 µl of ddH2O instantaneously. 
As control, the reaction was performed with vesicles lacking GFPND5Yl. Internal Na
+ 
concentration of vesicles was determined by atomic absorption spectroscopy. The size and 
morphology of the ER vesicles containing GFPND5Yl variants used for transport 
measurements was studied by cryo electron microscopy as described previously (Gemperli, 
Schaffitzel et al. 2007). 
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2.3. Results 
2.3.1. Organelle-specific expression of subunit ND5 of human complex I alters 
cation homeostasis in Saccharomyces cerevisiae 
2.3.1.1. Multiple sequence alignment of ND5 and related proteins 
The amino acid sequences of the ND5 subunits from mitochondrial complex I, the ND5 
homolog NuoL from bacterial complex I, the related subunit from multicomponent cation/H+ 
antiporters, and the corresponding subunit from energy-conserving hydrogenases related to 
complex I were compared (figure 6). The regions from amino acid residues 83 to 179, and 
from 222 to 422 (human ND5 numbering) are highly conserved, but there is practically no 
conservation on the level of primary sequence in the C-terminal parts of the proteins 
(residues 432 to 603). 
By summing the results of ten different methods and assigning an upper and lower 
probability threshold, topology prediction of the full length ND5Hs polypeptide (figure 7) 
resulted in a model consisting of 16 transmembrane segments with both N- and C-terminus 
pointing to the outside (intermembrane space), which is in accord with the experimentally 
determined topology model of NuoL of complex I from the bacterium 
Rhodobacter capsulatus (Mathiesen and Hägerhäll 2002). The topology is also in accordance 
with the 3D structure of the ND5 homolog (NuoL) from E. coli complex I, which was 
published during the course of this work (Efremov and Sazanov 2011). Several highly 
conserved residues cluster in the predicted transmembrane helices IV to VI, which may 
represent a functionally important region involved in cation translocation. The frequent 
occurrence of mutations in these residues in LHON, Leigh syndrome, MELAS and PD patients 
is noteworthy (Taylor, Morris et al. 2002; Liolitsa, Rahman et al. 2003; Mayorov, Biousse et al. 
2005; Parker and Parks 2005; Zhadanov, Grechanina et al. 2007), for example at position 
E145 in the predicted transmembrane helix V studied here. We also investigated the 
possible effect on ND5Hs function of the D179A mutation in the predicted transmembrane 
helix VI, since negatively charged, conserved amino acid residues in transmembrane 
segments were frequently reported to directly participate in cation translocation (Dimroth 
1997). 
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Figure 6: Alignment of human ND5 with related proteins from yeast and bacteria. 
Human ND5 (UniProt accession No. P03915), Yarrowia lipolytica ND5 (Yl ND5; accession no. 
Q9B6D3), Escherichia coli NuoL (Ec NuoL; accession no. P33607), Staphylococcus aureus 
MnhA (Sa MnhA; accession no. Q9ZNG6), Methanosarcina barkeri EchA (Mb EchA; accession 
no. Q46G55). Predicted transmembrane segments are underlined. Conserved residues are 
marked with stars (*), similar residues with colons (:). E145 represents a hot spot for 
mutations that were found in patients suffering from PD or MELAS. D179 is an amino acid 
residue strictly conserved in ND5 homologs but not in cation/H+ antiporters. 
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2.3.1.2. Expression strategy 
We previously cloned the 3'-truncated nuoL gene encoding for the N-terminal part of the 
ND5 homolog from E. coli complex I and heterologously expressed the protein in 
S. cerevisiae (Gemperli, Schaffitzel et al. 2007). No signal sequences were fused to this 
hydrophobic protein which was localized to membranes of the endoplasmatic reticulum in 
the default sorting pathway. The same strategy was applied for the ND5 gene encoding for 
the ND5 subunit from human complex I (ND5Hs) attached to a GFP at its N-terminus. To 
target ND5Hs to mitochondria, a fusion protein comprising a mitochondrial targeting 
sequence at the N-terminus and a Flag tag at the C-terminus was expressed (figure 8). The 
mutations E145V and D179A were introduced into the GFP- and Flag-tagged ND5Hs fusion 
proteins, respectively (figure 8). An N-terminal GFP tag was chosen for reasons of convenient 
detection and presumed beneficial effect on folding and stability of the very large, 
hydrophobic ND5Hs subunit. Fusion of a Flag peptide to the C-terminus of ND5Hs in case of 
ND5Hs directed to the mitochondrion by the N-terminal targeting sequence allowed for 
immunological detection of the full-length protein after insertion into the mitochondrial 
membrane. 
 
 
Figure 8: Fusion proteins and mutated variants of ND5Hs for insertion in the endoplasmatic 
reticulum or inner mitochondrial membrane. Wild type ND5Hs (vector pG5N), ND5Hs-E145V 
(vector pG5N1) and ND5Hs-D179A (vector pG5N2) were produced as N-terminal GFP (gray) 
fusion proteins. Adding the 22 residue signal sequence of S. cerevisiae ATP-synthase delta 
subunit at the N-terminus (black), and the Flag peptide to the C-terminus (hatched) yielded 
wild type ND5Hs (vector pM5NF), ND5Hs-E145V (vector pM5N1F) and ND5Hs-D179A (vector 
pM5N2F) targeted to mitochondria. AA: amino acid residue (ND5Hs numbering). 
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2.3.1.3. ND5Hs devoid of a targeting signal is inserted in membranes from the 
endoplasmatic reticulum 
ND5Hs variants were visualized in fixed and permeabilized cells, allowing the in-situ co-
localization of organelle-resident proteins by immunofluorescence. To detect ER membranes, 
S. cerevisiae BJ3505 cells were immunostained with anti-Dpms. Dolichol phosphate mannose 
synthase is required for glycosyl phosphatidyl-inositol anchoring, N-glycosylation and O-
mannosylation of protein in the rough endoplasmic reticulum (Orlean 1990). Mitochondria 
were visualized with antibody against porin which is localized in the outer mitochondrial 
membrane (Freitag, Benz et al. 1983). GFPND5Hs almost completely co-localized with Dpms 
whereas no overlap was detected with porin (figure 9A). SDS-PAGE, followed by in-gel 
fluorescence of GFP and immunostaining against Dpms confirmed that in the absence of a 
signal sequence, GFPND5Hs was predominantly localized in intracellular membranes of the 
ER obtained by fractionated centrifugation (figure 9B). Identical results were obtained with 
the E145V and D179A variants of GFPND5Hs (data not shown). We did not detect GFPND5Hs 
in the plasma membrane of S. cerevisiae, suggesting that this large, hydrophobic protein was 
retained in the ER (figure 10). 
The amount of ND5Hs and its variants in ER membranes was quantified (figure 11). GFPND5Hs 
wild type and its E145V variant were present in similar amounts (95 ± 3 ng versus 42 ± 6 ng 
per mg total protein, n = 3). Quantification of the D197A variant of ND5Hs was not possible, 
since the intensity of its fluorescence signal was less than 10 % of the intensity observed 
with the lowest GFP standard. Much higher yields were observed with the C-terminally 
truncated NuoL homolog of ND5 fused to the Protein A epitope expressed in S. cerevisiae. ER 
vesicles contained 1 - 1.6 µg ProtA-NuoL per mg total ER protein, which allowed studying its 
cation transport activities. Our attempts to measure cation transport by GFPND5Hs in ER 
vesicles were not successful, the likely reason being its low content. 
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Figure 9: GFPND5Hs chimerical protein is targeted exclusively to ER in S. cerevisiae. A: In 
vivo localization of recombinant GFPND5Hs. Fixed and permeabilized S. cerevisiae cells 
stained with DAPI and anti-Dpms or anti-porin antibodies followed by staining with Alexa 
555 or Cy3 coupled secondary antibodies. The cells were visualized by confocal laser 
scanning microscopy (excitation wavelengths: 405 nm for DAPI, 488 nm for GFP and 543 nm 
for Alexa 555) and are shown as top-down view of z-stacks. Upper panels: green; GFP, red; 
Dpms (ER-anchored protein), blue; DAPI (nucleus, only shown in merge). Lower panels: 
green; GFP, red; porin (mitochondrial outer membrane), blue; DAPI. The images were 
merged (Merge) and the overlap between GFP and Dpms was analyzed (Coloc). Scale bar 
represents 1 µm. B, Left: in-gel fluorescence of S. cerevisiae ER membranes containing 
GFPND5Hs (0.2 mg protein) separated on 10 % SDS-PAGE. Right: Western blot of the SDS-
PAGE shown left and immunodetection of the ER enzyme dolichol phosphate mannose 
synthase (Dpms). M: molecular weight marker proteins (from top to bottom: 250 kDa, 
150 kDa, 100 kDa, 75 kDa, 50 kDa, 37 kDa, 25 kDa). Due to its hydrophobic nature, GFPND5Hs 
exhibited an apparent molecular mass on SDS-PAGE which was approximately 30 - 35 % 
lower than its calculated mass of 95 kDa. 
 
 
 
 
Figure 10: Cortical and perinuclear ER localization of GFPND5Hs chimerical protein in 
S. cerevisiae. HCS CellMask stain (red) labels the entire cell (i.e. cytoplasm and nucleus) and 
provides a background for visualization of GFPND5Hs (green).  
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Figure 11: Expression levels of GFPND5Hs and its E145V and D179A variants in membranes 
from the ER. A: Purified GFP was separated on SDS-PAGE, and its fluorescence signal 
intensity was determined (0 - 1 pmol GFP). Within the applied GFP concentration range, the 
signal intensity increased linearly with the amount of protein loaded. B: ER vesicles 
containing GFPND5Hs or its E145V or D179A variants were separated on SDS-PAGE. Left lane, 
0.2 mg total ER protein; right lane, 0.4 mg total ER protein. In A, the fluorescence signal 
intensities of GFPND5Hs (circles) and GFPND5Hs-E145V (triangles) of the ER membranes (0.2 
or 0.4 mg protein) shown in B are indicated. The intensities observed with the GFPND5Hs-
D179A variant (panel B) were less than 10 % of the intensity observed with the lowest GFP 
standard (panel A) and were therefore excluded from the quantitative analysis. 
 
 
2.3.1.4. ND5Hs comprising a matrix signal sequence is integrated in the mitochondrial inner 
membrane 
We tried to change the sorting mode of GFPND5Hs to mitochondria by adding N-terminally 
the signal sequence of ATPase delta subunit (MTS). This resulted in aggregation of the fusion 
protein outside the mitochondria (data not shown), from which we concluded that the bulky, 
superfolding GFP might hinder membrane translocation or correct processing of the signal 
sequence. To circumvent this problem, the short Flag peptide was fused to the C-terminus of 
ND5Hs. Using this fusion protein (MTS-ND5Hs-Flag), ND5Hs wild type and mutant proteins 
were successfully targeted into mitochondria as shown by co-localization with mitochondrial 
porin (figure 12A). The same results were obtained with the E145V and D179A variants of 
MTS-ND5Hs-Flag. Cells incubated with anti-Dpms displayed only residual amounts of MTS-
ND5Hs-Flag in the ER (figure 12B). 
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Figure 12: Targeting of ND5Hs to the inner mitochondrial membrane. C-terminally Flag-
tagged human ND5 protein variants containing the signal sequence of S. cerevisiae ATP-
synthase delta subunit were expressed in S. cerevisiae. A: Cells were immunostained with 
anti-Flag followed by incubation with Alexa 488 coupled secondary antibodies (Flag), or anti-
mitochondrial porin followed by incubation with Cy3 coupled secondary antibodies (Porin). B: 
Cells were immunostained with anti-Flag followed by incubation with Alexa 488 coupled 
secondary antibodies (Flag), or Dpms antibodies followed by incubation with Alexa 555 
coupled secondary antibodies (Dpms). The images were merged (Merge) and the overlap 
analyzed (Coloc). The scale bar is 1 µm. 
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Fractionation of mitochondria into inner and outer membrane resulted in co-purification of 
ND5Hs with cytochrome c oxidase, a respiratory complex of the inner mitochondrial 
membrane (figure 13). This demonstrated that ND5Hs was inserted into the inner membrane 
of mitochondria. Note that the hydrophobicity of the MTS-ND5Hs-Flag fusion protein 
impeded its mobilization from SDS gels, which prompted us to use native MTS-ND5Hs-Flag for 
immunostaining of mitochondrial fractions (figure 13). The presence of ND5Hs in the inner 
mitochondrial membrane had no significant influence on the respiratory activity of 
S. cerevisiae. Rates of antimycin-sensitive NADH oxidation of mitochondrial membranes 
were 0.16 ± 0.02 µmol min-1 mg-1 in the absence of ND5Hs (control vector), 
0.16 ± 0.01 µmol min-1 mg-1 in the presence of wild type ND5Hs (vector pM5NF), and 
0.19 ± 0.01 µmol min-1 mg-1 with the ND5Hs-D179A variant (vector pM5NF2). In the presence 
of ND5Hs-E145V, NADH was oxidized at a rate of 0.27 ± 0.02 µmol min
-1 mg-1. 
 
 
Figure 13: Submitochondrial localization of MTS-ND5Hs-Flag. Detection was performed by 
immunostaining using anti-Flag antibodies. Outer membrane, OM; inner membrane, IM. 
Marker for inner mitochondrial membranes was the cytochrome c oxidase detected with 
anti-Cox2p antibodies. Marker for outer mitochondrial membranes was porin detected with 
anti-porin antibodies. Dilutions of each fraction were analyzed, containing, from top to 
bottom: 2.5 µg, 1 µg, 0.5 µg, 0.25 µg, 0.1 µg protein. 
 
 
2.3.1.5. Salt-dependent growth phenotypes of S. cerevisiae producing ND5Hs 
Without salt added, S. cerevisiae cells producing ND5Hs fusion proteins inserted in the ER or 
inner mitochondrial membrane exhibited the same growth behavior as cells transformed 
with the control vector pRS316 devoid of the ND5 gene. It is concluded that the large, 
hydrophobic ND5Hs protein was not toxic for S. cerevisiae (figure 14). 
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Figure 14: Salt-dependent growth phenotypes of S. cerevisiae producing ND5Hs and ND5Hs 
mutant variants. S. cerevisiae cell cultures, grown to saturation for 24 h in YNB-glucose and 
washed in water and YNB-galactose, were pipetted as 1:10 dilution series onto YNB-
galactose agar plates containing either no added salt, 100 mM LiCl, 600 mM NaCl or 800 mM 
KCl. Growth was recorded after 10 days. ND5Hs, ND5 E145VHs: Cells expressing the wild type 
or E145V variant of ND5Hs respectively; ER: ND5 protein localized in the ER, IMM: ND5 
protein localized in the inner mitochondrial membrane. Control: Cells transformed with 
vector pRS316 devoid of the ND5 gene. 
 
 
We next studied the influence of alkali cations on growth. In the absence of ND5Hs fusion 
proteins, growth of cells transformed with the control vector was prevented at high external 
concentrations of Na+ or K+. Expression of the ND5Hs fusion proteins rescued the cells, 
suggesting that ND5Hs located in the ER or the inner mitochondrial membrane participated in 
detoxification under conditions of elevated [Na+] and [K+]. The observation that ND5Hs and 
its E145V variant were expressed at similar levels (figure 11) allowed us to compare their 
impact on growth of S. cerevisiae. No significant difference in growth behavior was observed 
at high K+ for the wild type and E145V variant of ND5Hs inserted into the ER. In contrast, 
growth in the presence of wild type ND5Hs was impaired compared to the E145V variant 
when present in the inner mitochondrial membrane under these conditions (figure 14). At 
elevated Na+ concentrations, highest salt resistance was observed with ND5Hs present in the 
ER. Introducing a mutation at position 145 in ND5Hs had no effect compared to wild type 
ND5Hs under these conditions. Next, the effect of Li
+ on growth of S. cerevisiae in the 
presence or absence of ND5Hs was investigated. Li
+ is toxic at elevated concentrations but is 
exported from the cells by the Na+-dependent ATPase or Na+ exchangers which transport Li+ 
in addition to Na+ (Kinclova-Zimmermannova, Flegelova et al. 2004; Kinclova-
Zimmermannova and Sychrova 2006). Growth of S. cerevisiae transformed with the control 
vector was not impaired at an external Li+ concentration of 100 mM (figure 14). Under these 
conditions, a very similar phenotype was observed with cells containing ND5Hs wild type and 
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the E145V variant in the inner mitochondrial membrane or with the E145V variant located in 
the ER. In contrast, the presence of wild type ND5Hs in the ER membrane strongly inhibited 
growth at 100 mM Li+, indicating that the protein interfered with the systems for 
detoxification of Li+ in S. cerevisiae. The qualitative findings shown in figure 14 were 
confirmed in a quantitative analysis (table 6). 
 
Table 6: Survival of S. cerevisiae producing ND5Hs variants at elevated salt concentrations. 
ND5Hs variant No salt added 100 mM LiCl 800 mM KCl 
Located in the ER 
     ND5 wild type 
     ND5 E145V 
 
> 4 % 
> 4 % 
 
0.009 % 
3 % 
 
0.1 % 
0.4 % 
Located in mitochondria 
     ND5 wild type 
     ND5 E145V 
 
> 4 % 
> 4 % 
 
0.4 % 
2 % 
 
0.01 % 
0.08 % 
No ND5 present > 4 % 0.4 % < 0.001 % 
Number of cells which formed colonies is given as percentage of total number of cells in the 
inoculum. Growth was monitored after 10 days. A representative set of data from three 
independent growth experiments is shown. 
 
 
The number of colony-forming units of S. cerevisiae with or without ND5Hs fusion proteins 
observed in the presence of 100 mM LiCl or 800 mM KCl was monitored after 10 days and 
compared with the number of cells initially present in the inoculum. Again, growth without 
added salt was not affected in control cells, or in cells expressing the ND5Hs wild type or 
E145V variant. In the presence of Li+, growth of S. cerevisiae was heavily impaired when wild 
type ND5Hs was present in the ER, while the E145V variant of ND5Hs was less toxic for the 
cells. When ND5Hs was targeted to mitochondria, the viability of cells producing the ND5Hs 
E145V variant in the presence of Li+ was slightly improved compared to cells containing 
ND5Hs wild type (table 6). In the presence of K
+, the viability of S. cerevisiae producing ND5Hs 
fusion proteins was generally higher than in the absence of ND5Hs. Again, better growth was 
observed when cells produced the E145V variant. We also followed the growth of 
S. cerevisiae containing GFPND5Hs fusion proteins in the ER in liquid culture under aerated 
conditions. Without added salt, the doubling time of S. cerevisiae was not significantly 
influenced by the presence of GFPND5Hs (6 ± 1 hours in the absence or presence of ND5Hs 
fusion proteins; data not shown). Adding LiCl (100 mM) to the growth medium drastically 
inhibited growth of S. cerevisiae producing wild type ND5Hs, whereas cells containing the 
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E145V variant reached final cell densities comparable to S. cerevisiae cells transformed with 
the control vector lacking the ND5Hs fusion proteins (figure 15). These results further support 
the notion that ND5Hs affects cation homeostasis in S. cerevisiae in a sequence-dependent 
and organelle-specific manner. 
 
 
Figure 15: Increased Li+ sensitivity of S. cerevisiae containing ND5Hs in ER membranes. 
Growth was followed in the presence of 100 mM LiCl. Squares, no ND5Hs present; triangles, 
with ND5Hs-E145V; circles, with wild type ND5Hs. Mean values from duplicates are presented.  
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2.3.2. Expression, purification and functional characterization of subunit ND5 of 
complex I from the yeast Yarrowia lipolytica 
In chapter 2.3.1., we found strong indications for cation transport activity of the isolated 
ND5 subunit of human complex I in growing cells. However, the expression yield of 
GFPND5Hs variants in S. cerevisiae was too low to successfully perform in vitro cation 
transport experiments in native membrane vesicles or proteoliposomes (50 - 100 ng/mg 
membrane protein). Sufficiently strong expression is an absolute requirement for the 
solubilization, purification and reconstitution of the enzyme into liposomes. Preliminary 
tests showed that the expression level of GFP-tagged ND5 from complex I of the yeast 
Yarrowia lipolytica (GFPND5Yl) was one to two orders of magnitude higher than the 
expression level of the human analog (1 - 5 µg GFPND5Yl variant/mg membrane protein). The 
following chapter now describes the characterization of ND5Yl after expression in 
S. cerevisiae. 
 
2.3.2.1. Sequence alignment of ND5Yl and related proteins 
It is proposed that at least two energy coupling sites exist in the NADH:ubiquinone 
oxidoreductase of E. coli (Steuber 2003; Stolpe and Friedrich 2004); a primary electrogenic 
proton pump and a secondary Na+/H+ antiporter-like site. The same is proposed for 
R. marinus complex I (Batista, Fernandes et al. 2010). The sequence alignment of E. coli NuoL, 
ND5 from human and Y. lipolytica, Nqo12 from R. marinus with the Na+/H+ antiporter MnhA 
from S. aureus indicates a high degree of identity, especially within the areas which form the 
two ion half-channels proposed by (Efremov and Sazanov 2011) (figure 16). 
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Figure 16: Partial sequence alignment of human ND5 and its homologues from 
Escherichia coli, Yarrowia lipolytica, Rhodothermus marinus and related prokaryotic 
Na+/H+ antiporter subunit MnhA of Staphylococcus aureus. The areas which may build the 
first ion half-channel are accentuated in light gray, the areas forming the second potential 
half-channel are highlighted in dark gray. The investigated mutations are marked in bold. 
UniProt accession numbers: human ND5 (P03915), E. coli NuoL (P33607), Y. lipolytica ND5 
(Q9B6D3), R. marinus Nqo12 (Q4QSB1), S. aureus MnhA (Q9ZNG6). 
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2.3.2.2. The position of disease-associated mutations in ND5 
Five of the most frequently observed mutations of ND5 associated with diseases (table 4) 
were investigated concerning their impact on the transport properties of ND5. It is apparent 
that they are all clustered inside the membranous layer, and moreover, they are all found in 
the area of the first of two ion half-channels which were proposed by Efremov and Sazanov 
(Efremov and Sazanov 2011) and elaborated in this work (figures 17 and 26). Mutations 
F123L (TM 4), A170V (TM 6), A239T and M240T (TM7) point into the inner lumen of the 
putative channel, while mutation E144G (TM 5) is situated on the outside of the channel but 
in immediate vicinity to the neighboring ND4 subunit. 
 
 
Figure 17: Position of ND5Yl in the inner mitochondrial membrane. A: Side view of NuoL 
from E. coli complex I (PDB ID: 3RKO). B: Top view from the cytoplasm onto NuoL (PDB ID: 
3RKO), the putative ion half-channels are highlighted in blue and lavender. C: Structure-
based topology model of GFPND5Yl. The positions of the investigated mutations in ND5Yl 
within the membrane layer are shown in red (F123L, E144G, A170V, A239T, M240T, 
Y. lipolytica numbering). 
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2.3.2.3. Localization of GFPND5Yl in the ER of S. cerevisiae 
In accordance with previous results obtained with human ND5 (chapter 2.3.1.3.), Y. lipolytica 
ND5 was found to insert into membranes of the endoplasmatic reticulum of S. cerevisiae. 
The GFP fluorescence displayed almost complete co-localization with the ER membrane 
protein dpms. A co-localization of immunostained mitochondria and GFPND5Yl could not be 
observed (figure 18). Also, expression of the F123L, A170V, A239T, M240T and E144G 
variants of GFPND5Yl did not lead to a change in the expression or co-localization pattern 
(Data not shown). 
 
 
Figure 18: Localization of GFPND5Yl in S. cerevisiae. ND5Yl is detected by the fluorescence of 
GFP. ER or mitochondria were immunostained (ER: anti-dpms, mitochondria: anti-porin, 
both in red). The co-localization of both signals (yellow) shows the expression of ND5 in the 
ER. No visible co-localization of GFPND5Yl and mitochondria is observed. 
 
 
2.3.2.4. Orientation of GFPND5Yl within the membrane of native vesicles 
The preparation of membrane vesicles with uniformly oriented ND5 was a prerequisite for 
ion transport measurements. The intactness and sphericality of the vesicles containing 
GFPND5Yl was confirmed by cryo-electron microscopy (figure 19). We next investigated the 
orientation of GFPND5Yl using a protease protection assay. This method is based on the 
assumption that lumen-oriented protease cleavage sites in the protein are protected against 
proteases added to the external medium. In our particular case, cleavage by trypsin after 
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R24 (numbering ND5 Y. lipolytica), an amino acid in the loop after the first transmembrane 
helix, would yield a fragment of a calculated mass of 29.79 kDa if the loop was exposed to 
the outside, but no fragment if R24 was oriented towards the inside of the membrane 
vesicles. By disrupting the membranes with detergent, previously protected sites become 
accessible and a statement about the uniformity of the orientation of GFPND5Yl is possible. 
After 5 minutes of incubation with trypsin, a fragment with an apparent mass of about 
26 kDa was found when solubilized vesicles were digested (figure 20A, labeled as GFPND5t). 
The fragment was not detected in non-solubilized vesicles. Since the fragment did not 
migrate as far as GFP alone on a 14 % acrylamide gel, we assume it represents GFPND5Yl 
cleaved after R24 These results indicate that GFPND5Yl is uniformly orientated in the 
membrane, with the N-terminally linked GFP being exposed to the external lumen of the 
vesicles (figure 20B). In our previous study we used the C-terminally truncated NuoL 
homolog of ND5 fused to Protein A at its N-terminus, and also observed the 'N-terminus out' 
orientation of ProtA-NuoLtruncated in native ER vesicles from S. cerevisiae (Gemperli, 
Schaffitzel et al. 2007). 
 
 
Figure 19: Cryo electron microscopy of vesicles from S. cerevisiae containing GFPND5Yl. 
Micrographs were recorded at a magnification of x 53'000.  
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Figure 20: Fluorescent SDS-PAGE of fragments from a protease protection assay, using 
trypsin on native and solubilized vesicles from S. cerevisiae, containing GFPND5Yl. A: To 
analyze the orientation of GFPND5Yl within the membrane the accessibility of predicted 
trypsin sites in native (Lane 1 + 2) and solubilized (Lane 3 + 4) membrane vesicles was 
examined. 150 µg total protein were loaded per lane. B: Schematic view of the GFPND5Yl 
orientation in the vesicles. Scissors mark the likely cleavage site R24 in the loop after TM1 of 
ND5Yl. Asterisks mark other potential trypsin cleavage sites.  
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2.3.2.5. Na+ transport by GFPND5Yl 
The sodium ion transport properties of the ND5 subunit were investigated using native ER 
vesicles from GFPND5Yl expressing S. cerevisiae cells. Note that we prepared vesicles at 
slightly acidic conditions (pH 6.0), while applying a basic pH 8.0 during the assays, since this 
gave the most stable results of the conditions tested. If ND5Yl possesses Na
+/H+ antiporter 
activity as proposed for bacterial complex I from E. coli (Stolpe and Friedrich 2004), 
R. marinus (Batista, Fernandes et al. 2010) and bovine complex I (Roberts and Hirst 2012), an 
increased inside [H+] may induce Na+ uptake. The assay was started by adding 5 mM sodium 
chloride to the external lumen, applying a ΔμNa+. As a control, vesicles from S. cerevisiae 
which did not express GFPND5Yl were used. Measuring the internal Na
+ content of vesicles 
by atomic absorption spectroscopy revealed a measurable sodium ion uptake into vesicles 
containing GFPND5Yl and into vesicles lacking GFPND5Yl, but a significantly higher uptake rate 
was observed with the GFPND5Yl vesicles between 30 and 90 seconds after the addition of 
Na+ (figure 21). During the first 30 seconds, there was an expulsion of Na+ from the vesicles, 
with no significant difference between vesicles containing GFPND5Yl and control vesicles. We 
do not have an explanation for this observed flux of Na+ yet. The transport properties of the 
pathologically relevant ND5Yl E144G, F123L, A170V, A239T and M240T variants were also 
investigated. The E144G variant of ND5Yl showed a significantly lowered uptake of Na
+ 
compared to wild type ND5Yl between 60 and 90 seconds (figure 21). The F123L, A170V, 
A239T and M240T variants of ND5Yl exhibited Na
+ uptake which was not significantly 
different from the Na+ uptake of wild type ND5Yl (data not shown).  
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Figure 21: Na+ uptake by vesicles containing ND5Yl, its E144G variant or no ND5. Net Na
+ 
uptake by native vesicles containing wild type ND5Yl (squares), the E144G variant (circles) or 
control vesicles (triangles) in the presence of a pH gradient (inside acidic). To start the 
reaction at t = 0 s, 5 mM Na+ were added to the reaction mixture, and aliquots were 
withdrawn after 10, 30, 60 and 90 seconds. The internal Na+ content of the vesicles was 
determined by atomic absorption spectroscopy. Na+ content at t = 0 s corresponds to the 
Na+ content of the buffer. In the control reactions, vesicles from S. cerevisiae transformed 
with plasmid pRS316 were used. Each uptake experiment was done in triplicate, shown are 
representative single experiments. 
 
 
2.3.2.6. Solubilization trials 
Solubilization screens encompassing 13 different detergents revealed the preference of 
GFPND5Yl for zwitterionic detergents. The highest yield of solubilized GFPND5Yl was achieved 
with 1 % lauryl dimethylamine oxide (LDAO) (figure 22). LDAO is a detergent with favorable 
properties for crystallization studies but will denature many membrane proteins (Prive 2007). 
We thus performed subsequent solubilizations with n-Hexadecyl-N,N-dimethyl-3-ammonio-
1-propanesulfonate (Zwittergent 3-16) or Tetradecyl-N,N-dimethyl-3-ammonio-1-
propanesulfonate (Zwittergent 3-14), which also yielded satisfactory results. The unusually 
long alkyl chain of these Zwittergents may stabilize the transmembrane domains of the 
protein by mimicking the lipid bilayer which promotes co-purification of proteins with lipids 
(Infed, Hanekop et al. 2011). 
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Figure 22: Solubilization of GFPND5Yl with different ionic, non-ionic and zwitterionic 
detergents. Membranes containing 1 mg protein and indicated amounts of detergent in 
200 µl TBS were gently agitated at 4 °C for 2 h and then centrifuged at 100'000 x g for 30 min. 
The pellet was resuspended in the same volume. The supernatants S and pellets P containing 
non-solubilized membrane proteins were analyzed with SDS-PAGE. GFPND5Yl was detected 
by its fluorescence. 
 
2.3.2.7. Purification 
The enrichment of functional GFPND5Yl in detergent micelles is a prerequisite for its 
reconstitution into proteoliposomes. We chose Zwittergent 3-14 to purify His-tagged 
GFPND5Yl from S. cerevisiae membranes by Ni affinity chromatography (figure 23). The yield 
of enriched GFPND5Yl from 60 g of cells (wet weight) was approximately 0.5 mg. The 
concentration of GFPND5Yl was determined by absorption spectroscopy of GFP and 
compared with the total protein concentration determined by the bicinchoninic acid method. 
A ratio of 0.052 mg ND5Yl/mg total protein was achieved. When the imidazole concentration 
in the eluate from the Ni affinity column was decreased by dilution with buffer, GFPND5Yl 
precipitated from the solution. Possible reasons are instability of the protein in diluted 
Chapter 2 - The antiporter-like ND5 subunit of complex I  Powerful Proteins 
 
 
62 
 
solutions, or drop of detergent concentration below the critical micelle concentration. 
Nevertheless, we used denatured GFPND5Yl which was solubilized with sodium dodecyl 
sulfate as standard for the detection and quantification of GFPND5Yl variants in ER vesicles 
(see below). 
 
 
Figure 23: Purification of GFPND5Yl. The fluorescent SDS-PAGE is depicting the enrichment 
of GFPND5Yl from ER membranes, after solubilization and immobilized metal ion affinity 
chromatography. Lane 1: cellular debris, lane 2: supernatant after 50'000 x g centrifugation 
step, lane 3: ER membrane fraction, lane 4: supernatant after solubilization, lane 5: eluate 
from Ni-Sepharose HP. In lane 1 - 4, 100 µg total protein were loaded per lane, in lane 5, 
25 µg were loaded. 
 
 
2.3.2.8. Quantification and mass spectrometric analysis 
GFPND5Yl and mutant variants from S. cerevisiae membranes were quantified by SDS-PAGE 
as described in chapters 2.2.6. and 2.3.1.3. The membranes contained between 1 - 5 µg 
GFPND5Yl variant/mg membrane protein. The expression of all the analyzed ND5Yl variants 
was thus comparable. This is shown in figure 24, which depicts the fluorescent SDS-PAGE of 
the wild type and E144G variant of GFPND5Yl. Purified His-GFPND5Yl was used as a standard 
for quantification. The purified protein as well as the protein from membrane fractions 
display a lower apparent mass on the gel than expected. This effect can be attributed to the 
hydrophobicity of the protein, since LC-ESI-MS analysis of tryptic digests confirmed full 
length expression (figure 25). Since transmembrane stretches contain only few or no cutting 
sites for trypsin, the fragments that were found mainly originate from GFP and from 
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hydrophilic loops of the membrane protein, thus a complete sequence coverage could not 
be obtained. Nevertheless, the simultaneous finding of fragments from the N-terminus and 
the C-terminus in a single specimen indicate that no proteolytic degradation has taken place 
(figure 25). 
 
 
Figure 24: GFPND5Yl and its E144G variant are expressed in comparable amounts. Wt: Lane 
loaded with membranes containing wild type GFPND5Yl, 124 µg total protein, E144G: 
membranes containing the E144G variant of GFP-tagged ND5Yl, 191 µg total protein. Shown 
is the in-gel fluorescence of each lane. 
 
 
 
 
Figure 25: LC-ESI-MS analysis of purified His-GFPND5Yl. The fragments of ND5Yl which were 
found in the mass spectrometric analysis are highlighted in bold. The sequence of SFGFP has 
an italic font. 
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2.4. Discussion 
2.4.1. Sequence alignment of ND5 and related proteins 
The structure of NuoL reported by Efremov and Sazanov strengthens the notion that this 
subunit - and its eukaryotic homolog ND5 - are involved in ion channeling and the generation 
of a proton motive force (PMF) and also provide a structural means to couple the energy 
from the electron transport chain to the opening and closing of ion channels (Efremov and 
Sazanov 2011; Efremov and Sazanov 2011). The mechanism of channeling and the nature 
and stoichiometry of the charged moieties involved is still unclear. Studies investigating the 
holo-complex from E. coli and from the related enterobacterium K. pneumoniae, supplied 
indications that the complex works as a primary Na+ pump which is not driven by the PMF 
(Steuber, Schmid et al. 2000; Steuber 2003). For the ND5 homolog from E. coli, a Na+ 
transport function without any evidence for stimulation by the PMF was proposed (Gemperli, 
Schaffitzel et al. 2007). Other studies revealed a secondary Na+ transport function, 
stimulated by the PMF, but with differing evidence concerning the direction of Na+ and H+ 
translocation (Stolpe and Friedrich 2004; Roberts and Hirst 2012). Investigations of different 
E. coli complex I subunits (NuoL, M, and N) showed that the ND5 homolog NuoL was able to 
complement a Na+/H+ antiporter deficient mutant of B. subtilis (Mathiesen and Hägerhäll 
2002; Mathiesen and Hägerhäll 2003). This suggests that the mitochondrial homolog of NuoL, 
the ND5 subunit of complex I, also exhibits antiporter activity. A PMF-dependent antiporter 
function is also proposed for complex I from R. marinus (Batista, Fernandes et al. 2010). 
These hypotheses prompted us to include the corresponding ND5 homologs from E. coli and 
R. marinus complex I, as well as the sequence of a Na+/proton antiporter, the MnhA subunit 
from S. aureus in the alignment. It is noteworthy that the areas which show the highest 
sequence conservation are the ones proposed to build the ion channels (Efremov and 
Sazanov 2011). Particularly, these regions comprise TM4 - TM8, forming the predicted 
channel 1, and TM9 - TM13, forming the predicted channel 2 (figures 17 and 26). The 
identity of ND5 homologs and bacterial Na+/proton antiporters in key areas strongly suggests 
that ND5 and its homologs are also able to transport sodium ions, which we went on to 
demonstrate in this study.  
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2.4.2. Expression and localization of ND5 
Allotopic expression and mitochondrial targeting of the mitochondrially encoded, 
hydrophobic ND4 subunit of complex I has been demonstrated in mammalian cells (Guy, Qi 
et al. 2002) but could not be reproduced in a later study (Oca-Cossio, Kenyon et al. 2003). 
Here we describe the targeted production of the mitochondrially encoded ND5 subunit from 
man and from the yeast Y. lipolytica in Saccharomyces cerevisiae, paving the way for the 
functional and structural analysis of a whole family of these very hydrophobic, mitochondrial 
proteins which are frequently altered in neurodegenerative diseases (Wallace 1999; Leonard 
and Schapira 2000). In the absence of a signal sequence, ND5Hs and ND5Yl were localized to 
the ER membrane. The sorting mode of ND5Hs was altered by adding a mitochondrial 
targeting sequence, with the majority of ND5Hs co-localizing with mitochondrial marker 
protein. We chose a signal sequence of a matrix-resident ATPase subunit, previously used to 
engineer a matrix-targeted GFP (Arimura and Tsutsumi 2002), and could confirm the 
integration of the 67 kDa, hydrophobic ND5Hs polypeptide in the inner mitochondrial 
membrane. The insertion of ND5Hs probably required the TOM and TIM complexes (Pfanner 
and Meijer 1997). Transfer of ND5Hs into the matrix space and subsequent reinsertion into 
the inner mitochondrial membrane could depend on the action of TIM23, mtHsp70 and 
OXA1, or could be catalyzed via the TIM22 complex (Stuart and Neupert 1996; Stojanovski, 
Johnston et al. 2003). 
 
2.4.3. Orientation of GFPND5Yl in native ER vesicles 
Knowledge of the orientation of the GFPND5Yl fusion protein within the vesicle or liposome 
membrane was a requirement for the subsequent transport studies aimed at elucidating the 
function of the ND5Yl subunit from complex I. More important than to know the effective 
orientation was to assure that the protein is uniformly orientated. The analysis with a 
protease protection assay using trypsin indicates that a uniform orientation is given. The lack 
of a similar cleavage pattern in non-solubilized vesicles indicates that a majority of the 
vesicles adopt the same orientation and that most trypsin sites are oriented to the internal 
side of the vesicles and thus only become accessible after solubilization. In addition, we can 
say with high confidence from these and previous (Gemperli, Schaffitzel et al. 2007) 
experiments that the vesicles are formed in the 'right side out' orientation, with the N-
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terminally fused GFP on the outside (figure 20B). This is best seen with the fragment 
appearing at about 25 kDa when using solubilized vesicles; it lies above the band of GFP 
alone, but is too small to be the fragment cleaved after TM 8 at R265, which is the closest 
potential trypsin site that lies on the 'outside'. Instead it is most likely a fragment cleaved on 
the 'inside', directly after TM 1 at R24 of Y. lipolytica ND5. There is the possibility that the 
appearance of additional fragments after solubilization does not stem from the 'opening' of 
uniformly oriented vesicles but is an effect of denaturation of the protein by the detergent, 
as a denatured and partially unfolded protein would also result in more accessible trypsin 
sites. Although zwitterionic detergents, such as Zwittergent 3-16 used in this work, are 
usually reported as being less denaturing than ionic detergents and able to stabilize 
membrane proteins (Infed, Hanekop et al. 2011), this possibility has to be taken into account. 
By mass spectrometric analysis, we could show that ND5Yl was isolated in its full length. 
However, after proteolysis with trypsin we were not able to detect fragments from the more 
hydrophobic stretches of ND5Yl. Better results may be achieved by proteolysis with 
chymotrypsin or other endopeptidases that preferably cleave at hydrophobic residues. Once 
the Na+ transport activity of solubilized and reconstituted ND5 (in proteoliposomes) has 
been confirmed, this would unequivocally demonstrate that no denaturation and unfolding 
have occurred during solubilization. 
 
2.4.4. ND5 imbalances the cation homeostasis of intracellular organelles 
We previously showed that the ND5 homolog from a bacterial complex I, the NuoL subunit, 
functions as transporter for Na+ and K+ when inserted in ER membranes from S. cerevisiae 
(Gemperli, Schaffitzel et al. 2007). The ND5/NuoL proteins are evolutionary related to 
subunits of multicomponent cation/H+ antiporters (Mathiesen and Hägerhäll 2003). 
Understanding the catalytic function of mitochondrially encoded complex I subunits like ND5 
which are frequently altered in neurodegenerative disorders is of utmost importance when 
it comes to understanding the causative link between mutations in mitochondrial DNA and 
diminished complex I activity in patients (Thorburn, Sugiana et al. 2004). We found that the 
isolated ND5 subunit of human complex I increased the resistance to elevated Na+ and K+ 
concentrations if present in mitochondria and ER from S. cerevisiae. This is in marked 
contrast to the situation observed in the presence of Li+, where ND5Hs in the ER increased 
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the sensitivity of cells towards this alkali cation. Interestingly, the toxic effect of Li+ was 
diminished when the E145V variant of ND5Hs was present in the ER, supporting the notion of 
Li+ flux catalyzed by ND5Hs which is diminished in case of the E145V variant of the protein. 
S. cerevisiae possesses several transport systems for the detoxification of alkali metal cations. 
Surplus Li+ and Na+ are sequestered by Na+-ATPase Ena1/Pmr2 and Na+/H+ antiporter Nha1 
or internalized by endosomal Na+/H+ exchanger Nhx1p (Kinclova-Zimmermannova, Flegelova 
et al. 2004; Kinclova-Zimmermannova and Sychrova 2006) Intracellular K+ levels are held at 
an optimal steady state of 200 - 300 mM by active import (Trk1p and Trk2p) and K+ channels 
(Tok1p and Nsc1p) (Rodriguez-Navarro 2000; Sychrova 2004). Yeast mitochondria are lacking 
the specific Na+/H+ antiporter, but contain a homolog of the mammalian K+/H+ antiporter 
which is unspecific as it will extrude all alkali cations out of the mitochondrial matrix 
(Welihinda, Trumbly et al. 1993). It is proposed that the altered salt tolerance of S. cerevisiae 
expressing ND5Hs reflects a change of intracellular cation gradients caused by ND5Hs. The 
effect of ND5Hs could be due to a general stress response of S. cerevisiae, induced by 
expression of this hydrophobic membrane protein. However, we favor a direct role for ND5Hs 
linked to its putative cation transport activity: Introducing a single point mutation (E145V) 
altered Li+- and K+-dependent growth behavior, yet the expression levels of wild type ND5Hs 
and its E145V variant did not differ significantly. The E145V mutation of ND5Hs is observed in 
PD patients (Parker and Parks 2005), but an impact of this mutation on the function of ND5Hs 
has not yet been reported. Our study illustrates how S. cerevisiae is suited to study the effect 
of mutations on the function of mitochondrially encoded complex I subunits by an in vivo 
test based on the cation-dependent growth behavior of the cells, and paves the way for the 
in vitro analysis of the catalytic properties of ND5. 
 
2.4.5. A putative role of E144 of the ND5Yl subunit of complex I in cation transport 
The results of the transport studies clearly show that the presence of wild type GFPND5Yl in 
native vesicles raises the Na+ uptake rate in comparison to the control vesicles without ND5Yl. 
The quantification of the uptake rate is difficult: The observation of the effective sodium ion 
content within the vesicles is always discontinuous, and GFPND5Yl only represents a 
percentage of the total protein content within the membranes (1 - 5 µg/mg total protein). 
Still, it is possible to differentiate the Na+ content of vesicles containing wild type, mutant, or 
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no GFPND5Yl. The most drastic effect on Na
+ uptake was observed with the E144G variant of 
ND5Yl. The detected Na
+ uptake was significantly lower than with wild type GFPND5Yl, which 
strongly suggests that the glutamic acid residue on position 144 in the Y. lipolytica ND5 
participates in cation translocation. We have shown here that a mutation of E144 reverts the 
negative impact of human ND5 on cation homeostasis in S. cerevisiae, and an involvement of 
E144 in proton translocation was also already demonstrated for the ND5 homolog from 
E. coli (Nakamaru-Ogiso, Kao et al. 2010). 
 
2.4.6. Correlation between structure and function of ND5 
The results described herein allow speculating about the structure-function relationship of 
ND5 with respect to the structure of the related NuoL subunit of complex I from E. coli 
(Efremov and Sazanov 2011). Efremov and Sazanov propose two opposing half-channels 
connected by a series of polar or charged residues in the middle of the membrane. They 
argue that the first putative channel is closed to the periplasm and the second channel is 
closed to the cytoplasm by hydrophobic residues and thus a single, proton translocating 
pathway is most likely. Indeed residues such as Leu 130, Trp 143, Ala 261 and Leu 265 on 
one side and Leu 308, Phe 341, Leu 345 and Phe 346 on the other side create hydrophobic 
'choking points' that seem to block off further progress of the respective pathways. 
Interestingly, these residues are strongly conserved in complex I and H+/Na+ antiporter 
subunits, which raises the question what role they might play in an antiporter environment. 
Further analysis of the structure of NuoL concerning cavities and additional pathways 
revealed that the areas behind the choking points contain cavities linking to the surface that 
can accommodate protons or sodium ions. These cavities are lined with hydrophilic residues, 
most of which are conserved (figure 26). One can thus propose that instead of two half-
channels, two continuous channels exist, the passage through which is controlled by 
essential hydrophobic residues, acting as gates opened and closed by conformational change. 
The first such channel is accessible on the cytoplasmic side as described in (Efremov and 
Sazanov 2011), but with Phe 123 has to pass a first choking point on this side already. 
Phe 123 is highly conserved and mutations in its human homolog F124 are linked to MELAS, 
PD and Leigh disease (Taylor, Morris et al. 2002; Parker and Parks 2005; Zhadanov, 
Grechanina et al. 2007). The channel continues on past Trp 143 to the periplasm, supported 
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by the sulphurs of Met 127 and Met 139 and the side chains of Tyr 264, Arg 268, Ser 85, 
Asp 134 and Asp 82. Mutations in Asp 134 and Asp 82 were shown to decrease proton 
pumping activity (Nakamaru-Ogiso, Kao et al. 2010). The second channel comprises the 
periplasmic half-channel as described in (Efremov and Sazanov 2011), continues on by 
Lys 342, His 338, Thr 312 and His 254 and further to the cytoplasm by Met 234, Ser 250, 
Lys 305, Thr 247, Asp 303, Gln 360, Ser 349, Tyr 106 and Glu 359. Mutation of Asp 303 has 
been shown to decrease proton pumping activity (Nakamaru-Ogiso, Kao et al. 2010) and the 
human Met 234 homolog was mutated in patients suffering from MELAS syndrome (Liolitsa, 
Rahman et al. 2003). 
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Figure 26: Cavity search suggests the existence of two membrane-spanning ion transport 
pathways in ND5 homolog NuoL. Subunit NuoL of the membrane arm of E. coli complex I 
(PDB 3RKO) was analyzed for cavities with a 1.4 Å radius probe using the program CAVER. 
Tunnels that could support ion translocation and supporting polar side chains were 
visualized with PyMOL. Two putative ion transport pathways to the cytosolic or periplasmic 
surface respectively are shown for each channel. Hydrophobic side chains forming choking 
points in the channels are drawn in red. 
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2.4.7. Model of H+/Na+ Antiport in NuoL (ND5) 
The homology of NuoL/M/N to antiporter subunits prompted us to ask if antiporter function 
is retained in complex I. Secondary Na+ transport coupled to proton translocation would be 
in accord with findings that the ND5 homolog from E. coli translocates protons in the 
opposite direction as Na+ (Mathiesen and Hägerhäll 2003) and that Na+ was not necessary 
for the proton transport but only stimulated proton transport by the holo-complex I from 
R. marinus (Batista, Fernandes et al. 2010). The Na+ uptake experiments presented in this 
study indicate an important role of the E144 in the transport process (figure 21). With the 
elucidation of the crystal structure of the membrane domain of complex I, the functional 
understanding of this complex machine has increased. A continuously rising number of 
mutation and transport studies will eventually narrow down the pathways and precise 
transport mechanism. Using the data available, we present three different models of H+/Na+ 
antiport: 
 
 
Figure 27: Two half-channels. 
 
 
Assuming there is only a single continuous channel through the membrane, antiport function 
is still thinkable: A proton entering from the cytoplasmic side and a sodium ion coming from 
the periplasm coordinate to polar residues Thr 257 and His 254 respectively on central TM8. 
A conformational signal, transmitted by the long, amphipathic helix of NuoL on to 
discontinuous transmembrane helix 7, allows the two ions to exchange simultaneously 
(figure 27). The cavities on either side of TM8 are large enough to accommodate two ions at 
once. This model requires a gating mechanism that keeps the half-channels closed from the 
outside until an antiport cycle is fully completed. Phe 123 and Phe 341 seem ideally placed 
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to assume a conformation which interrupts incoming ion flow from the cytoplasm or the 
periplasm respectively (figure 26). 
 
 
Figure 28: Two discrete channels. 
 
 
As ionizable residues in the proposed connection between ion half-channels 1 and 2 are 
quite far apart, it can be argued that no ion transport occurs across this cavity, but rather 
that the space is necessary for the conformational flexibility of TM8 (figure 28). As central 
helix of NuoL, TM8 'communicates' between the two channels, coordinating the gating 
system which is invariably necessary in any directed ion transport. One such gating 
mechanism may be formed by the electrostatic interactions of Lys 229, Glu 144 and or 
Asp 178; a salt bridge between the glutamate and lysine residues may induce a rotation in 
TM5, closing off channel 1 from the periplasm with the bulky Trp 143. 
 
 
Figure 29: Two crossing channels. 
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Figure 29 depicts a combination of the first two models. Ions enter from the cytoplasmic and 
the periplasmic half-channel and are exchanged by a simultaneous or alternating-access 
mechanism at TM8, which therefore controls most of the gating. In the light that most 
mutation studies in NuoL/ND5 up to date have focused on charged conserved residues of 
the first putative ion channel, it would be promising to investigate mutations which are 
localized in putative channel two and in conserved hydrophobic residues to further 
investigate the sodium ion transport and gating properties of the ND5 subunit. 
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3.1. Introduction 
3.1.1. Silver, a potent bactericide and inhibitor of the Na+-NQR 
Safe drinking water is the sine qua non of public health (Aldhous 2003). Since antiquity, silver 
is used for disease control without reports on toxic side effects, and nowadays, many 
effective water purification systems for public and individual applications rely on the 
bacteriotoxic effect of silver (Davies and Etris 1997; Silver 2003). The mode of action of Ag+ 
against bacteria is not understood, but the microcidal activity of silver was proposed to 
result from the inhibition of bacterial respiration (Silver 2003). However, the target molecule, 
and the mechanism of its modification by Ag+, remained unknown. Pathogenic strains of the 
water-borne bacterium Vibrio cholerae cause the diarrheal disease cholera (Sack, Sack et al. 
2004) and are efficiently killed by Ag+ (Aguilar, Jimenez et al. 2006). By the help of a 
respiratory Na+ pump, V. cholerae maintains an electrochemical Na+ gradient across the 
inner membrane to drive central processes like flagellar rotation, nutrient uptake, and 
detoxification (Häse and Barquera 2001). The respiratory Na+ pump, also called Na+-
translocating NADH:quinone oxidoreductase (Na+-NQR), is a membrane-bound enzyme 
complex composed of six subunits (NqrABCDEF) which contains four flavins, one [2Fe-2S] 
cluster and ubiquinone-8 as cofactors (Barquera, Ramirez-Silva et al. 2006; Tao, Casutt et al. 
2008; Casutt, Nedielkov et al. 2011) (table 2). Ag+ inhibited O2-dependent NADH oxidation by 
subcellular membrane fractions from V. cholerae (Lin, Türk et al. 2007), and the Na+-NQR 
from the related Vibrio alginolyticus was inhibited by Ag+ in vitro (Unemoto, Ogura et al. 
1993; Steuber, Krebs et al. 1997). We speculated that the reported sensitivity of V. cholerae 
cells towards Ag+ (Aguilar, Jimenez et al. 2006) resulted from the inactivation of the Na+-NQR, 
leading to diminished respiratory activity and energy production, and eventually, to the 
killing of this human pathogen. Here, the characterization of an Ag+-insensitive C378A 
variant of the NADH-oxidizing FAD domain of the Na+-NQR is presented, and the 3D 
structure of the FAD domain in complex with Ag+ is shown. Furthermore, we demonstrate 
that the insertion of this cysteine mutation into V. cholerae expressing the Na+-NQR causes 
the bacteria to exhibit an increased tolerance against Ag+. The results are the basis for the 
development of silver-based drugs targeting the Na+-translocating NADH dehydrogenase, a 
central enzyme of bacterial catabolism which is not found in higher eukaryotes. 
 
Chapter 3 - Structure and function of catalytic Na+-NQR subunits Powerful Proteins 
 
 
 
76 
 
3.1.2. Structure and function of the NADH oxidizing domain of the Na+-NQR, 
a flavoprotein 
Flavoproteins belong to the most-studied and versatile classes of enzymes, catalyzing redox 
reactions ranging from apoptotic signaling to DNA repair, photosynthesis, bioluminescence 
and cellular respiration (Massey 2000). The Na+-translocating NADH:quinone oxidoreductase 
(Na+-NQR) from the pathogenic bacterium Vibrio cholerae is a membrane-spanning 
respiratory complex consisting of six subunits NqrA - F. It contains three distinct flavin 
species: two covalently bound flavin mononucleotides (FMN), a non-covalently bound flavin 
adenine dinucleotide (FAD) and a riboflavin (Casutt, Huber et al. 2010). The NqrF subunit 
comprises a ferredoxin-like N-terminal domain that harbors a [2Fe-2S] cluster and a C-
terminal part with binding motifs for NADH and FAD. Its role in the catalysis of the initial 
electron transfer from NADH to FAD, and from there to the [2Fe-2S] cluster has been 
discussed (Türk, Puhar et al. 2004) but not yet structurally elucidated. Local regions of strong 
homology place NqrF into the family of ferredoxin-NADP+ reductases (FNR) (Rich, Meunier et 
al. 1995). Several crystal structures of different FNRs have been reported (Karplus and Faber 
2004). Among these, the structure showing a productive NADP+/H binding mode of pea FNR 
has been particularly helpful in understanding the mechanism of hydride transfer in this 
widespread enzyme family (Deng, Aliverti et al. 1999). It revealed that the nicotinamide 
moiety lies at an angle of 30 ° against the plane of the flavin isoalloxazine ring and that four 
active site residues fulfill important roles in the catalysis: Ser 90, Cys 266, Glu 306 and 
Tyr 308 (pea FNR numbering). Ser 90 and Glu 306 and their conserved equivalents seem to 
be primarily involved in nicotinamide binding (Aliverti, Bruns et al. 1995; Aliverti, Deng et al. 
1998; Deng, Aliverti et al. 1999). The sulfhydryl group of Cys 266 has been found in close 
proximity to the C4 atom of the nicotinamide ring and is substantially involved in catalytic 
turnover, but less so in nicotinamide binding (Aliverti, Piubelli et al. 1993; Deng, Aliverti et al. 
1999). These findings were confirmed with the Na+-NQR in chapter 3.3.1. of this thesis. It 
was proposed that the cysteine forces the nicotinamide to adopt boat conformations that 
pucker towards the flavin and thus facilitate hydride transfer. Productive puckering 
conformations, induced by the binding of the nicotinamide to the protein, are suggested for 
lactate dehydrogenase and other enzymes (Young and Post 1996). The stacking of the 
aromatic ring of Tyr 308 with the isoalloxazine ring of the flavin in the nicotinamide binding 
pocket appears to be a thermodynamically favored conformation. Tyr 308 does not seem to 
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be directly involved in the catalysis of hydride transfer, but rather in product release and 
stabilization of the flavin (Orellano, Calcaterra et al. 1993; Deng, Aliverti et al. 1999; Piubelli, 
Aliverti et al. 2000; Nogues, Tejero et al. 2004). 
Here, a structure-function study of the C-terminal domain of the NqrF subunit of the 
respiratory Na+-NQR is presented. By site-directed mutagenesis of the Phe 406 residue, a 3D 
crystal structure of NAD+/H in complex with the enzyme was obtained. We observed a 
productive binding mode in which the nicotinamide is angled towards the flavin. In addition, 
kinetic data of F406A and F406S variants are presented which show that the phenyl ring acts 
as intrinsic competitor to the nicotinamide and that it also exercises a stabilizing effect on 
the flavin.  
In contrast to FNRs, which mainly catalyze the two-electron transfer from flavohydroquinone 
to oxidized nicotinamide, the Na+-NQR catalyzes the transfer of a hydride from the reduced 
nicotinamide of NADH to the fully oxidized flavoquinone. It can thus be postulated that 
despite the high structural identity to FNRs, a unique selectivity mechanism must exist in the 
NADH-binding domain of Na+-NQR, which allows the enzyme to discriminate between the 
oxidized and the reduced form of the cofactor. We present structural evidence of such a 
mechanism which involves a conformational change in the nicotinamide and the formation 
or loss of hydrogen bonds with serine 213 and aspartate 404 of NqrF. 
 
3.1.3. The catalytic quinone binding site of Na+-NQR 
Vibrio cholerae is a marine-born pathogen causing in 3 - 5 million disease cases estimated 
100'000 - 130'000 deaths per year (World Health Organization, 2010). This pathogen, like 
many other bacteria, harbors a unique respiratory enzyme complex, the Na+-translocating 
NADH:quinone oxidoreductase (Na+-NQR), that is unrelated to the eukaryotic complex I on 
the level of primary structure, but serves a similar purpose in that it generates an 
electrochemical gradient across the cytoplasmic membrane which in turn drives many other 
cellular processes like H+/Na+-antiporters, solutes uptake and rotation of the flagellum (Häse 
and Barquera 2001). 
Na+-NQR is composed of six subunits NqrA - F and harbors at least five redox active cofactors: 
non-covalently bound FAD and [2Fe-2S] cluster in the NqrF subunit, two covalently bound 
FMNs in subunits NqrB und NqrC and one non-covalently bound riboflavin in subunit NqrB 
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(Barquera, Ramirez-Silva et al. 2006; Tao, Casutt et al. 2008; Bogachev, Bloch et al. 2009; 
Bogachev, Kulik et al. 2009; Casutt, Huber et al. 2010). Upon oxidation of NADH, electrons 
are transferred from NADH via FAD and [2Fe-2S] cluster on NqrF to FMN on NqrC, FMN on 
NqrB, and finally, to riboflavin on NqrB (Juárez, Morgan et al. 2009). However, the final step 
of the reaction cycle - the reduction of the quinone substrate - as well as the coupling of 
redox chemistry to sodium ion translocation are still largely unclear. 
Already in 1992 it was recognized that the resistance of V. alginolyticus towards korormicin, 
a putative quinone analogue, is brought about by two mutations in the NqrB subunit of its 
Na+-NQR (Hayashi, Shibata et al. 2002). It was therefore expected that the NqrB subunit 
would carry the active site for quinone binding and reduction. Instead, we have recently 
identified the NqrA subunit to bind ubiquinone-8 and to interact with short chain quinones - 
in the context of the membrane-embedded/detergent-solubilized holo-Na+-NQR enzyme 
complex as well as with the isolated, soluble NqrA subunit (Casutt, Nedielkov et al. 2011). On 
the other hand, Juárez et al. have shown that the point mutations at glycine 140 and glycine 
141 of the NqrB subunit affect Na+-NQR reduction activity (Juárez, Neehaul et al. 2012), 
which led them to conclude that NqrB would harbor the binding site for Q1. 
The quinone analogue 2,5-dibromo-3-methyl-6-isopropylbenzoquinone (DBMIB, figure 30) is 
a potent inhibitor of the mitochondrial bc1 complex and the cytochrome b6f complex of 
chloroplasts (Draber, Trebst et al. 1970; Loschen and Azzi 1974; Chain and Malkin 1979; 
Degli Esposti, Rugolo et al. 1983; Rich 1984), but can also serve as an electron acceptor with 
a favorable potential of E0 = +180 mV (Simkovic and Frerman 2004). The binding of two 
equivalents of DBMIB into the quinol oxidase (Qo) pocket of the b6f complex has been 
proposed. One equivalent binds with high affinity to a proximal niche, whereas the binding 
of a second equivalent with low affinity to a distal niche induces a rotation of the Rieske 
iron-sulfur protein domain of the complex (Roberts, Bowman et al. 2004). By EPR it was 
shown that DBMIB attaches to and modifies the iron-sulfur center in the bc1 complex with 
inhibition in the nanomolar range and also interacts with cytochrome b. A mechanism was 
proposed where DBMIB does not just act as a simple competitor or redox mediator at the 
quinol oxidase site, but as antagonist to ubiquinone, inducing a redox bypass of the 
respiratory chain (Degli Esposti, Rotilio et al. 1984). 
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Figure 30: Structures of 2,5-Dibromo-3-methyl-6 isopropyl-p-benzoquinone (DBMIB) and 
ubiquinone-1 (Q1). 
 
 
Here, we show that DBMIB both acts as an inhibitor and as alternative substrate of the Na+-
NQR of V. cholerae by a specific interaction with the NqrA subunit of the complex. 
Furthermore, NMR experiments indicate that the NqrA subunit possesses an extended 
binding site for quinone-type ligands that can simultaneously accommodate two quinones 
involving a high-affinity and a low-affinity binding mode. Similar dual occupancy models have 
been proposed for other quinone-converting enzymes based on indirect experimental 
evidence (Ding, Moser et al. 1995; Bartoschek, Johansson et al. 2001; Efremov, Baradaran et 
al. 2010). Our findings provide important insight into mechanistic aspects of the final redox 
step catalyzed by the Na+-NQR. 
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3.2. Materials and Methods 
3.2.1. Chemicals and enzymes 
Unless otherwise noted, all chemicals and reagents were purchased from Sigma-Aldrich. 
Restriction enzymes and T4 DNA ligase were purchased from New England Biolabs. DNA 
polymerase and PCR buffers were obtained from Finnzymes. 
3.2.2. Construction of plasmids 
The gene coding for the N-terminally hexa-histidine-tagged polypeptide consisting of amino 
acids 129 - 408 of NqrF, in the following termed FAD domain, from the Na+-translocating 
NQR of Vibrio cholerae (Tao, Fritz et al. 2008) was synthesized taking into account optimal 
codon usage of E. coli (Mr. Gene, Regensburg). The synthetic gene was cloned into pET15b 
to generate plasmid pFNF53. Likewise, plasmids pFNF378A, pFNF406A and pFNF406S 
encoding for Cys 378 Ala, Phe 406 Ala and Phe 406 Ser substituted variants of the FAD 
domain were constructed (Trenzyme, Konstanz). The plasmids include a rhinovirus 3C 
protease cleavage site which allows removal of the histidine-tag from the FAD domain and 
its variants. To introduce the mutations C378A, F406A and F406S into the subunit NqrF of 
the NQR complex, PCR on plasmid pNQR1 (Tao, Casutt et al. 2008) was performed using 
primers 5'-GACAGGCTACACCGGTTTCATCCATAACG-3' (forward), 5'-CATCGGAGGTCCCGC 
CATGTAGTATTCAC-3' (reverse) and 5'-GTGAATACTACATGGCGGGACCTCCGATG-3' (forward), 
5'-CGTCTTCAAGAATTCTTAACCACCGAAGTC-3' (reverse), 5'-GACAGGCTACACCGGTTTCATCCAT 
AACG-3' (forward), 5'-TCAAGAATTCTTAACCACCCGCGTCATCCAG-3' (reverse) and 5'-
GACAGGCTACACCGGTTTCAT CCATAACG-3' (forward), 5'-TCAAGAATTCTTAACCACCAGAGTCA 
TCCAG-3' (reverse). Mutation sites are marked in bold font. PCR products were inserted in 
pNQR1 using restriction sites EcoRI and AgeI to obtain plasmids pNQR378A, pNQR406A and 
pNQR406S respectively. All constructs were confirmed by DNA sequencing (GATC Biotech AG, 
Konstanz). 
 
3.2.3. Preparation of FAD domain and its variants 
E. coli TunerTM (DE3) strain was transformed with plasmid pFNF53, pFNF378A, pFNF406A or 
pFNF406S. Cells were grown in DYT medium containing 100 µg ml-1 ampicillin at 37 °C. 
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Expression of the FAD domain was induced with 1 mM isopropylthio-β-D-galactoside (IPTG) 
at an OD600 of 0.9. Cells were harvested after 5 h at 30 °C and washed in 10 mM Tris-HCl, 
0.3 M NaCl, 5 mM MgCl2 , pH 7.4. Cells were broken by one passage through an Emulsiflex C3 
cell disruptor (Avestin) at approx. 20 kPsi in the presence of 1 mM DTT and protease 
inhibitors (complete EDTA-free, Roche Diagnostics). Cell debris was removed by 
centrifugation at 20'000 x g for 20 minutes. After ultracentrifugation of the cellular extract at 
150'000 x g (Beckman Type 70Ti), the supernatant was filtrated and loaded onto a Ni 
Sepharose HP column (5 ml bed volume, GE Healthcare) equilibrated with buffer A (20 mM 
Tris-HCl. 0.5 M NaCl, pH 8.0). The column was washed with 5 volumes of buffer A containing 
30 mM imidazole and histidine-tagged protein was eluted with 400 mM imidazole in buffer A. 
Peak fractions were combined and diluted at least 1:10 in 50 mM HEPES-NaOH, pH 7.0. The 
histidine tag was cleaved off by incubation for 15 h at 4 °C with PreScission protease (GE 
Healthcare). Per 1 mg of protein, 6.7 µg of protease was added. By loading the digest onto 
the Ni+ column and washing with 50 mM HEPES-NaOH, pH 7.0, FAD domain devoid of the 
histidine tag was obtained. The target protein was further enriched by loading it onto a 
SourceQ column (10 ml bed volume, GE Healthcare) equilibrated with 50 mM HEPES-NaOH, 
pH 7.0 and eluting with a linear gradient from 0 to 0.4 M NaCl. Protein for crystallization and 
enzymatic assays was frozen in liquid nitrogen in the presence of 5 % glycerol. The yield from 
15 g of cells (wet weight) was 45 mg, 23 mg, 36 mg and 30 mg of the wild type FAD domain, 
the C378A variant, its F406A and F406S variants, respectively. All chromatographic steps 
were performed at 4 °C using an Äkta Prime chromatography system (GE Healthcare). 
 
3.2.4. Preparation of Na+-NQR complex and its NqrF C378A, F406A and F406S 
variants 
The Na+-NQR complex linked to an N-terminal hexa-histidine tag on subunit NqrA and its 
variants with single amino-acid substitutions C378A, F406A or F406S in subunit F were 
purified from Vibrio cholerae strain O395 N1 Δnqr transformed with the corresponding 
plasmids, using methods described previously (Casutt, Wendelspiess et al. 2010). The yield 
from 12 g of cells (wet weight) was 15, 14, 15 and 16 mg of the Na+-NQR, Na+-NQR C378A, 
Na+-NQR F406A and the Na+-NQR F406S variant respectively. 
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3.2.5. Preparation of NqrA 
Subunit NqrA encoded on plasmid pBR322 (Casutt, Nedielkov et al. 2011) was produced in 
E. coli BL21 (DE3). Perdeuterated NqrA was produced in labeled M9 media according to 
(Marley, Lu et al. 2001). The cells were grown in unlabelled lysogeny broth (LB) medium at 
37 °C, shaken at 150 rpm. At an optical cell density at 600 nm (OD600) of approximately 0.7, 
the cells were pelleted by centrifugation for 15 minutes at 5'000 x g at room temperature. 
The cells were then washed once with M9 medium in D2O and pelleted again. Cells were 
resuspended in deuterated M9 medium supplemented with perdeuterated glucose and 
incubated for one hour at 37 °C and 150 rpm. Subsequently, protein expression was started 
by addition of IPTG to a concentration of 1 mM. After 4 hours of incubation the cells were 
harvested. To purify His6-NqrA, washed cells (25 g) were suspended in 50 mM sodium 
phosphate, pH 8.0, 300 mM NaCl, 5 % (v/v) glycerol. One spatula tip of MgCl2, DNase I 
(Roche) and one tablet of protease inhibitor cocktail (Roche) were added to the cell 
suspension which was passed twice through a French pressure cell at 7.58 MPa. Cell lysate 
was centrifuged at 100'000 x g for 60 min. The supernatant was filtrated through a syringe 
filter with 0.2 µm SFCA membrane (Corning) and loaded onto a His-Trap 2 ml (GE Healthcare) 
column equilibrated with running buffer (50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 
5 % (v/v) glycerol, 4 mM NaN3) containing 20 mM imidazole. NqrA was eluted with running 
buffer containing 130 mM imidazole. All experiments were performed with monomeric NqrA 
which was separated from NqrA aggregates on a Superdex 200 16/60 (GE Healthcare) 
column in 50 mM phosphate buffer, pH 8.0, 300 mM NaCl, 5 % (v/v) glycerol, and 4 mM 
NaN3 (Casutt, Nedielkov et al. 2011). 
 
3.2.6. Analytical Methods 
The concentration of catalytically active FAD domain variants was calculated from the 
concentration of FAD in the supernatant of the trichloroacetic acid precipitated purified 
protein. FAD, NADH and ubiquinone-1 (in ethanol) were determined photometrically using 
extinction coefficients ε450 (11.3 mM
-1 cm-1), ε340 (6.22 mM
-1 cm-1) and ε275 (13.7 mM
-1 cm-1), 
respectively (Türk, Puhar et al. 2004). Photometric measurements were performed on a Cary 
50 spectrophotometer (Agilent) at 25 °C if not stated otherwise. Purity of protein-associated 
FAD was verified with a C18 column (Grom) on a Sykam HPLC system using a gradient from 1 
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to 50 % methanol in 50 mM sodium acetate pH 5.0 and comparing the elution profile 
measured at 450 nm to the profile of a 1 to 1 mix of commercial flavin adenine dinucleotide 
and flavin mononucleotide standards. Protein was determined by the bicinchoninic acid 
method (Smith, Krohn et al. 1985) using the reagent from Pierce. Molecular weight and 
purity of protein was estimated by SDS-PAGE (Schägger and von Jagow 1987) by comparison 
with a prestained molecular weight marker (Carl Roth GmbH). 20 µg of protein was loaded 
per lane. Gels were stained with Coomassie Blue Silver (Candiano, Bruschi et al. 2004). 
 
3.2.7. Protein crystallization and X-ray analysis 
FAD domain crystals for X-ray analysis were grown using the hanging-drop vapor-diffusion 
method by mixing 2 µl FAD domain (7 mg ml-1, in 5 mM Tris/HCl, pH 7.5) with 2 µl of 
crystallization solution (0.1 M citric acid, pH 5.0, 35 % (by weight) monomethyl polyethylene 
glycol 5'000 (PEG 5'000 MME), 0.2 M MgOAc) equilibrated against 500 µl crystallization 
solution at 293 K. The yellow crystals with a size of 40 x 80 x 80 m were flash-frozen in the 
cryo-nitrogen stream. 
Crystals of the C378A variant of the FAD domain were grown by mixing 2 µl of 5 mg ml-1 FAD 
domain C378A in 5 mM Tris-HCl, pH 7.5 with 2 µl reservoir solution containing 28 % PEG 
5'000 MME, 0.1 M sodium acetate, pH 5.0, 0.2 M magnesium acetate, and equilibrating the 
drops against 500 µl reservoir solution at 19 °C. 
Crystals of the F406A and the F406S variants of the FAD domain were grown using the 
hanging-drop vapor diffusion method by mixing 2 µl 6 mg ml-1 protein solution in 5 mM Tris-
HCl, pH 7.5 with 2 μl reservoir solution (22 - 27 % PEG 5'000 MME, 0.2 M magnesium acetate, 
0.1 M sodium citrate, pH 5.0 or 5.2). This was followed by streak-seeding of the drops (using 
a cat whisker) with seeding crystals from the FAD domain C378A variant (see below). The 
seeded drops were equilibrated against 0.5 ml reservoir solution at 292 K. To obtain seeds, 
crystals of the FAD domain C378A variant were transferred to 50 μl stabilization solution (24 % 
PEG 5'000 MME, 0.1 M sodium acetate, pH 5.2, 0.2 M magnesium citrate) and grinded using 
the Seed Bead kit (Hampton Research). The concentrated seed stock was diluted 1:10 with 
stabilizing solution to obtain the final seed solution. Crystals of all FAD domain variants were 
soaked for 15 to 20 min in the crystallization solution containing 0.1 M NAD+, 0.2 M NADH 
(disodium salt, Carl Roth GmbH) or 0.2 M NADH with some grains of dithionite, respectively. 
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Crystals were passed through crystallization solution containing 35 % PEG 5'000 MME as 
cryo-protectant and were immediately flash-frozen in liquid nitrogen. X-ray data were 
collected at 100 K using monochromatic synchrotron radiation (λ = 0.9 Å) at the beamlines 
X06SA and X10SA, Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland. The 
diffraction data were processed with the program package XDS (Kabsch 2010). 
 
3.2.8. Structure determination and refinement 
Optimization of the initial crystallization conditions of the FAD domain (Tao, Türk et al. 2006) 
yielded yellow crystals with a size of 40 x 80 x 80 µm. Crystals diffracted to 1.8 Å and 
belonged to space group P212121. Phases were determined by MAD of a crystal soaked with 
K2 Pt(NO2)4 for 3 days. Selected crystals were soaked with mother liquor containing 40 mM 
NADH for 10 - 60 min, or 0.1 mM AgNO3 for 2 - 48 h, prior to flash-freezing. Phases of FAD 
domain C378A, F406A and F406S variants were determined by molecular replacement, 
carried out with the molrep program (Vagin and Teplyakov 2010) from the CCP4 suite (Winn, 
Ballard et al. 2011) and using the structure of the NqrF FAD domain wild type (unpublished 
data, provided by Günter Fritz) as a search model. Refinement was performed with the 
refmac5 program (http://www2.mrc-lmb.cam.ac.uk/groups/murshudov/, access date 
28.9.2011) from the CCP4 suite. Structural alignment and images were generated with Coot 
(Emsley, Lohkamp et al. 2010), PyMOL (Schrödinger 2010) and Discovery Studio (Accelrys). 
 
3.2.9. Enzymatic activities 
NADH dehydrogenase activities of Na+-NQR and FAD domain variants were determined with 
NADH (0.002 - 0.1 mM) and 0.1 mM ubiquinone-1 (Q1; MCAT GmbH) at pH 7.5 in the 
absence of chloride (Tao, Fritz et al. 2008). Quinone reductase activities were determined 
with Q1 (0.005 - 0.05 mM) as electron acceptor at a fixed NADH concentration of 50 µM. 
Rates of NADH oxidation were followed at 340 nm and quinol formation was determined 
from the difference in absorption at 248 nm - 268 nm. Kinetic measurements were 
performed under aerobic or anaerobic conditions under magnetic stirring on a Cary 50 
spectrophotometer (Agilent) or a HP 8452A diode array spectrophotometer (Agilent) in a 
temperature-controlled quartz cuvette at 25 °C and 37 °C. Specific enzyme activities were 
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determined in the presence of 50 µM NADH in buffer temperated to 25 °C if not indicated 
otherwise. For the calculation of KM , apparent KM and Vmax, the Michaelis-Menten or the Hill 
equations were used. The turnover number kcat was calculated using a molecular weight of 
32 kDa for the FAD domain and a molecular weight of 220 kDa for the Na+-NQR complex. Ag+ 
inhibition was assayed by incubating the enzymes for 24 h at 4 °C in the absence or presence 
of AgNO3 and starting the reaction by the addition of NADH. For demonstrative purposes, 
kinetic data are depicted in the double-reciprocal Lineweaver-Burk projection. The inhibition 
constant for Ag+ was calculated assuming an irreversible inactivation (resembling mixed 
inhibition) of the enzyme by silver binding. DBMIB inhibition of the Na+-NQR was assayed by 
incubating the enzyme for 17 h at 4 °C in reaction buffer containing DBMIB and Q1 in 0.1 % 
or 0.25 % ethanol and starting the reaction by addition of NADH. KI for inhibition of NADH 
dehydrogenase activity by DBMIB was calculated assuming an uncompetitive mode of 
inhibition (Voet and Voet 2004). The inhibition of specific quinone reductase activity was 
analyzed assuming a mixed mode of inhibition (Voet and Voet 2004). The correlation 
coefficients and kinetic constants are listed in table 11. The rates were background-
corrected by the changes in absorbance arising from DBMIB reduction by the Na+-NQR to 
enable kinetic analysis of ubiquinol-1 formation only. The reductase activity of Na+-NQR 
using only DBMIB as electron acceptor (Simkovic and Frerman 2004) was assayed under 
identical conditions as Q1 reductase activity with DBMIB concentrations between 0 - 100 µM 
and using the same extinction coefficient as for Q1. Kinetic constants are given in table 12. 
 
3.2.10. Inhibition of growth of Vibrio cholerae by Ag+ 
The effect of Ag+ on the viability of Vibrio cholerae O395 N1 Δnqr expressing Na+-NQR wild 
type and the NqrF C378A Na+-NQR variant was investigated by growth assays: 
Vibrio cholerae cells were grown in Erlenmeyer flasks under agitation in chloride free 
minimal medium with succinate as energy and carbon source. Single colonies of both strains 
were used to inoculate 2 ml minimal medium and were grown at 37 °C overnight. These 
cultures were used to inoculate 20 ml expression cultures. At an OD600 nm = 0.4, expression of 
Na+-NQR wild type and C378A variant was induced by the addition of 5 mM arabinose. 
Cultures were grown for another 16 h to allow expression of Na+-NQR. Cells were harvested 
by centrifugation at 4'000 x g and resuspended in phosphate-free minimal medium. The cell 
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density was adjusted to OD600 nm = 0.1. Different concentrations (0 - 20 µM) of AgCl were 
added and cells were incubated for 26 h at 37 °C under agitation. To address final cell mass 
and growth, the OD600 nm of the cultures with AgCl was determined. 
 
3.2.11. Fluorescence spectroscopy 
To measure the thermal stability during heat denaturation, FAD domain variants were 
diluted in 20 mM Tris-H2SO4, pH 7.5, 50 mM NaSO4 to a concentration of 0.02 mg ml
-1. 
Starting at 10 °C, temperature was increased in steps of 5 °C to a final temperature of 60 °C. 
The intensity of tryptophan fluorescence emission was determined at indicated 
temperatures at 348 nm (λexcitation 295 nm). Alternatively, the fluorescence emission of 
dissociated FAD was measured at 522 nm (λexcitation 450 nm) in steps of 2.5 or 5 °C. Melting 
points were defined as the midpoint temperature of a sigmoidal fit of fluorescence intensity 
plotted against temperature. The correlation coefficient R2 was > 0.995. The dissociation of 
FAD by Ag+ was measured over time at 527 nm. The experiment was started by the addition 
of 5 µM AgCl to 0.63 µM of FAD domain variant in a fluorescence cuvette at 25 °C. Binding of 
DBMIB to NqrA was determined as follows: NqrA was diluted in 50 mM Tris-HCl, 300 mM 
NaCl, pH 8.0 and 5 % (v/v) glycerol to a concentration of 0.25 µM. DBMIB was added from an 
ethanol stock solution to final concentrations between 0 and 200 µM (final ethanol 
concentration ≤ 2 %). Measurements were performed in triplicate at 25 °C. The intensity of 
tryptophan fluorescence emission was determined at 338 nm (λexcitation = 295 nm). The 
increase in quenching (ΔF) of the tryptophan emission was normalized to values between 0 
and 1 and plotted against the concentration of DBMIB. Non-linear regression analyses using 
the Hill equation and the Michaelis-Menten equation were performed. In addition, the data 
were transformed into a linear form using the methods of Rosenthal and Scatchard 
(Scatchard 1949; Rosenthal 1967) and fitted with a second degree polynomial. All 
fluorescence measurements were performed with a Fluorolog 3 spectrofluorometer (Horiba 
Scientific) using a temperature-controlled fluorescence cuvette. 
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3.2.12. NMR spectroscopy 
NqrA was transferred to D2O containing 10 mM potassium phosphate, pH 8.0, 150 mM NaCl, 
4 mM NaN3 by repeated ultrafiltration with Ultrafree 4 membranes (Millipore; molecular 
weight cut-off, 10 kDa). To 10 µM NqrA, Q1 was added from 20 mM stock solutions in DMSO-
d6 to a final concentration of 100 µM. DBMIB was added from stock solutions in DMSO-d6 to 
obtain NqrA samples containing 0 - 150 µM DBMIB as indicated. Additional DMSO-d6 was 
added to keep its concentration constant within the series (1.5 % v/v). The STD NMR 
experiment with DBMIB alone was performed with 2.5 µM NqrA in PBS buffer. DBMIB was 
added to a concentration of 100 µM. Controls were prepared in the same way without NqrA. 
All NMR experiments were acquired at 300 K on a Bruker AVANCE III 600 MHz spectrometer 
equipped with a cryogenic 5 mm TCI-H/C/N triple resonance probe with actively shielded z-
gradient. The samples were transferred to 5 mm NMR tubes and STD NMR experiments 
(Mayer and Meyer 1999) were performed as described (Casutt, Nedielkov et al. 2011). The 
resonances of Q1 were assigned as described in (Casutt, Nedielkov et al. 2011). Water 
suppression was achieved by excitation sculpting (Hwang and Shaka 1995). Resonances of 
NqrA were saturated by applying a train of low-power Gaussian-shaped pulses at 0.2 ppm 
with a total saturation time of 2 s. Off-resonance irradiation was set to 33 ppm. On- and off-
resonance spectra were acquired in an interleaved manner and subtracted after processing. 
Up to 4096 transients were collected at a spectral width of 12 ppm. STD effects were 
determined within the multiple display mode by scaling the off-resonance spectrum down to 
superimpose with the signal of interest in the difference (off - on) spectrum. The influence of 
DBMIB on Q1 STD effects was plotted in Origin 8.1G and fitted to a one-site binding model. 
One value for k was obtained from globally fitting all Q1 signals. Experiments for interligand 
Overhauser effects (ILOEs) were performed in the same buffer as STD NMR experiments. To 
25 µM NqrA or perdeuterated NqrA, 200 µM Q1 or 400 µM DBMIB from 20 mM stock 
solutions in DMSO-d6 were added. DMSO-d6 was added as required to achieve a constant 
concentration of 5 % in the sample. Two samples for the control experiments were prepared 
in the same manner excluding NqrA or quinones respectively. Water suppression was 
achieved by low-power presaturation of water signal during relaxation delay and mixing time 
(Hoult 1976; Hore 1989). The mixing time was set to 600 ms. Up to 960 increments with 48 
scans in each increment were collected at a spectral width of 10 ppm. Spectra were 
processed and analyzed with the software TopSpin (Bruker; v3.1).  
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3.3. Results 
3.3.1. Ag+-mediated killing of Vibrio cholerae originates in silver ion binding to 
cysteine 378 of subunit F of the Na+-NQR 
The Na+-NQR is a six-subunit membrane-bound complex with a molecular mass of 220 kDa 
(Tao, Casutt et al. 2008). In the Na+-NQR, NADH is oxidized by the subunit NqrF which is 
composed of the FAD domain accepting the hydride from NADH, and the ferredoxin domain 
catalyzing electron transfer to other redox centers present in the complex (Türk, Puhar et al. 
2004; Tao, Casutt et al. 2008). The FAD domain of NqrF was previously overproduced in 
V. cholerae, crystallized and biochemically characterized (Türk, Puhar et al. 2004; Tao, Türk 
et al. 2006). It comprises amino acids 129 - 408 and represents the C-terminal part of the 
NqrF subunit. The following chapters describe the production of the FAD domain of the Na+-
NQR from V. cholerae in E. coli. The protein was purified and the 3D crystal structure was 
determined. By introducing mutations in conserved residues of the active site of NADH 
oxidation, we were able to identify Cys 378 of the NqrF subunit as a strong binder of silver 
ions and as a key player in conferring Ag+ sensitivity to Vibrio cholerae. Furthermore, the 
mutagenesis of the Phe 406 residue of NqrF served to analyze the mechanism of NADH 
oxidation in-depth, as described in chapter 3.3.2. 
 
3.3.1.1. Production and purification of the FAD domain of Na+-NQR 
The FAD domain and its variants were purified based on established protocols (Türk, Puhar 
et al. 2004). Figure 31 depicts the enrichment of the wild type FAD domain by immobilized 
metal affinity and anion exchange chromatography. The purified protein exhibited migration 
behavior on SDS-PAGE corresponding to the calculated molecular masses of 34'272 Da (with 
His-tag) and 31'981 Da (His-tag cleaved) respectively. The non-covalently bound FAD adds 
another 786 Da to the molecular mass. 
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Figure 31: Purification of the FAD Domain of the Na+-NQR from Vibrio cholerae. Au: 
Absorption units. A: Enrichment by nickel affinity chromatography. The broad peak 
represents the flow-through fraction. Protein eluting at 110 ml represents the fraction 
collected after washing with 30 mM imidazole. The final maximum at 130 ml contains His-
tagged FAD domain. B: Polishing step by ion exchange chromatography. Dotted line 
represents conductivity of the elution buffer (linear gradient from 0 to 0.4 M NaCl). C: SDS-
PAGE depicting the enrichment of the FAD domain. Lane 1: cellular extract of E. coli 
expressing FAD domain, the amount of cells contained in 200 µl of a culture with OD600 nm = 1 
was loaded. Lane 2: Elution fraction from A. Lane 3: Elution fraction from B, representing 
purified FAD domain without His-tag. The gel was stained with Coomassie blue. 
 
 
It was unknown if the E. coli cells used as expression host for the V. cholerae enzyme would 
be able to supply enough FAD to complement the polypeptide or if the E. coli host would 
resort to incorporate other flavin species. HPLC analysis confirmed that only the flavin 
adenine dinucleotide was inserted into the holo-enzyme (figure 32). Only residual amounts 
of FMN and riboflavin were detected. The FAD domain wild type contained 0.81 mol 
FAD/mol, the C378A variant contained 0.93 mol FAD/mol. 
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Figure 32: FAD domain produced in E. coli contains flavin adenine dinucleotide as sole 
cofactor. HPLC elution profile of a mixture of flavin standards (grey) is superimposed with 
the profile of the supernatant from trichloroacetic acid precipitation of the purified FAD 
domain (black). 
 
 
3.3.1.2. Binding of Ag+ to the FAD Domain of Na+-NQR 
The FAD domain catalyzed NADH oxidation with Q1 as electron acceptor. A Vmax of 
225.2 ± 6.5 µmol min-1 mg-1 and a KM of 7.4 ± 0.8 µM was observed (figure 33). This is in 
accord with the activity of the Na+-NQR complex which was overproduced in V. cholerae. The 
kinetic constants are summarized in table 7. The activities of the isolated FAD domain and 
the Na+-NQR were further assayed in the presence of Ag+ (figure 33; dashed lines). In both 
cases, a significant decrease in Vmax and almost no change in KM was observed, which is best 
interpreted as the inhibition mode of an irreversible inactivator (Voet and Voet 2004), 
effectively lowering the total concentration of catalytically active enzyme. The derived 
inhibition constants KI = KI' were 36 nM for the Na
+-NQR and 20 nM for the FAD domain 
(table 7). This inactivation by low nanomolar concentrations of Ag+ most likely resulted from 
the binding of the heavy metal cation to a cysteine residue close to the NAD(H) binding 
pocket, which in turn prevented hydride transfer from the nicotine amide moiety of NADH to 
the isoalloxazine moiety of the FAD cofactor. To confirm this notion, and to describe the 
interaction of the substrate with the electron input domain of the Na+-NQR at atomic 
resolution, we determined the 3D structure of the FAD domain in complex with Ag+ or NADH. 
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Indeed, the binding of silver ions to a cysteine residue corresponding to position 378 of NqrF, 
in close vicinity to the NADH binding site could be observed (figure 34). Hereupon, a 
mutation of the Cys 378 residue of the FAD domain was introduced which was expected to 
cause a significant loss in the ability of Ag+ to bind to and inhibit the NADH oxidation activity. 
 
 
Figure 33: Inhibition of the Na+-NQR and its NADH-oxidizing FAD domain by Ag+. Rates of 
NADH oxidation with ubiquinone-1 as electron acceptor were determined in the presence or 
absence of AgCl. Mean values from three experiments are presented. Data are shown as a 
Lineweaver-Burk plot and were fitted by linear regression to illustrate the mode of 
irreversible inhibition. A: Na+-NQR complex in the presence (dashed line) or absence (solid 
line) of 100 nM Ag+. B: isolated FAD domain from subunit NqrF in the presence (dashed line) 
or absence (solid line) of 10 nM Ag+.  
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Figure 34: Structure of the NADH-oxidizing FAD domain in complex with Ag+ and/or NADH. 
A: Cartoon view of the FAD domain in complex with NADH. B: Binding of silver atoms to 
Cys 378 in the active site of the FAD domain of subunit NqrF from the Na+-NQR. The FAD 
cofactor (orange) as well as NADH (green) and the conserved amino acids Cys 378 and 
Phe 406 (grey) are shown. The pink orbs represent two silver ions close to Cys 378, which 
spatially overlap with the nicotinamide in its binding pocket. The position of NADH was 
determined from a different crystal of the FAD domain, soaked with NADH. 
 
 
3.3.1.3. Ag+ inhibition is lost in the C378A variant 
Substitution of cysteine 378 by an alanine resulted in the lowering of Vmax to 
60.1 ± 1.0 µmol min-1 mg-1 and the lowering of the KM to 1.2 ± 0.2 µM in the isolated FAD 
domain and a lowering of Vmax to 58.3 ± 3.4 µmol min
-1 mg-1 and of KM to 12.0 ± 2.8 µM in 
the Na+-NQR complex (table 7). These results indicate that the mutation induced a 
conformational change in the active site, to a point where NADH is bound more efficiently by 
the enzyme, but is processed more slowly. It was found that the NADH oxidation activity of 
the C378A variant was completely unaffected at Ag+ concentrations at which the wild type 
was inhibited (figure 35), confirming our notion that cysteine 378 of the NqrF is responsible 
for the irreversible binding and inhibition by Ag+. The inhibition constants were increased by 
one order of magnitude in the C378A variant of the Na+-NQR complex and even by three 
orders of magnitude in the C378A variant of the isolated FAD domain (table 7). 
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Figure 36: Ag+ Inhibition of the Na+-NQR and its NADH-oxidizing FAD domain is reverted in 
the C378A variant. Absorbance of reduced NADH, plotted against time. Reactions were 
started by the addition of 0.1 mM NADH to enzyme pre-incubated in chloride-free buffer 
containing 0.1 mM ubiquinone-1 and either no Ag+ (solid lines), 150 nM (A + B, dotted lines) 
or 1 µM Ag+ (C + D, dotted lines). A: Na+-NQR wild type, B: Na+-NQR C378A, C: FAD domain 
wild type, D: FAD domain C378A. Experiments were done in triplicates, of which one trace 
each is shown. 
 
 
Table 7: Kinetic constants and Ag+ inhibition of the NADH dehydrogenase activity in the 
wild type and C378A variants of the Na+-NQR complex and its FAD domain. 
 Vmax [μmol mg-1 min-1] kcat [s-1] Km [µM] KI [nM] 
NQR wt 108.5 ± 5.6 397.8 36.3 ± 5.2 3.6 x 101 
NQR C378A 58.3 ± 3.4 213.8 12.0 ± 2.8 2.8 x 102 
FAD Domain wt 225.0 ± 7.0 119.9 7.4 ± 0.8 2.0 x 101 
FAD Domain C378A 60.0 ± 1.0 31.9 1.2 ± 0.2 3.0 x 104 
 
 
The mode of Ag+ inhibition was further analyzed by assessing the increase in fluorescence of 
FAD after addition of 5 µM Ag+ to the FAD domain variants. Enhanced flavin fluorescence 
indicates the dissociation of the cofactor from the enzyme. It was found that the C378A 
variant of the FAD domain exhibits a strongly decelerated release of FAD compared to the 
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wild type (figure 36). Additionally, the FAD dissociation over time was best fitted with a 
sigmoidal curve for the wild type FAD domain (Hill coefficient n = 1.3), whereas the 
dissociation of FAD from the C378A variant resembled a hyperbolic curve (sigmoidal and 
hyperbolic fitting data not shown). This indicates that FAD is released from the wild type FAD 
domain in a cooperative manner, involving the specific Ag+ binding site at C378 and one or 
more unspecific binding sites. In the C378A variant only the unspecific Ag+ binding site(s) 
remain, resulting in an uncooperative FAD dissociation mechanism. 
 
 
Figure 36: Dissociation of FAD from the FAD domain and its C378A variant in the presence 
of 5 µM AgCl2. Ag
+ was added at t = 0 s. Black: FAD domain wild type. Grey: FAD domain 
C378A variant. 
 
 
The sensitivity of Vibrio cholerae to Ag+ was analyzed by growth experiments in which the 
expression medium was supplemented with Ag+ concentrations in the nanomolar to 
micromolar range. After 26 h of exposure to silver ions, V. cholerae cells expressing the wild 
type Na+-NQR were either killed or did not replicate at Ag+ concentrations higher than 1 µM 
(figure 37). Concentrations up to 0.5 µM had no effect on cell density or growth. At 
concentrations between 0.5 µM and 1 µM Ag+ the cells grew to significantly higher densities. 
In contrast, cells expressing the C378A variant of the Na+-NQR could sustain Ag+ 
concentrations up to 1.5 µM and showed only a slight increase in final cell mass at 
concentrations between 0.5 µM and 1.1 µM Ag+. 
Powerful Proteins   Chapter 3 - Structure and function of catalytic Na+-NQR subunits 
 
 
95 
 
 
Figure 37: Ag+ mediated killing of Vibrio cholerae and rescue in the mutant expressing the 
C378A variant of the Na+-NQR. Effect of Ag+ on cell density, recorded after 26 h of 
incubation in chloride free minimal medium containing indicated amounts of Ag+. White: 
cells expressing the wild type Na+-NQR. Hatched: cells expressing the C378A variant of the 
Na+-NQR.  
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3.3.2. Structure-function analysis of the NADH oxidizing domain of the Na+-NQR 
from Vibrio cholerae 
3.3.2.1. Crystal structure of the FAD domain in complex with NADH 
Elucidation of the X-ray structure of the FAD domain in complex with NADH revealed an 
unproductive binding mode as reported before for plant-like FNR and related flavoproteins 
(Deng, Aliverti et al. 1999) (figure 38). Phenylalanine 406 is stacked with the isoalloxazine 
ring of FAD and hinders hydride transfer from nicotinamide. 
 
 
Figure 38: Crystal Structure of the FAD Domain in complex with NADH. The structure of the 
holo-enzyme is represented as a space-filling model. The FAD and NADH cofactors (white) 
and the magnified C-terminus (cyan) are shown in a stick representation. 
 
 
3.3.2.2. Phe 406 variants display enhanced nicotinamide binding and catalytic efficiency 
but loss of stability and FAD binding  
The visible spectra of the F406A and F406S variants of the FAD domain displayed a 
significant blue-shift and increased extinction of the 400 nm flavin peak compared to the 
wild type, indicating the loss of stacking interaction from the phenyl ring with the 
isoalloxazine ring (figure 39). A further difference was observed in the absorbance shoulder 
of the second flavin peak at about 480 nm, corresponding to the adenine part of FAD, which 
was reduced in the F406A and F406S variants. The F406S and F406A variants of the FAD 
domain notably exhibit almost identical spectra. 
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Figure 39: UV-visible spectra of free FAD and the wild type, F406A and F406S variants of 
the FAD domain of the Na+-NQR. Spectra were scaled to the measured absorbance of free 
FAD at 451 nm. Solid gray line; FAD, dashed line; FAD domain wild type, solid black line; FAD 
domain F406A, dotted line; FAD domain F406S. 
 
 
The mutagenesis of the phenylalanine 406 residue led to an increase in catalytic efficiency of 
the NADH oxidase reaction at 25 °C (figure 40). The Michaelis constant KM was significantly 
decreased compared to the wild type (wt 7.4 ± 0.8, F406A 2.1 ± 0.2, F406S 3.5 ± 0.4 μM) and 
the maximal reaction rates were determined to be about twice as high (wt 225 ± 7, F406A 
410 ± 7, F406S 509 ± 11 μmol mg-1 min-1). By increasing the reaction temperature to 37 °C, 
reaction rates of the F406 variants decreased to 3 and 5 % of their respective activity at 
25 °C, whereas wild type activity almost doubled (table 8). 
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Figure 40: Kinetics of NADH oxidation of FAD Domain variants at 25 °C. Initial NADH 
oxidation rates were determined in triplicate for each substrate concentration and Vmax/KM 
pairs were calculated by non-linear curve fit. Squares; FAD domain wild type, circles; F406A 
variant, triangles; F406S variant. 
 
 
Thermal stability of the FAD domain variants was analyzed by plotting fluorescence emission 
of tryptophan or free FAD cofactor against temperature (figure 41). The mean fluorescence 
intensity of these molecules in general increases when a protein unfolds and can be 
described by a sigmoidal curve. Melting points were defined as slope maxima temperatures 
of the curve fits. The melting point of the wild type enzyme was observed at 49 - 50 °C, 
whereas the F406A and F406S variants exhibited lower melting points (39 - 43 °C, table 8). 
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Figure 41: Thermal stability of FAD domain variants. Increase in Fluorescence emission 
intensities of intrinsic A: tryptophan or B: FAD. Melting points were determined by sigmoidal 
curve fit. Squares; FAD domain wild type, circles; F406A variant, triangles; F406S variant. 
Experiments were done in triplicate, of which one each is presented. 
 
 
 
Table 8: Kinetic constants and thermal stability of FAD domain and Na+-NQR variants, n = 3. 
 
FAD d.  
wild type 
FAD d. 
F406A 
FAD d. 
 F406S 
Na+-NQR  
wild type 
Na+-NQR 
F406A 
Na+-NQR 
F406S 
Vmax  
[µmol mg-1 min-1] 
225.0 ± 7.0  410.2 ± 7.2  509.2 ± 11.3  108.5 ± 5.6  n.d. n.d. 
KM [µM] 7.4 ± 0.8  2.1 ± 0.2  3.5 ± 0.4  36.3 ± 5.2  n.d. n.d. 
kcat [s-1] 119.9  218.0  270.8  397.8  n.d. n.d. 
Tryptophan 
melting point [°C] 
50.4 ± 0.1  41.6  39.2 ± 0.4  n.d. n.d. n.d. 
Flavin melting 
point [°C] 
48.7 ± 0.2  42.7 ± 0.2  43.4 ± 0.2  n.d. n.d. n.d. 
Sp. activity 25 °C  
[µmol mg-1 min-1] 
199 ± 5 391 ± 7 478 ± 23 37.8 ± 2.1 14.9 ± 0.8 10.5 ± 0.7 
Sp. activity 37 °C 
[µmol mg-1 min-1] 
389 ± 21 20 ± 3 15 ± 2 20.8 ± 2.9 2.1 ± 0.5 2.5 ± 0.3 
                 
                 
  
Ratio in [%] 
195  5  3  54  14  24  
Sp. activity: Specific enzymatic activity. Melting points are defined as midpoints of the 
sigmoidal fit of the fluorescence  of flavin dissociation or tryptophan unfolding.  
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Additionally, analysis of NADH oxidase activity of the F406 variants displayed their increased 
product inhibition. The presence of 1 mM NAD+ had only minor impact on the specific 
activity of the wild type, but reaction velocities of F406A and F406S decreased by 55 % and 
73 %, respectively (table 9). 
 
Table 9: Product inhibition data of FAD domain variants. 
Specific NADH oxidation rates 
[µmol mg-1 min-1] 
FAD Domain  
wild type 
FAD Domain  
F406A 
FAD Domain  
F406S 
No NAD+ added 190 ± 15 457 ± 22 489 ± 10 
1 mM NAD+ added 184 ± 8 206 ± 19 130 ± 15 
% inhibition in the presence of 
1 mM NAD+ 
3 55 73 
 
 
3.3.2.3. Productive binding with NAD+ and NADH 
Soaking of crystals obtained from the purified F406A and F406S variants of the FAD domain 
with 0.1 M NAD+ or 0.2 M NADH yielded electron density maps with the nicotinamide ring in 
a productive binding mode for hydride transfer. A superposition of F406S structures with 
either form of the cofactor is shown in figure 42. Both NAD+ and NADH nicotinamide are 
tilted relative to the plane of the isoalloxazine ring. C4 of nicotinamide is about equidistant 
from Cys 378 Sγ and isoalloxazine N5 (3 - 3.6 Å) in both the oxidized and reduced forms. 
NAD+ nicotinamide is slightly shifted, increasing the distance from carboxamide to Ser 213 
Oγ by 2 - 2.5 Å. The C-terminal residues are flexible (high B-factors) and could not completely 
be modeled in all cases. Positions of the FAD cofactors are comparable, but the isoalloxazine 
is tilted by 16 ° counterclockwise in the NAD+ structure. 
 
Powerful Proteins   Chapter 3 - Structure and function of catalytic Na+-NQR subunits 
 
 
101 
 
 
Figure 42: Nicotinamide binding mode in the F406S variant of the FAD domain bound to 
NAD+ or NADH. A: Superposition of the active site. Yellow: FAD domain F406S-NADH 
complex. White: FAD domain F406S-NAD+ complex. Dotted lines show stabilizing interactions 
between the nicotinamide and the surrounding isoalloxazine, serine, cysteine and aspartate 
moieties. B + C: Side views of the NADH and NAD+ complexes, respectively with 2Fo-Fc 
electron density maps contoured at 1 σ (left panels). Hydrogen atoms are highlighted in the 
middle panels. For clarity, the right panels show the formulas of the ribosyl-nicotinamide of 
NADH and NAD+. 
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3.3.2.4. Structural superposition of ferredoxin:NADP+ reductase Y308S and FAD Domain 
F406S variants in complex with NAD+ 
The F406S-NAD+ complex was also compared with the structure of the FNR Y308S-NADP+ 
complex (PDB 1QFY). The Rossmann fold forming the nicotinamide dinucleotide binding 
pocket and the anti-parallel beta-sheet structure which forms part of the flavin adenine 
dinucleotide pocket are highly conserved (figure 43). Residues Cys 378, Ser 213 and Asp 404 
are closely positioned to their respective counterparts. Similar to the situation in F406S-
NAD+/NADH superposition, the carboxamide group of the F406S NAD+ is slightly shifted and 
rotated around the C7 - C3 bond. The isoalloxazine moiety in the FNR structure is shifted by 
about 1 Å and also rotated clockwise by 22 °, leading to a shorter distance between 
nicotinamide C4 and isoalloxazine N5. The adenine groups of FAD are arranged differently by 
rotation of about 180 ° around the 4'C - 5'C bond of the ribose. 
 
 
Figure 43: Structural alignment of the Na+-NQR FAD domain F406S-NAD+ complex (white) 
and the FNR Y308S-NADP+ complex (green). Right panel: Magnification of the nicotinamide 
binding site. Dotted lines show stabilizing interactions between the nicotinamide and the 
surrounding isoalloxazine, serine, cysteine and aspartate/glutamate moieties. 
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3.3.3. The catalytic quinone binding site of the Na+-translocating NADH:quinone 
oxidoreductase from Vibrio cholerae accommodates two quinones 
3.3.3.1. Interaction of Na+-NQR with Q1 and DBMIB monitored by the  
electron transfer activities 
As DBMIB is an analogue and antagonist of ubiquinone, it was used in this work to obtain 
information on quinone binding by the Na+-NQR. First, we asked whether DBMIB has an 
influence on NADH oxidation by the Na+-NQR. The effect of DBMIB on NADH oxidase activity 
was assayed by maintaining a constant concentration of the artificial electron acceptor Q1 
while varying the concentration of the substrate NADH. Both NADH oxidation and quinol 
formation were recorded. Determined Vmax and Km values were 147.5 ± 1.7 µmol min
-1 mg-1 
and 29.6 ± 0.6 µM, respectively, for NADH oxidation and 38.9 ± 1.2 µmol min-1 mg-1 and 
24.5 ± 1.5 µM, respectively, for quinol formation (table 10). Pre-incubation of the enzyme 
with 10 µM DBMIB led to a decrease in the NADH oxidation rate Vmax as well as in the 
Michaelis constant KM with similar manifestations on the NADH oxidation and the quinol 
formation rates (figure 44, table 10). 
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Figure 44: Inhibition of Na+-NQR by DBMIB determined at varying concentrations of NADH. 
Assays were performed in the presence of 0.1 mM Q1. Specific activities (V) are expressed as 
µmol NADH used or µmol QH2 formed per mg of enzyme per minute in the absence (squares) 
or presence of 10 µM DBMIB (triangles). Kinetic constants are summarized in table 10. 
Upper panel: NADH oxidation. Lower panel: Quinol formation.  
 
 
 
Table 10: Inhibition of Na+-NQR by DBMIB at varying NADH concentrations described by 
the Michaelis-Menten formalism. 
Activity recorded as Kinetic constants 0 µM DBMIB 10 µM DBMIB  
NADH oxidation R2 0.9998 0.9956 
 Vmax [µmol min
-1 mg-1] 147.5 ± 1.7 63.1 ± 2.5 
 KM [µM] 29.6 ± 0.6 15.1 ± 1.4 
 KM/Vmax  0.2 0.24 
 KI' [µM]  - 7.5 
Quinol formation R2 0.9985 0.9904 
 Vmax [µmol min
-1 mg-1] 38.9 ± 1.2 19.4 ± 1.0 
 KM [µM] 24.5 ± 1.5 12.4 ± 1.7 
 KM/Vmax  0.63 0.64 
 KI' [µM] - 9.9 
Powerful Proteins   Chapter 3 - Structure and function of catalytic Na+-NQR subunits 
 
 
105 
 
The concentration of Q1 in the assays was 0.1 mM. Corresponding rates are presented in 
figure 44. For calculation of KI', the equation for uncompetitive inhibition was applied: 
     
        
        
 
where α' = 1 + [I] / KI' (Voet and Voet 2004). 
 
 
Varying the ubiquinone-1 concentration of the buffer while starting the assay always by the 
addition of 50 µM NADH allowed the kinetic description of the quinone reductase activity of 
the Na+-NQR. Assays in the absence of DBMIB displayed a clearly defined Michaelis- 
Menten-like behavior of the enzyme (figure 45, upper panel) with a Vmax value of 
25.8 ± 0.6 µmol min-1 mg-1 and a KM value of 14.0 ± 0.9 µM for quinol formation (table 11). 
No cooperativity in substrate binding was detectable (Hill coefficient n = 1.1 ± 0.1, table 11), 
indicative of only one catalytically active quinone site. If quinone reductase activity was 
measured in the presence of 10 µM or 25 µM DBMIB (figure 45, middle and lower panel 
respectively), decrease of Vmax and increase of Km values was observed, however, when 
assuming pure Michaelis-Menten behavior the quality of the fit was significantly decreased 
compared to the situation without DBMIB, manifested in lower correlation coefficients 
(table 11). Fits using the Hill equation yielded better results with respect to the squared 
correlation coefficient R2, with cooperativites of n = 1.3 ± 0.2 in the presence of 25 µM 
DBMIB and n = 1.5 ± 0.2 in the presence of 10 µM DBMIB (table 11). 
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Figure 45: Quinone reductase activities of Na+-NQR in presence or absence of DBMIB. 
Specific activity (V) is expressed as µmol Q1 reduced per mg of enzyme per minute. Rates 
were measured without addition of DBMIB (squares) and in the presence of 10 µM (triangles) 
or 25 µM (circles) DBMIB. The upper panel depicts Michaelis-Menten fits, the middle panel 
shows the same data with sigmoidal Hill fits. The lower panel shows a close-up of the data 
from the inhibition with 10 µM DBMIB where the difference between fitting models is the 
most distinctive. 
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Table 11: Analysis of the rates of quinol formation by Na+-NQR at varying Q1 
concentrations in the absence or presence of DBMIB by the Michaelis-Menten or the Hill 
formalism. 
Michaelis-Menten 
ν0 = (Vmax * [S]) / (KM + [S]) 
No DBMIB 10 µM DBMIB 25 µM DBMIB 
R2 0.9963 0.9811 0.9874 
Vmax [µmol min
-1 mg-1] 25.8 ± 0.6 22.6 ± 1.4 15.2 ± 1.1 
KM [µM] 14.0 ± 0.9 19.4 ± 3.1 39.5 ± 6.0 
KI [µM] - 35.9 38.7 
KI' [µM] - 70.6 35.8 
    
Hill 
ν0 = (Vmax * [S]
n) / (Kn + [S]n) 
No DBMIB  10 µM DBMIB 25 µM DBMIB 
R2 0.993 0.9878 0.9896 
Vmax [µmol min
-1 mg-1] 25.1 ± 1.2 19.1 ± 0.9 12.5 ± 1.1 
K [µM] 13.3 ± 1.5 13.9 ± 1.2 25.7 ± 4.7 
n  1.1 ± 0.1 1.5 ± 0.2 1.3 ± 0.2 
The NADH concentration in the assays was 50 µM. Corresponding rates are presented in 
figure 45. For calculation of KI and KI', the equation for mixed inhibition was applied:  
     
        
         
 
where α = 1 + [I] / KI and α' = 1 + [I] / KI' (Voet and Voet 2004). 
 
 
 
As DBMIB can also serve as electron acceptor in quinone reducing enzymes (Simkovic and 
Frerman 2004), reductase activity of the Na+-NQR using DBMIB as substrate was determined 
separately (table 12). DBMIB inhibition data were corrected for this effect. 
 
Table 12: Kinetic constants of the Na+-NQR quinone reductase activity using DBMIB as 
substrate. 
Michaelis-Menten 
ν0 = (Vmax * [S]) / (KM + [S]) 
 
 
NADH oxidation R2 0.9956 
 Vmax NADHox [µmol min
-1 mg-1] 14.39 ± 0.65 
 KM NADHox [µM] 39.97 ± 3.77 
DBMIB reduction R2 0.9944 
 Vmax [µmol min
-1 mg-1] 5.62 ± 0.34 
 KM [µM] 53.67 ± 6.29 
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3.3.3.2. Binding of DBMIB to the NqrA subunit 
It was recently shown that subunit NqrA of the Na+-NQR harbors a Q binding site (Casutt, 
Nedielkov et al. 2011). We now asked if NqrA also interacts with DBMIB. NqrA contains three 
tryptophan residues. Measurement of tryptophan fluorescence during DBMIB titration 
enabled us to detect changes in the microenvironment of the binding site. Incubation of 
NqrA with DBMIB lead to quenching of the fluorescence. Saturation of the quenching was 
observed at concentrations > 100 µM DBMIB, with 15 % of the original fluorescence 
remaining, indicating that at least two of the three tryptophan residues of the protein are 
closely affected by DBMIB binding. The data were fitted to a one-site binding and a Hill 
model (figure 46). The goodness of fit was significantly higher with the sigmoidal Hill model 
yielding an apparent KD of 5.05 ± 0.25 µM and Hill coefficient of n = 1.95 ± 0.20 (table 13). 
The Scatchard plot of the data revealed a parabola which is open at the bottom, confirming 
the findings of a positive cooperativity (figure 46, lower panel). 
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Figure 46: Binding of DBMIB to NqrA monitored by quenching of tryptophan fluorescence. 
Upper panel: Fluorescence emission spectra, from top to bottom (using 338 nm as 
reference): 0.25 μM NqrA titrated with 0, 1, 5, 10, 20, 30, 50, 75, 100 and 200 μM DBMIB. 
Bottom-most spectrum is buffer only (50 mM Tris-HCl, 300 mM NaCl, pH 8, 5 % glycerol). 
Excitation wavelength was 295 nm. Samples were measured in triplicates, one spectrum is 
shown of each condition. DBMIB exhibits no fluorescence in the analyzed wavelength range. 
Lower panel: The increase in quenching (ΔF) of the tryptophan emission at 338 nm depicted 
in the upper panel was normalized to values between 0 and 1 and plotted against the 
concentration of DBMIB. Non-linear regression analysis using the Hill equation (dashed line) 
and a one-site binding model (solid line) was performed. Inset: Scatchard plot with 
polynomial fit, visualizing the cooperative binding of two equivalents of DBMIB to NqrA. 
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Table 13: Binding of DBMIB to the NqrA subunit according to tryptophan fluorescence 
quenching. 
One-site binding model:   y = (P1 * x ) / (P2 + x)  
R2   0.97495 
P1   1.06 ± 0.04 
P2   5.14 ± 1.05 µM 
  
Hill equation:   y = (P1 * x
n) / (P2
n + xn)  
R2   0.99464 
P1   0.98 ± 0.01 
P2   5.05 ± 0.25 µM 
n   1.95 ± 0.20 
  
Polynomial, 2nd degree:   y = A + B * x + C * x2  
R2   0.93672 
A   0.03 ± 0.01 
B   0.30 ± 0.05 
C - 0.33 ± 0.04 
Fluorescence data were fitted to a one site binding model and to the Hill equation 
(cooperative binding of more than one ligand). In addition, the data, plotted according to 
Scatchard, were fitted to a 2nd degree polynomial. 
 
 
STD NMR confirmed DBMIB binding to NqrA with, at a given ligand-to-protein-ratio, STD 
effects that were even stronger (max. 25 %) than with Q1 (max. 8.5 %) (figure 47). 
Furthermore, signals in the proton NMR spectrum of DBMIB became broad and shifted upon 
binding to NqrA which is indicative for a binding kinetic at the intermediate NMR time scale. 
In order to circumvent problems caused by exchange broadening, STD effects were 
quantified at a higher excess of DBMIB (40:1) as compared to experiments with Q1. The 
strongest STD signals originated from the isopropyl group of DBMIB (methyl groups: 25.0 %, 
CH group: 24 - 25 %). The methyl group bound directly to the quinone ring showed an STD 
effect of 16.1 %. This suggests that the isopropyl group of DBMIB is in closest contact to 
NqrA. 
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Figure 47: Saturation transfer difference NMR of DBMIB interacting with NqrA. Reference 
(upper panel) and STD NMR (lower panel) spectra of DBMIB in the presence of NqrA (molar 
ratio = 40:1). The reference spectrum was scaled to 14 % of its original intensity. Signals of 
the same intensity in the STD spectrum correspond to an STD effect of 14 %. 
 
 
3.3.3.3. DBMIB and ubiquinone Q1 bind simultaneously to the NqrA subunit 
In order to investigate how DBMIB affects the binding of Q1 to the NqrA subunit we studied 
the influence of DBMIB on the STD effects of Q1 at a constant concentration of Q1 (figure 
48A). The changes of STD effects of all Q1 signals were quantified and are presented in figure 
48B. To this end, STD effects in the absence of DBMIB were set as a reference and 
subtracted from all other effects measured in the presence of the inhibitor. Importantly, STD 
effects increased with increasing concentrations of DBMIB. STD effects of Q1 were affected 
by DBMIB in a concentration dependent fashion. This effect leveled off at DBMIB 
concentrations above 80 - 100 µM. STD changes of all five signals of Q1 were fitted globally 
to a one-site binding model, leading to an EC50 value of k = 26.1 ± 2.5 µM. 
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Figure 48: Saturation transfer difference NMR spectroscopy of Q1 and DBMIB in the 
presence of NqrA. A: Reference (upper panel) and three STD NMR (three lower panels) 
spectra of Q1 with increasing DBMIB concentration in the presence of NqrA. The reference 
spectrum was scaled to 37 % of its original intensity. Signals of the same intensity in the STD 
spectrum correspond to an STD effect of 37 %. The picture shows growing STD effects of Q1 
signals with increasing DBMIB concentration. B: Changes of saturation transfer difference 
NMR effects of Q1 depending on the concentration of DBMIB. Experimental data points are 
fitted to a one-site binding model (y = Bmax * x / (k + x), solid lines), the constant k was fitted 
globally for all curves. 
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The influence of DBMIB on STD effects of Q1 was also analyzed with regard to the binding 
mode of Q1 (table 14). For this purpose a ratio between STD effect of Q1 at maximal 
concentration of DBMIB and in the absence of DBMIB was calculated. These ratios were then 
normalized to the minimal ratio (for H10) that was set to 1. Rather than increasing or 
decreasing all STD effects of Q1 homogeneously, the quinone analogue DBMIB affected the 
STD intensities of H-5’ and H-7 more strongly than the remaining signals of Q1. Our analysis 
shows that STD effects of H-5’ and H-7 increase disproportionately upon addition of DBMIB. 
 
Table 14: Relative changes of the STD effects of Q1 induced by the presence of DBMIB. 
 STD effects of Q1, % Ratio 150 µM / 
0 µM DBMIB 
Relative ratio, 
ratio(H10) = 1 Signal no DBMIB DBMIB 150 µM 
H11 6.0 26.3 4.38 1.07 
H10 7.5 30.7 4.09 1.00 
H5' 5.1 25.8 5.06 1.24 
H7 3.4 20.0 5.88 1.44 
OCH3 8.5 34.9 4.11 1.00 
 
 
3.3.3.4. DBMIB and ubiquinone Q1 occupy an extended quinone binding site 
The fact that, according to STD NMR, DBMIB does not displace Q1 from the binding site but 
alters the binding mode of the native substrate led us to ask whether both quinones interact 
with NqrA in direct vicinity to each other. To test this we recorded NOESY spectra of both 
ligands in the presence of NqrA (figure 49). Indeed, we observed interligand NOE 
correlations (ILOEs) between Q1 and DBMIB (London 1999). These correlations are only 
observed in the presence of NqrA. A mixture of both ligands in the absence of NqrA does not 
show ILOEs (figure 49) nor does NqrA show crosspeaks at these positions in the absence of 
Q1 and DBMIB. It is important to note that the observation of ILOEs critically depends on the 
presence of NqrA but proved independent on whether protonated or perdeuterated NqrA 
was used during NOESY experiments. That means that the correlations observed originate 
from direct transfers between the ligands and not from protein-mediated effects.  
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Figure 49: Interligand Overhauser 
effects between Q1 and DBMIB in the 
presence of NqrA. A: Scheme illustrating 
the build-up of an intermolecular NOE 
due to simultaneous binding of both 
ligands in direct vicinity to each other. B: 
Expansion of the NOESY spectrum of 
200 µM Q1 and 400 µM DBMIB in the 
presence of 25 µM NqrA in deuterated 
PBS buffer (150 mM NaCl, 10 mM NaPi, 
4 mM NaN3 in D2O). The mixing time was 
600 ms. Chemical shifts at which traces 
were extracted for panel C are indicated 
by dashed lines. C: Three panels C1, C2, 
and C3, showing traces extracted from 
the NOESY spectrum of Q1 and DBMIB. 
In each panel, the blue trace originates 
from the NOESY spectrum measured in 
the presence of protonated NqrA; the 
green trace was measured in the 
presence of perdeuterated NqrA; the 
red trace was measured in the absence 
of NqrA. ILOEs are indicated by 
arrowheads. The position of the 
diagonal signal is marked with an 
asterisk. 
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3.4. Discussion 
3.4.1. Ag+-mediated killing of Vibrio cholerae originates in silver binding to 
Cys 378 of subunit F of the Na+-NQR 
We determined the high-resolution 3D structures of the FAD domain in complex with NADH 
or Ag+. An overlay of the two structures (figure 34) revealed the presence of the heavy metal 
cation in a site occupied by the nicotine amide moiety of the enzyme during catalysis. Ag+ 
was ligated to the thiolate sulfur of C378 protruding into the active site. In parallel, kinetic 
studies determined that the Na+-NQR and the isolated FAD domain are irreversibly 
inactivated by nanomolar concentrations of Ag+ (figure 33). The C378A variants of these 
enzymes did not exhibit this inactivation, or only in a very diminished form (figure 35, 
table 7). 
A study on the Na+-translocating NADH-quinone reductase from Vibrio alginolyticus found 
Ag+ to act as a competitive inhibitor in respect to quinones (Unemoto, Ogura et al. 1993). 
However, effects on NADH oxidation were not investigated. Furthermore, the inhibition 
experiments were performed in the presence of 200 mM Cl-. Due to the low solubility of 
AgCl (solubility product constant [AgCl] = 1.7x10-10 mol-2 l-2;(Weast 1981)), it can be assumed 
that the free Ag+ concentration in these experiments was much lower than specified. A 
subsequent study concluded that the mode of inhibition by nanomolar concentrations of Ag+ 
on Na+-NQR must be one of irreversible inactivation, most likely involving the displacement 
of FAD from the NADH dehydrogenase site by Ag+ (Steuber, Krebs et al. 1997). Our findings 
confirm this mode of inhibition and reinforce the conclusion that the cysteine 378 of subunit 
NqrF is the primary attack point for silver ions in the Na+-NQR. 
Our in vivo experiments show that V. cholerae exhibits increased viability if expressing the 
Na+-NQR C378A variant versus the Na+-NQR wild type when 1 - 1.5 µM Ag+ are present in the 
medium. This implies that the Na+-NQR represents one of the most sensitive and essential 
components in the cell. Ag+ concentrations lower than 1 µM did not have a measurable 
effect in spite of the Na+-NQR having a KI in the low nanomolar range (table 7). There might 
be several reasons accounting for this fact: Ag+ most likely cannot easily pass the cell 
membrane. Since Cys 378 of NqrF is located on the cytoplasmic side of the membrane, there 
might be limited access of the free Ag+ to this residue. Also, succinate present in the medium 
may chelate Ag+ and lower the free Ag+ concentration. Other components of the cell may 
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bind Ag+ as well, diminishing the drastic toxic effect on the bacterial cell. Such a component 
is e.g. glutathione. At Ag+ concentrations above 1.5 µM, there is no visible protective effect 
of the C378A mutation. Since we a look at whole cell viability, there may be many factors 
which influence the survival of the bacterial cell. Energy metabolism is just one aspect. 
Higher concentrations of Ag+ very likely target other essential systems, as well leading to 
bacterial death. 
Central processes like synthesis of proteins and respiration are essential for the survival of 
microorganisms. Respiratory enzymes like the Na+-NQR are putative targets for antibacterial 
drugs, as shown for the complex V (ATP synthase) from Mycobacterium tuberculosis (Andries, 
Verhasselt et al. 2005). The Na+-NQR does not exhibit sequence homology to the 
mitochondrial complex I from eukaryotes, an enzyme which is not inhibited by Ag+ (Lin, 
Puhar et al. 2008) and whose NADH binding site does not contain a cysteine residue which 
could act as a ligand for Ag+ (Sazanov and Hinchliffe 2006). In accord with that finding, the 
toxicity of Ag+ in humans is very low (Silver 2003), and it seems as if the full potential of 
silver, especially as constituent of different chemical entities, is not yet tapped. Our study 
represents the basis for the development of novel, silver-based strategies to combat 
bacterial infections in the future. 
 
3.4.2. Structure-function analysis of the NADH oxidizing domain of the Na+-NQR 
from Vibrio cholerae 
Cysteine residues in active sites of enzymes are often stabilized in their thiolate state as they 
are readily deprotonated by the microenvironment of the surrounding protein (Klomsiri, 
Karplus et al. 2011). It is observed in numerous NADH dehydrogenases that cysteines are 
involved in critical catalytic steps. In liver alcohol dehydrogenase, two deprotonated 
cysteines help coordinate the catalytic Zn2+ ion. In addition, one of these cysteines, Cys 174, 
was found in close distance to the C4 of the NAD+ nicotinamide, so that sulfhydryl-
nicotinamide adducts have been proposed (Hackett, Novoa et al. 1986). Such adducts were 
also implicated with the first catalytic step of glyceraldehyde-3-phosphate dehydrogenase 
(Moras, Olsen et al. 1975) and in cytochrome b5 reductase (Hackett, Novoa et al. 1986). In 
the flavoprotein family of ferredoxin:NADP+ reductases, to which the FAD domain of NQR 
belongs, a cysteine is structurally conserved directly in the binding pocket of the nicotine 
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amide moiety, as shown in figure 34. It has been proposed that this cysteine helps forcing 
the nicotinamide against the flavin and restricting its conformational freedom to facilitate 
hydride transfer (Deng, Aliverti et al. 1999). Based on our functional and structural findings, 
we suggest a more active role of this residue and propose that the thiolate group of cysteine 
378 catalyses hydride transfer by directly stabilizing the δ+ on C4 of the nicotine amide ring 
during the transition state of the reaction, either as a charge-transfer complex or in a SN2-
like substitution. Supporting this hypothesis are data presented in chapter 3.3.1., in which 
the C378A variant of the FAD domain showed improved NADH binding but significantly 
decreased catalytic turnover (27 % of wild type). 
The role of the phenylalanine 406 residue in the NADH-oxidizing FAD domain seems in many 
ways comparable to the role of the C-terminal tyrosine in ferredoxin:NADP+ reductase which 
has been described, among others, in (Orellano, Calcaterra et al. 1993; Piubelli, Aliverti et al. 
2000) and (Nogues, Tejero et al. 2004). The authors of latter publication described the 
function of the C-terminal tyrosine as "[...] lowering the affinity for NADP+/H to levels 
compatible with steady-state turnover [...]". In this work, phenylalanine mutants F406A and 
F406S were analyzed, resulting in enhanced nicotinamide binding of the respective FAD 
domain variant. In addition, both FAD domain variants were not impaired in their catalytic 
activity, but surprisingly displayed even higher turnover rates than the wild type at 25 °C. 
This effect, not observed in the respective FNR analogs, comes at the cost of losing enzyme 
stability, the FAD cofactor, and is accompanied with a loss of function at increasing 
temperatures. It cannot completely be ruled out that the presence of the ferredoxin-like N-
terminal domain, which harbors the [2Fe-2S] cluster of NqrF and which was not part of this 
study, would diminish this effect and lead to tighter FAD binding, but kinetic data of the 
phenylalanine variants of the holo-NQR complex (table 8) also suggest a destabilizing effect 
of the mutation. We thus conclude that phenylalanine acts as an internal competitor for the 
nicotinamide and that it enhances stability by keeping the FAD in place. Stabilization by 
stacking interaction with the isoalloxazine ring seems plausible and has been proposed 
before (Orellano, Calcaterra et al. 1993). When phenylalanine lowers the affinity for NAD+/H, 
it does so without much discrimination. The KM for NADH of the Na
+-NQR was determined at 
36 µM in this work. The KI for competitive inhibition of Na
+-NQR by NAD+ is reported as 
11 mM (Bogachev, Belevich et al. 2009). The reason for the at least 100-fold higher affinity of 
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the enzyme for the reduced over the oxidized nicotinamide is still unclear, but possibly best 
explained by conformational differences between the oxidized/reduced nicotinamide moiety.  
In the structure of pea FNR where productive NADP+/H binding was observed, Ser 90 and 
Glu 306 have been identified as active site residues forming hydrogen bonds with the amide 
group and thus are pivotal in the binding of nicotinamide (Deng, Aliverti et al. 1999). In the 
FAD domain of Na+-NQR, Ser 213 and Asp 404 take analogous roles, positioned very similarly 
in the nicotinamide binding pocket. With the structural elucidation of the productive binding 
mode, a direct involvement of the serine residue in hydride transfer could be excluded. That 
this residue is nevertheless critical for catalysis has been shown in (Aliverti, Bruns et al. 1995), 
where a serine 96 to valine mutation of the spinach FNR led to an almost complete loss of 
activity. Similar conclusions were made regarding the function of the Glu 312 residue of FNR 
from the same species (Aliverti, Deng et al. 1998). 
While the alignment between the FNR-Y308S-NADP+ and NADPH structures revealed no 
significant differences in the coordinates of the nicotinamide group (Deng, Aliverti et al. 
1999), we found that the nicotinamide ring was shifted by about 2 Å between the NADH and 
NAD+ soaked structures (figure 42) of FAD domain F406S as well as F406A. This shift causes 
the distances between the amide nitrogen to Ser 213 Oγ to increase from 2.5 Å to 5.2 Å and 
the distance from the amide nitrogen to the Asp 404 Oε2 to increase from 3.2 Å to 3.6 Å in 
the oxidized form, effectively losing its hydrogen bonding. This difference, especially the 
serine/amide shift, was found consistently in both monomers of the asymmetric unit and in 
all measured crystals with small variations in the overall position of the nicotinamide-ribose 
and the C-terminus (n NAD+-soaks = 14, n NADH soaks = 20). Model bias can be excluded, 
since the coordinates of a crystal soaked with NADH were used for molecular replacement to 
solve the structure of the FAD domain soaked with NAD+. 
In addition, we found that the carboxamide group of NAD+ is best fitted into the 2Fo-Fc 
density map with a torsion angle of 20 ° to 25 ° relative to the plane of the nicotinamide ring, 
whereas the carbonyl amide group of NADH stays mostly planar with the ring (figure 42B + 
42C). This turn of the carboxamide group has been observed in various protein structures 
with NAD+ cofactors (Eklund, Samama et al. 1984) and in the X-ray structure of the NAD+ 
molecule (Wright and King 1954) and represents an energetic minimum with respect to the 
relative orientation of the C7 - C3 bond (Coubeils, Pullman et al. 1971). In this orientation, 
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the amide hydrogens are arranged in a synclinal manner with respect to the hydrogen on the 
sp2-hybridized C4 atom. 
It may well be that this internal change in nicotinamide conformation can tip the scales 
towards formation or loss of hydrogen bonding, the productive binding of nicotinamide and 
thus represents the determinant of the selectivity mechanism of the Na+-NQR. 
 
3.4.3. The catalytic quinone binding site of the Na+-translocating NADH:quinone 
oxidoreductase from Vibrio cholerae accommodates two quinones 
The kinetic characterization of the Na+-NQR complex suggests that quinone reduction is best 
described by pure Michaelis-Menten formalism, indicating a single quinone binding site. 
However, our recent surface plasmon resonance study of ubiquinone-1 (Q1) binding to the 
isolated NqrA subunit provided hints for the presence of a second quinone binding site with 
lower affinity (Casutt, Nedielkov et al. 2011). Furthermore, numerous studies report 
uncompetitive inhibition of the Na+-NQR by inhibitor molecules that are supposed to 
interact with the quinone binding site (Nakayama 1999; Yoshikawa, Nakayama et al. 1999; 
Hayashi, Shibata et al. 2002). It is also noteworthy that enzyme complexes catalyzing related 
chemical reactions (bc1 complex, b6f complex, complex I) were indirectly shown to have 
quinone binding sites that can accommodate more than one quinone equivalent at a time - 
at least according inhibitor studies by HR-MAS NMR spectroscopy (Bartoschek, Johansson et 
al. 2001), according to EPR experiments (Ding, Moser et al. 1995) and when taking into 
account the locations of different inhibitors in various crystal structures (Efremov, Baradaran 
et al. 2010). 
Here we show that the NqrA subunit of the Na+-NQR binds two quinone-type ligands 
adjacent to each other in an extended binding site. 
We employed the quinone analogue and antagonist DBMIB, a well-known inhibitor of 
electron transfer complexes, to serve as a second quinone-type ligand that can easily be 
distinguished from Q1 by NMR spectroscopy. 
In the current study we provide - to our knowledge for the first time in the case of quinone 
binding enzymes - direct experimental evidence that two quinone-type molecules are 
situated in immediate vicinity to each other in the binding pocket of NqrA. This result was 
obtained by measuring interligand NOEs (ILOEs) between ubiquinone-1 and DBMIB. NOEs 
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between both molecules could, in principle, derive from several situations. If Q1 and DBMIB 
formed stable complexes in solution one would expect intermolecular NOEs, however, in the 
absence of NqrA we do not detect intermolecular NOEs. Alternatively, NOEs between Q1 and 
DBMIB could have been mediated by protons of the binding site of NqrA. Such 
intermolecular NOEs called INPHARMA effects could build-up even in a purely competitive 
binding situation (Sanchez-Pedregal, Reese et al. 2005). However, for INPHARMA effects to 
develop, the magnetization has to be 'stored' on the receptor during the ligand exchange 
process. This transfer is not possible if the experiment is carried out with a perdeuterated 
receptor and, thus, INPHARMA effect should be absent or at least strongly reduced under 
these conditions. We have performed the same experiment with protonated as well as 
perdeuterated NqrA and see no significant reduction in the intensity of the ILOE crosspeaks 
(figure 49). The only plausible interpretation is simultaneous binding of both ligands directly 
adjacent to each other within an extended quinone binding site of NqrA. 
The precise relative arrangement of both ligands in the binding site cannot be determined to 
great accuracy from the ILOEs because of the in general low signal intensity and because 
essentially all protons of Q1 show ILOEs to all protons of DBMIB with slightly varying intensity. 
According to this the most likely arrangement is a stacking interaction of both quinone 
moieties in the binding site. 
That DBMIB does not displace Q1 from the binding site in a competitive manner is 
furthermore supported by an STD NMR titration. In a competitive binding situation the STD 
effects of Q1 should decrease upon titrating in DBMIB because DBMIB would displace Q1 
from the binding site lowering the fraction bound of Q1 and, thus, lowering the amount of 
saturation transferred from NqrA to Q1. However, we observe exactly the opposite. 
Increasing the concentration of DBMIB leads to markedly increasing STD effect of Q1. In 
addition, in presence of DBMIB the ratio of STD effects of individual protons differs from the 
situation without inhibitor. This suggests that DBMIB alters the binding mode of Q1 which in 
turn leads to a more efficient saturation transfer and therefore stronger STD effects. The 
EC50 of this interaction is 26 M. 
The presence of two binding sites for quinone-type ligands is furthermore supported by 
tryptophan fluorescence quenching experiments. The fluorescence of NqrA depending on 
the concentration of added DBMIB can be fitted by a Hill-model consistent with positively 
cooperative binding of two equivalents of this inhibitor. 
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Can these results obtained with the isolated NqrA subunit be transferred to the holo-NQR 
complex? To gain insight into the physiological relevance we have performed enzyme 
inhibition experiments with the entire enzyme complex. In presence of DBMIB the rate of 
NADH oxidation (Vmax) is decreased and KM is lowered. This is characteristic of an 
uncompetitive mode of inhibition typical for multi-substrate enzymes (Voet and Voet 2004). 
That the catalytic site of NADH oxidation is not perturbed by DBMIB is indicated by the fact 
that the ratios of Vmax to KM in presence or absence of DBMIB remain constant (table 10). 
First, this confirms the notion that DBMIB disrupts the electron pathway further 
downstream, most likely at the quinone reductase site due to the structural resemblance 
with ubiquinone (figure 30). Second, this ascertains that NADH oxidase and quinone 
reductase sites of the Na+-NQR are coupled in our experimental setup and no electrons 
short-circuit to quinone at the level of the NADH oxidase. This needs to be considered since 
Q1 can serve as an artificial electron acceptor when assaying the isolated NADH 
dehydrogenase domain (Türk, Puhar et al. 2004). 
For quinone reduction we observe a mixed mode of inhibition in the presence of DBMIB as 
documented by the rates of quinol formation. 
Evaluating our experiments according to a Michaelis-Menten model yields an average 
inhibition constant of KI’ = 53.2 M, and also in a Hill model Vmax drops to 50 % at a DBMIB 
concentration of 25 M. These IC50 values are strikingly similar to the EC50 (26.1 ± 2.5 µM) 
determined in the STD NMR experiment with the NqrA subunit. Taken together, this strongly 
indicates that the interaction of the inhibitor DBMIB with the extended binding site of the 
NqrA subunit is causing the inhibition of enzymatic turnover measured with the holo-
enzyme complex. 
Recently, Juarez et al. investigated two mutations in the Na+-NQR of V. cholerae (Juárez, 
Neehaul et al. 2012) that had been discovered earlier in the Na+-NQR of V. alginolyticus. 
These mutations in subunit NqrB conferred resistance towards the antibiotic korormicin to 
V. alginolyticus (Hayashi, Shibata et al. 2002). Mutation of glycine residues G140 and G141 
located in the NqrB subunit to alanines were found to have a profound effect on enzymatic 
activity of Na+-NQR leading the authors to propose that the NqrB subunit would carry the 
site of quinone reduction (Juárez, Neehaul et al. 2012). Our current study supports our 
earlier results indicating that the NqrA subunit carries the catalytically relevant quinone 
binding site of the Na+-NQR. One should consider that long range structural perturbations 
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induced by mutations on subunit NqrB might affect the quinone binding properties of 
subunit NqrA. 
Our results suggest that holo-Na+-NQR binds two equivalents of the natural substrate 
ubiquinone Q8 with their hydrophilic head groups. We propose that these two quinones are 
central to the last electron transfer steps. In this model, two subsequent one-electron 
transfers - probably from a flavosemiquinone located on the NqrB subunit - would reduce 
ubiquinone to the ubisemiquinone and subsequently to ubiquinol which is then released by 
the enzyme. 
The presence of two quinones in the binding site could enhance the efficiency of catalysis in 
at least two ways: One quinone ligand could serve essentially as a cofactor that remains 
tightly bound to the enzyme and switches between the quinone and the semiquinone state 
while the other quinone ligand is much less tightly bound, reduced in two steps to the quinol, 
and then released from the enzyme. Alternatively, the second, low-affinity binding site could 
constitute a waiting position for the next ubiquinone substrate to enter the site of reduction 
leading to faster supply of fresh substrate and, thus, accelerated enzymatic turnover. Which 
of these mechanisms is finally operational in the Na+-NQR will be addressed in future studies. 
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The results presented in this work characterize structural and functional properties of key 
catalytic subunits of NADH:quinone oxidoreductases. Due to the elaborate nature of these 
enzyme complexes, we seek to reduce complexity to its necessary minimum, as someone 
who seeks to deduce the function of a sophisticated machine would disassemble it to its 
basic components and analyze each one of them separately and in detail. We were able to 
draw conclusions about the ion transport capabilities of subunit ND5 of complex I, about the 
structure, mechanism and silver ion inhibition of the NADH-oxidizing electron input 
component of the Na+-NQR and about its quinone-reducing electron output module, the 
subunit NqrA. Together with many excellent previous studies by various investigators, these 
findings enhance the understanding of large electrogenic, redox-type enzymes. However, 
the 'holy grail' of this type of membrane-embedded complexes, the molecular mechanism 
underlying the energetic coupling between electron transfer and ion transport, remains 
enigmatic. 
Concerning complex I, earlier theories assumed direct redox coupling where proton shuttling 
is accomplished by 2 or even 3 quinone sites (Brandt 1997; Ohnishi and Salerno 2005) or 
where the two-electron reduction of quinone is connected to the simultaneous 
unidirectional translocation of two protons and two sodium ions (Steuber 2001). In contrast, 
some studies proposed an indirect mechanism of conformational coupling involving a 
hydrophobic ramp or other means of long-range transmission elements (Brandt, Kerscher et 
al. 2003; Zickermann, Bostina et al. 2003; Hunte, Zickermann et al. 2010). The elucidation of 
the high-resolution structure (Efremov, Baradaran et al. 2010; Efremov and Sazanov 2011) 
has led to a plethora of new suggestions on how the coupling mechanism might work: In the 
current opinion, a mixed model is preferred, where at least two protons per two electrons 
are pumped through indirect coupling by the antiporter-like subunits and one or two 
protons are directly transferred by ubiquinone at the ND1/ND3/ND6/ND4L interface 
(Ohnishi, Salerno et al. 2010; Ohnishi, Nakamaru-Ogiso et al. 2010; Efremov and Sazanov 
2011; Treberg and Brand 2011). Based on mechanical coupling by the long, rod-like 
amphipathic helix of ND5, the operating mode of complex I has been compared to a steam 
engine (Efremov and Sazanov 2011) or even to a semi-automatic shotgun (Gonzalez-Halphen, 
Ghelli et al. 2011). The stoichiometry of the proton/electron ratio and the vectors of ion 
translocation remain controversial (Wikstrom 1984; Bogachev, Murtazina et al. 1996; Brandt 
1997; Mathiesen and Hägerhäll 2003; Efremov and Sazanov 2011; Roberts and Hirst 2012). 
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In particular, different models for cation/H+ transport need to be established and empirically 
scrutinized. Our study with the isolated ND5 subunit of complex I paves the way for such 
experiments, e.g. the in vitro analysis of antiporter-like subunits reconstituted into 
liposomes. 
As of now, the Na+-NQR holo-complex has been successfully crystallized (Casutt, 
Wendelspiess et al. 2010), but no high-resolution structures are yet available. Nevertheless, 
advances in recent years have determined the subunit and cofactor composition of the 
enzyme and have drawn a rough roadmap of the electron transfer pathway (Hayashi, 
Nakayama et al. 2001; Barquera, Zhou et al. 2002; Türk, Puhar et al. 2004; Juárez, Morgan et 
al. 2009; Casutt, Huber et al. 2010; Casutt, Nedielkov et al. 2011; Casutt, Schlosser et al. 
2012). Also, residues from subunits NqrB, D and E which are potentially involved in Na+ 
translocation have been identified (Juárez, Athearn et al. 2009). Figure 50 depicts a current 
working model of the complex, which integrates the findings of two adjacent quinone 
binding sites on NqrA, as investigated in the present thesis. 
 
 
Figure 50: Current working model of the Na+-NQR from Vibrio cholerae. The likely flow of 
electrons between cofactors is indicated by arrows. Flavin cofactors are colored yellow.  
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The energetic coupling between redox reaction and Na+ translocation in the Na+-NQR is still 
a black box. In analogy to complex I, direct (Rich, Meunier et al. 1995) and indirect (Bogachev 
and Verkhovsky 2005) coupling mechanisms are proposed. However, direct redox coupling 
would require an additional one-electron cofactor, since none of the known cofactors 
exhibits a midpoint potential Em,7.5 corresponding to the redox dependency of Na
+ binding 
(Bogachev, Bertsova et al. 2007). Such a cofactor could not be found to date (Bogachev, Kulik 
et al. 2009) but cannot be excluded. Evidence exists for long-range indirect coupling effects, 
such as correlation of Na+ translocation with the [2Fe-2S] cluster (Bogachev, Bloch et al. 
2009), with the FMNs on NqrB and NqrC and with riboflavin (Juárez, Morgan et al. 2009). A 
mechanism operating by conformational changes at multiple sites in the complex is 
proposed (Juárez and Barquera 2012). These results are derived from de-energized and 
detergent-solubilized Na+-NQR, which may be misleading. A more native and promising 
approach might be to analyze energetic coupling in phospholipid bilayers such as nanodiscs 
(Ritchie, Grinkova et al. 2009), which allow the direct application of a ΔμNa+. In addition, 
structure-function analysis of the hydrophobic subunits NqrB, C, D and E as well as high-
resolution structures of the holo-complex could provide evidence for solving the coupling 
mechanism or could at the very least shed some light on this black box of energy conversion 
machinery. 
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Contributions by collaborating authors 
Chapter 1: 
Figure 3 and the data depicted in table 3 were generated by Marco Casutt. 
 
Chapter 2:  
Figures 16 - 18 were generated in collaboration with Hanna Grönheim. 
Analyses with electron microscopy as depicted in figure 19 were performed by 
Manikandan Karuppasamy and Christiane Schaffitzel.  
The data depicted in figure 21 was generated by Hanna Grönheim. 
 
Chapter 3: 
The construction of plasmids pNQR378A, pNQR406A and pNQR406S used throughout 
chapter 3 was performed in collaboration with Valentin Muras. 
The protein crystals used to generate the results in chapter 3.3.2. were produced by and X-
ray data collected by Marco Casutt and Günter Fritz. 
The data depicted in figures 34, 37 and 38 were provided by Günter Fritz. 
Data depicted in figure 36 and table 7 were generated in collaboration with Valentin Muras. 
Analyses by NMR spectroscopy as depicted in figures 47 - 49 and table 14 were performed 
by Ruslan Nedielkov and Heiko Möller. 
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Abbreviations 
ACN  Acetonitrile 
DAPI   4', 6-Diamidino-2-phenylindol 
DBMIB  2,5-Dibromo-3-methyl-6-isopropyl-p-benzoquinone 
Dpms  Dolichol phosphate mannose synthase 
EIPA  5'-(N-ethyl-N-isopropyl)amiloride 
ER  Endoplasmatic reticulum 
GFP  Green fluorescent protein 
FAD  Flavin adenine dinucleotide 
Fe-S  Iron-sulfur 
FMN  Flavin mononucleotide 
FNR  Ferredoxin:NADP+ oxidoreductase 
HQNO  2-n-heptyl-4-hydroxyquinoline N-oxide 
ILOE  Interligand Overhauser effects 
IPTG  Isopropylthio-β-D-galactoside 
LDAO  Lauryl dimethylamine oxide 
LHON  Leber's hereditary optic neuropathy 
MELAS  Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke 
MERRF Myoclonic epilepsy with ragged red fiber 
MTS  Mitochondrial targeting sequence 
Na+-NQR Sodium ion translocating NADH:quinone oxidoreductase 
OXPHOS Oxidative phosphorylation 
PD  Parkinson's disease 
PEG MME Polyethylene glycol monomethyl ether 
PMF  Proton motive force 
Q  Ubiquinone 
QH2  Ubiquinol 
STD  Saturation transfer difference 
TMH   Transmembrane helix 
YNB  Yeast nitrogen base 
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